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ABSTRACT
STUDIES OF DIETARY COPPER ON ZINC-BINDING TO OVINE
ALPHA 2-MACROGLOBU LIN 
A hypothesis was proposed that dietary copper level 
influences the Zn-binding to alpha 2-macroglobulin 
(alpha2-M) in ovine plasma and is dependent on the ratio 
of dietary concentrations of Cu and Zn.
Sheep plasma alpha2-M was purified and was used in 
raising antiserum in rabbits for use in immunoadsorbent 
chromatography (IAC).
Alpha2-M showed a high capacity for Zn-binding and the 
relationship between Zn and alpha2-M was linear, in the 
absence of copper.
Incubation of alpha2-M with various Cu concentrations for 
varying periods showed on PAGE that Zn-binding was 
related to Cu concentration and to the period of 
incubation with alpha2-M. Zn-binding was significantly 
(P<0.001) less after alpha2-M was incubated with Cu for 
24 hours. This strongly indicated that Cu and Zn were 
probably competing for the same sites on alpha2-M.
Zn-binding to alpha2-M was studied at two levels (150 and 
1500 p.g Zn) of Zn incubation. In Cu-deficient sheep, 
plasma alpha2-M showed significantly (P<0.001) increased
( iii )
Zn-binding. Whereas, in high-Cu diet fed sheep plasma 
alpha2-M showed significantly (P<0.001) decreased 
Zn-binding. The differences in Zn-binding in Cu-deficient 
and high-Cu sheep at both levels of Zn indicated the 
existence of different Zn-binding sites on alpha2-M.
During the study of Zn-binding in vivo to alpha2-M, the 
method also showed Zn-bound to the major Zn-binding 
protein in plasma, albumin. These studies showed a shift 
in Zn-binding towards alpha2-M in Cu-deficient sheep 
plasma, which was absent in high-Cu sheep.
The in vitro results were confirmed by further studies on 
Zn-binding in sheep fed Cu-deficient and high-Cu diets. 
Analysis of purified alpha2-M from the plasma of sheep 
fed the Cu-deficient diet showed higher Zn and no Cu. 
Whereas, alpha2-M from the plasma of sheep fed high-Cu 
diet showed presence of Cu but less Zn than Cu-deficient 
alpha2-M. Thus these results confirmed the observations 
of the in vitro influence of Cu and showed further 
evidence that Cu competes with Zn for binding sites on 
alpha2-M. These results also indicated two types of 
binding sites differing in their Zn-binding affinity.
The results from three breeds of pregnant ewes maintained 
indoors on a variable Cu,Zn diet in the ratio 1:4, 






The essential metabolic role of dietary copper and its 
importance in animal nutrition has been the subject of 
considerable research, but inspite of this many 
nutritional and clinical problems remain to be solved. 
Similarly biochemical interactions between Cu and Zn have 
also been recognized but the significance and mechanisms 
of these interactions is unclear. It is beyond the scope 
of this thesis to review all the studies; hence,an 
attempt has been made to review the essential requirement 
of Cu and Zn in the nutrition of sheep and the 
interrelationships between these two metals. This was 
followed by a review of human plasma alpha2-macroglobulin 
(alpha2-M) a Zn-binding protein. Host of the studies were 
carried out in human plasma alpha2-M and not many studies 
are reported on ovine alpha2-M. Alpha2-M is reviewed as a 
Zn-binding protein and the role of zinc transport by 
alpha2-M is highlighted. At the end of the review the 
need for the proposed dietary influence of Cu on 
Zn-binding to sheep plasma alpha2-M is established.
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ALPHA2-MACROGLOBULIN(ALPHA2-M)
This is a high molecular weight plasma glycoprotein and 
has been known as an inhibitor of several serine 
proteinases. It seems that Jacobsson (1953, 1955) was 
amongst the first to recognize the importance of this 
protein and Brown et al (1954) characterized it according 
to its carbohydrate content of 8.4 per cent. Schultze and 
colleagues first isolated alpha2-M from human serum in 
1955, but for a long time its biological function 
remained obscure.
In animals studies on alpha2-macroglobulins have mainly 
concentrated on the isolation of this protein from the 
plasma of a variety of species: dog (Ohlsson, 1971), 
rabbit (Picard and Heremans, 1963; Got et al, 1965; 
Lebreton de Vonne and Mouray, 1968), mouse (Greene et al, 
1971), pig (Jacquot-Armand and Guinard, 1967; Tsuru et 
al, 1975), horse (Pepper, 1968; Lavergne and Raynaud, 
1970), rat (Ganrot, 1973); cow (Nagasawa et al, 1970) and 
hedge hog (Picard et al, 1966). None of these reports 
attempted to study the binding properties of alpha2-M, 
and somewhat surprising no reports have been found on 
alpha2-M in sheep with exception of the studies of 
allotypes of alpha2-M (Curtain, 1971). The large amount 
of work done, mainly in human serum, has been reviewed by 
Steinbuch (1971), Heimburger et al (1971), Bourrillon and 
Razafimahaleo (1972), Barrett and Starkey (1973), Laurel1
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and Jeppson (1975), Harpel (1976), Starkey and Barrett 
(1977) and Barrett (1981) and is summarised below.
COMPOSITION. STRUCTURE AND PROPERTIES OF.HUMAN 
ALPHA2“MACROGLOBULIN
The amino acid composition of alpha2~M has been 
determined (Bourrillon and Rasafimahaleo, 1972; Hamberg 
et al, 1973; Heimburger et al, 1964; Dunn and Spiro, 
1967; Demaille et al, 1970) and a variable number of 
terminal NH2 groups have been described. Schultze (1960) 
identified aminoterminal serine, valine, and aspartic 
acid, and later Razafimahaleo et al (1969) showed 
additional amino acids, glutamic acid, alanine and 
glycine.
A variety of molecular weight for human alpha2-M have 
been reported ranging from 650,000 by Saunders et al 
(1971) to 840,000 by Parisi and Vallee (1970), 
Schonenberger et al (1968) and Dunn and Spiro (1967). 
Other workers agree on 725,000 daltons (Jones et al, 
1972; Barrett and Starkey, 1973 and Roberts et al, 1974). 
The probable explanation for these different values is 
differences in technique.
The structure of the alpha2-M molecule has been 
investigated by several investigators (Isliker, 1958; 
Schonenberger*tal968; Poulik, 1960; Schultze et al, 1962; 
Gentou, 1968; Razafimahaleo et al, 1969; Frenoy et al,
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1972; Jones et al, 1972; Harpel, 1973; Roberts et al, 
1974; Barrett et al, 1979). The alpha2-M molecule is a 
tetramer of identical subunits linked in pairs by 
disulphide bonds, the two half molecules are joined by 
non-covalent bonds but there is no agreement as to its 
subunit structure (Gentou, 1968; Barrett et al, 1979).
Alpha2-M has the unique property of inhibiting 
proteinases specifically. Barrett and Starkey (1973) have 
proposed a molecular mechanism for this interaction and 
described three important aspects of it: (1) Many
proteinases interact with alpha2-M and as they represent 
all four classes of these enzymes (Hartley, 1960) they 
differ widely in catalytic mechanism and specificity. (2) 
The inhibition of proteinase by alpha2-M is accompanied 
by binding to alpha2-M. Barrett and Starkey (1973) 
postulated that binding is irreversible, which is the 
most important aspect of the interaction with alpha2-M 
and that the inhibition was a secondary result of 
binding. (3)In the presence of alpha2-M, the reactivity 
of a proteinase with high-molecular-weight substrates and 
inhibitors typically is decreased to a much greater 
degree than that with low-molecular-weight compounds. 
This aspect of the interaction is particularly relevant 
to the 'trap* hypothesis of interaction of alpha2-M with 
proteinases.
In the ’trap’ hypothesis, Barrett and Starkey (1973)
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proposed that the binding of an enzyme by alpha2-M was a 
two stage process. The first stage consisted of 
proteolytic attack by the enzyme on alpha2-M molecule, 
which has a region (the 'bait* region) susceptible to 
limited proteolysis(Barrett, 1981; Van Leuven, 1982) and 
resulting in peptide bond cleavage. In the second stage, 
a conformational change occurs such that the enzyme 
molecule is irreversibly trapped within the alpha2-M 
molecule. The inhibition of enzyme activity was suggested 
to be the result of steric hindrance of access of 
substrates to the enzyme in its enclosed environment.
Evidence for conformational change was briefly reported 
by Morelis et al (1969) for the trypsin-rabbit alpha2-M 
reaction. This was extended to human and porcine alpha2-M 
by Barrett et al (1974) and they obtained electron 
micrographs which clearly demonstrated the change in 
shape on binding of a proteinase to alpha2-M. Barrett et 
al (1979) also attributed the change in electrophoretic 
mobility of alpha2-M after treatment with ammonium salts 
to conformational change.
There is evidence by Barrett et al (1979) to show that 
changes in electrophoretic mobility of alpha2-M could 
occur after treatment with ammonium salts.
Alpha2-M may dissociate into half molecules but there is 
confusion among the reported observations on alpha2-M
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dissociation. Schonenberger et al (1968) showed that 
alpha2-M dissociates into half molecules in 5M urea, 
whereas Jones et al (1972) found that although half 
molecules formed in 3M urea, the dimeric subunits tended 
to aggregate spontaneously, unless thiol groups were 
alkylated. In contrast to the above reports, McConnell 
and Loeb (1974) were able to remove the urea without
reassociation or aggregation of fragments, by dialysis 
and gel filtration chromatography. Alpha2-M also 
dissociated into half molecules after treatment with 
dodecyl sulphate under non reducing conditions (Harpel, 
1973).
Alpha2-M may be inactivated by temperature changes. Abe 
and Nagai (1972) reported inactivation of alpha2-M by 
repeated freezing and thawing which possibly caused
dissociation. However, Gentou (1968) reported that 
freezing and thawing caused dissociation which was 
reversed during 30 minutes at 20° C. Later Harpel (1973) 
confirmed the observations of Gentou (1968). Loss of 
functional activity could be caused by repeated freezing 
and thawing at warmer temperatures, but quick freeze in 
dry ice and acetone mixture and storage at -70° C
preserved the enzyme binding activity of alpha2-M for at
least one year (Steinbuch et al, 1968; Harpel, 1976).
Barrett et al (1979) found using gel electrophoresis that 
native alpha2-M has two readily distinguishable forms.
The plasma which is capable of binding, proteinases was 
called the electrophoretically ’slow* S-form and this 
could be converted to the electrophoretically ’fast’ 
F-form after treating with either ammonium sulphate or 
methylammonium chloride. There is no evidence to date of 
the reverse change from F to S-form. They observed that 
freshly isolated alpha2-M ran as a single zone of low 
mobility in pore-limit electrophoresis and in rate 
electrophoresis. The observations by Barrett et al (1979) 
a gradual change of the S-form into the F-form with the 
appearance of transitional forms of intermediate 
mobility, after storage between -200C and 4°C in various 
buffers (pH 5-6.5) may explain the 5 bands of human 
alpha2-M reported by Saunders et al (1971) and the 
doublet in human alpha2-M seen by Zais and Roberts 
(1977).
Isoelectric focusing of alpha2-M has been reported by 
several workers. Four molecular forms were reported by 
Frenoy and Bourrillon (1974) and Barrett et al (1979) 
using a pH gradient of 4-6. Ohlsson and Skude (1976) 
reported a change in pi of alpha2-M from 5 to 6 
associated with the complexing of a proteinase but were 
unable to confirm this when they electrofocused an equal 
mixtures of inactivated S-alpha2-M and F-alpha2-M. Both 
forms were in the same fractions at pH 5.2.
Alpha2-M exhibits affinity of a hydrophobic type as seen
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by binding to endotoxin (Yoshoko and Konno, 1970), 
phenyl-Sepharose, liposomes (Black and Gregoriadis (1976) 
and various cell membranes (Nachman and Harpel, 1976). 
There is no evidence to show that F or S alpha2-M differ 
in hydrophobic properties. However, it is not clear 
whether this has any part to play in the rapid clearance 
of F-alpha2-M from the circulation (Ohlsson, 1971), or 
whether there is any binding difference between the S and 
F-forms of alpha2-M.
Immunological studies showed a relationship between human 
alpha2-M and a component of animal sera (James, 1965; 
Butler and Brunner, 1967). In these studies, rabbit 
anti-human serum, adsorbed with sera in the monkey, goat, 
sheep, cow, donkey, zebra, dog, cat, pig and guinea pig 
(James, 1965); sera from sheep and rhesus monkey 
exhibited strong cross reaction with human alpha2-M.
Although alpha2-M was characterized in 1955 by Schultze 
and his coworkers, it was not until 1970 that Parisi and 
Vallee were able to characterize human alpha2-M as a zinc 
metalloprotein. They showed that alpha2-M accounts for 30 
to 40% of the total zinc content of serum or plasma, with 
the remaining 60-70% associated with albumin (Vikbladh, 
1951; Vessel and Bearn, 1957). Zinc is firmly bound to 
alpha2-M in plasma (Adham et al, 1977). The implications 
of this distribution of zinc could have significance in 
several disease conditions (Vallee, 1959; Parisi and
Vallee, 1969).
A number of factors may influence the concentration of 
circulating alpha2-M. In children, there is 2.5 times as 
much alpha2-M as in adults (160 mg/100 ml) (Ganrot and 
Shersten, 1967). There is no agreement on the 
concentration levels of alpha2-M in serum of adults, but 
the range in males is from 150-370 mg/100 ml serum and in 
females from 265-460 mg/100 ml serum (James et al,
1966a). The suggestion that females have higher levels of 
alpha2-M than males (Ganrot and Schersten, 1967; James et 
al, 1966; Housley, 1968); was not confirmed by Adham et 
al (1968). Increases in alpha2-M concentration have been 
observed in pregnancy (Horne et al, 1970; Ganrot and 
Bjerre, 1967). Ganrot and Bjerre (1967) reported that in 
early pregnancy alpha2-M concentration in serum reached a 
steady state of about 20% higher than before pregnancy 
and was maintained at that level for some days after 
parturition.
Elevated alpha2-M values have also been recorded in the 
following disease states: systemic lupus erythromatosus 
(Norberg et al, 1970); hypogammaglobulinemia (Norberg et 
al, 1970; James et al, 1966a), ataxia telangiectasia , 
atopic dermatitis mangolism (James et al, 1966a); 
nephrotic syndrome (Housely, 1968; Peterkofsky et al, 
1956; Hartman et al, 1958; Schultze and Schwick, 1959;
Steines and Mehl, 1966); pulmonary disorders, diabetes 
mellitus and agammaglobulinemia (James et al, 1966a) and 
in patients with liver disease (Housely, 1968; Damus and 
Wallace, 1975). Virji et al (1985) demonstrated the 
effective use of alpha2-M as a diagnostic tool in 
differentiating bacterial and aseptic meningitis. They 
observed the mean cerebrospinal fluid (CSF) concentration 
of alpha2-M was 15 times higher in the bacterial 
meningitis group.
PURIFICATION OF HUMAN ALPHA 2-MACROGLOBULIN 
Alpha2-M is precipitated by ammonium sulphate in the 
range of 1.6 - 1.92 M, at pH 6 (Bourrillon and
Razafimahaleo, 1972). However, Mehl et al (1964) pointed 
out the risk of inactivation of alpha2-M by ammonia 
during fractionation with ammonium sulphate and this was 
later re-emphasized by the observation of Heimburger et 
al (1971) that the inactivation occurs at pH 8 but not at 
pH 5. However, Hamberg et al (1973) and Tsuru et al 
(1975) successfully used ammonium sulphate for the 
fractionation of human alpha2-M. Harpel (1973) and Giroux 
(1975) used polyethylene glycol and showed complete 
precipitation at 4-12% and 10% respectively. Sucrose 
density gradient centrifugation of human serum proteins 
also yielded pure alpha2-M (Song and Adham, 1979). 
Preparative isoelectric focusing in the range of pH 4-6 
has been used in the purification of alpha2-M by Green et 
al (1971), Berne et al (1972), Hamberg et al (1973) and
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Frenoy and Bourrillon (1974).
Lipoproteins may be removed by precipitation with 0.4% 
Rivanol (6, 9-diamino-2-ethoxyacridine lactate) (Barrett 
and Starkey, 1973; Song et al, 1975), by precipitation 
with dextran sulphate, Ca2+ or Mn2 + (Frenoy et al, 1972; 
Barrett and Starkey, 1973), or by ultracentrifugation 
(Havel et al, 1955) effectively.
THe high molecular weight of alpha2-M proved advantageous 
in purification step, because of its total exclusion from 
Sephadex 6*200 (Pharmacia) and near exclusion from 
Sepharose 6B (Pharmacia). Starkey and Barrett (1977) 
obtained best results from Ultrogel ACA22 (LKB 
Instruments Ltd.).
Immunoglobulins have been removed by anion exchange 
chromatography (Steinbuch et al, 1965; Jones et al, 1972; 
Harpel, 1973) and preparative electrophoresis (Bloth et 
al, 1968; Harpel, 1973; and Hamberg et al, 1973).
In general, there is always a risk of contamination by 
haptoglobin during purification and this can be solved by 
using haptoglobin type 1-1 plasma or by adsorption on to 
haemoglobin covalently linked to Sepharose 4B (Starkey 
and Barrett, 1973).
The discovery by Porath et al (1975) that chelate forming
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ligands for metal ions (Cu, Zn, Cd, Hg, Co and Ni) could 
be attached to agarose derivatives has provided the basis 
for the purification of alpha2-M. Zinc chelate affinity 
chromatography has been used by several workers
(Lebreton, 1977; Kurecki et al, 1979; Sottrup-Jensen, 
1980; Sinosich, 1984).
The methods described so far used large quantities of 
plasma or serum (200-500 ml) gave yields of less than 40 
per cent and were not convenient for individual samples. 
Virca et al (1978) described a simple method combining 
gel filtration and affinity chromatography on Cibacron
Blue Sepharose, in which recovery of alpha2-M was 75 
percent. This was further modified by Bridges et al
(1982) giving a recovery of 98 per cent pure alpha2-M
from as little as 5 ml plasma. This method is applicable 
to all plasma samples regardless of haptoglobin type. 
Immunoadsorbent chromatography method (McEntire, 1978) 
utilizing rabbit antihuman alpha2-M conjugated Sepharose 
4B also offered a rapid, simple and inexpensive method 
for purifying alpha2-M from as little as 2 ml of plasma 
or serum.
The above review of alpha2-M has shown in particular it 
relates entirely to human alpha2-M and very few studies 
are reported in ovine species.
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ASSAY AND DETECTION OF ALPHA2-M
Trypsin binding activity was originally used for the 
assay of alpha2-M (Haverbaci et al, 1962); Mehl et al, 
1964; Ganrot, 1966). However, because of the two readily 
distiguishable forms of alpka2-M in gel electrophoresis 
(Barrett et al, 1979) determination of total alpha2-M is 
best quantified immunologically. The total concentration 
of alpha2-M in solution has been determined by radial 
immunodiffusion (Barrett and Starkey, 1973) and 'rocket* 
Immunoelectrophoresis (Weeke, 1973); using a reference 
serum of known alpha2-M concentration.
Barrett (1981) reported a better procedure which depends 
upon the inhibition of thermolysin activity on dyed hide 
powder. Hide thermolysin is rather selective, being 
inhibited by few other proteins. The substrate used, hide 
powder, is of such a large particle size that the steric 
inhibition by alpha2-M was complete (Barrett et al, 1979; 
Rinderknecht et al, 1975).
13
ESSENTIAL REQUIREMENT FOR COPPER
McHargue (1926) first suggested that copper was an 
essential requirement in the diet of rats. But conclusive 
evidence of the biological requirement for copper, was 
offered by Hart et al (1928), working with anaemic 
milk-fed rats. They reported that the anaemia was not 
corrected by iron supplementation alone, or by a liver 
extract alone, but by feeding iron and liver extract 
together they observed a marked increase in the 
haemoglobin and packed cell volume, within two weeks. A 
bluish tinge of the ashed preparation was a clue to its 
copper content and later this important discovery was 
confirmed and extended to other species.
Host mammals consume diets containing copper in excess of 
minimum daily requirements (Schroeder et al, 1966). The 
first indication of copper deficiency occuring naturally 
were reported in live stock in the 1930s (Neal et al, 
1931; Sjollema, 1933 & 1938). Bennetts and Chapman (1937) 
also reported that enzootic ataxia (swayback) was a 
manifestation of inadequate intake of copper.
Anaemia was shown as a common expression of copper 
deficiency (Beck, 1941a & b). The copper deficiency was 
characterised by a slow reduction in body copper stores, 
including a fall in the copper concentration in plasma 
until the concentration was below the normal level
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required to maintain a normal rate of haematopoiesis. 
Beck (1941) and Marston et al (1948) showed that levels 
below 0.12 p.g Cu/ml plasma limit blood formation in 
sheep.
A number of disorders have been associated with copper 
deficiency or with response to copper therapy. They 
include depressed growth, bone disorders, depigmentation 
of hair and wool, abnormal wool growth, neonatal ataxia, 
impaired reproductive performance, heart failure, 
cardiovascular defects and gasterointestinal
disturbances. The degree of disorder due to copper 
deficiency varies with the species and the stage of 
maturity of the animal (Underwood, 1971).
Copper is the prosthetic element of several enzymes which 
are essential for mammalian life. Any deficiency of the 
metal may lead to clinical abnormalities (Sternlieb, 
1980; Committee on Medical and Biologic Effects of 
Environmental Pollutants, 1977). Schultze (1939) showed 
greatly decreased cytochrome oxidase activity of liver 
and the ventricles of copper deficient rats. Later 
studies by Labbe and Fischer (1984a & b) in rats observed 
reduced activity of serum ceruloplasmin, liver and heart 
superoxide dismutase and heart cytochrome c oxidase. 
Similarly, Saylor and Leach (1980) reported a lower 
ceruloplasmin activity and lower direct reacting copper 
concentrations in the plasma of lambs fed on copper
15
deficient diet when compared with control lambs during a 
period of 120 days.
ESSENTIAL ROLE OF ZINC
The first indication that zinc has a function in higher 
animals was published by Birckner (1919). Attempts to 
experimentally demonstrate such a function using 
semipurified diets met with limited success (Bertrand and 
Benson, 1922; Hubbell and Mendel, 1927; McHargue, 1926), 
until Todd, Elvehjem and Hart (1934) produced the first 
indisputable evidence for zinc as a dietary essential for 
the rat. 20 years later, Tucker and Salmon (1955) made 
the important discovery that zinc cures and prevents 
parakeratosis in pigs. Various investigations reported 
growth retardation and testicular atrophy as a result of 
experimentally induced zinc deficiency in animal species 
such as rats (Follis et al, 1941; Todd et al, 1934), 
calves (Miller and Miller, 1960), lambs (Ott et al , 
1964; Mills et al, 1967; Pierson, 1966; Underwood and 
Somers, 1969) and dogs (Robertson and Burns, 1963).
Zinc is present in the plasma and in erythrocytes, 
leucocytes and platelets. About two thirds of the plasma 
zinc is loosely associated with albumin and the remainder 
is more firmly bound to globulins (Prasad and Oberleas, 
1970 & Prasad, 1976). A small percentage of zinc has been 
shown to be ultrafilterable. In vitro studies indicated 
that zinc could combine with transferrin (Surgenor et al,
16
1949; Boyett and Sullivan, 1970; Scott and Bradwell, 
1983). The whole of the zinc in erythrocytes is bound to 
carbonic anhydrase (Hove et al, 1940).
Mills et al (1967) showed a rapid fall in plasma zinc 
concentration in lambs and calves after 36 hours which 
continued to decrease to less than half the control 
values within a week when fed diets contained less than 1 
mg Zis/kg of diet. They concluded from their studies that 
ruminants had a capacity of converting tissue stored 
zinc to the mobilized form in the plasma, thus explaining 
the rapid fall in plasma zinc when dietary zinc 
deficiency was practised.
Abundant evidence has accrued to show that zinc is 
involved in protein synthesis, nucleic, amino acid and 
carbohydrate metabolism, bone formation and many other 
essential metabolic processes in most mammals (Li, 1966; 
Matrone, 1970; Miller, 1970; Mills, 1990; Nelsen et al, 
1970; Parisi and Vallee, 1970; Somers and Underwood, 
1969; Underwood, 1962). Consequently as would be expected 
many pathological effects resulting from dietary zinc 
deficiency and dietary zinc excess have been observed in 
ruminants (Miller, 1970; Mills et al, 1969; Prasad, 1966; 
Underwood, 1962; Rao, 1977, Parry and Rao, 1975, 1977,
1981; Parry et al, 1984). Unfortunately few of these 
conditions have been fully understood with regard to 
their biochemical mechanisms; thus nutritional control or
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an avoidance of an imbalance is still not practical.
DIETARY REQUIREMENTS OF COPPER AND ZINC
The recommended copper requirements for sheep is 5 mg 
Cu/kg dry diet and the toxic level is 8-25 mg Cu/kg, 
while the recommended requirement for zinc is 35-50 mg 
Zn/kg diet and the toxic level is 1000 mg Zn/kg diet (The 
Nutrient Requirements of Ruminant Livestock, 1980). 
However, ambiguity does arise in the optimum level of 
dietary copper required to produce symptoms of copper 
toxicity in sheep and the form in which it is available 
is an important consideration (Todd and Thompson, 1963; 
Todd et al, 1962).
DIETARY RATIOS OF COPPER AND ZINC
Much has been published on the essential role of copper 
and zinc as individual nutrients in mammalian metabolism; 
whilst considering these elements as a nutritional ratio 
has received less attention (Bremner and Marshall, 1974a 
& b; Klevay, 1977; Taper et al, 1980; Parry and 
Al-Mukhtar, 1980; Parry et al, 1984).
An example of how the ratio of Cu to Zn can become 
important can be illustrated by the work of Klevay 
(1975c). His work has developed a hypothesis based on the 
ratio of Cu to Zn (Klevay, 1973, 1974a-c, 1975a-c,
1976a-c, Klevay and Forbush, 1976; Klevay et al, 1975,
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1976). This hypothesis states that a "metabolic imbalance 
in regard to sine and copper is a major factor" in the 
etiology of ischaemic heart disease. This metabolic 
imbalance is "either a relative or an absolute deficiency 
of copper characterized by a high ratio of zinc to 
copper". Klevay’s studies in rats produced evidence that 
the effect on cholesterol metabolism was produced by an 
alteration in the ratio of zinc to copper and not by 
other dietary component closely associated with copper or 
zinc. In a similar experiment, Looney et al (1977) found 
that dietary high zinc and low copper produced greater 
hypercholesterolemia in rats than a diet low in copper.
Again, work by Parry and Rao (1981) showed in rabbits 
that the ratio of Zn to Cu was important in the level of 
rabbit plasma cholesterol; they related the concentration 
of plasma cholesterol to the ratio rather than to an 
individual element. It is now becoming far more important 
to consider these two elements together especially in 
association with a molecule such as alpha2-M.
DIETARY EXCESS OF COPPER AND ZINC. COMPETITION BETWEEN 
COPPER AND ZINC AND ANTAGONISM BETWEEN COPPER AND ZINC 
There are numerous examples of metabolic disorders 
resulting from inadequate supply and excess of both zinc 
and copper (Marston and Lee, 1948; Marston et al, 1948; 
Lafanetre et al, 1935; Todd and Thompson, 1963; Todd et 
al, 1962; Todd, 1969; Ishmael et al, 1971 and 1972;
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Saylor et al, 1980; Labbe and Fischer, 1984a & b).
However, much research needs to be done on the 
elucidation of the biochemistry of these disorders.
There are fewer reports on high dietary sine than studies 
on dietary zinc deficiency because the clinical symptoms 
of deficiency have been more easily observed and defined.
The antagonism between Zn and Cu was studied in rats by 
Sutton and Nelson (1937) and Smith and Larson (1946) who 
showed that high dietary zinc (between 5000 - 10000 mg 
Zn/kg of diet) produced anaemia as a result of induced 
copper deficiency (Van Reen, 1966). Smith and Larson 
(1946) further showed that copper supplementation reduces 
anaemia in rats. Thus confirming the importance of Cu for 
haemoglobin formation (Hart et al, 1928).
In a series of experiments Van Reen and Pearson (1953) 
and Van Reen (1953) showed that a dietary level of 5000 
to 7000 mg Zn/kg of diet administered to rats as zinc 
carbonate resulted in a marked reduction in liver 
catalase and cytochrome oxidase activities. However, when 
dietary copper was supplemented with the high zinc diets, 
an increase in liver catalase and cytochrome oxidase 
activities occured until they returned to normal values. 
In these later studies, while copper supplementation 
influenced the activities of liver enzymes, it had no 
effect in correcting the growth inhibition produced by
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the high dietary sine levels. Thus, this is in evidence 
where the antagonism effects between Zn and Cu worked on 
biochemical mechanisms in opposite directions.
Zinc has been shown to be a dietary essential to maintain 
normal growth and performance (Ott et al, 1964). However, 
they reported certain differences from those of rats when 
high dietary zinc was fed to lambs and cattle. They 
observed subnormal liver copper levels and the anaemia 
was much less pronounced than rats and the iron 
concentration of the liver increased in lambs and cattle 
(Ott et al, 1966a & b). Contrary to the reports by
Sadasivan (1951a, b & 1952) observing defective
development and demineralisation of bone in zinc-toxic 
rats, Ott et al (1966a & b) produced evidence showing 
depressed feed consumption, reduced gain, decreased feed 
efficiency and increased mineral consumption as a result 
of high zinc diets. Prolonged consumption of high levels 
of zinc can however cause death. Furthermore,the lambs 
refused to eat the basal diet supplemented with 4000 mg 
Zn/kg diet, this suggested that the high concentration of 
zinc in the diet could effect the palatability.
Sheep are very sensitive to excess copper. The 
biochemical reasoning for this is not clear but it is 
becoming obvious that zinc and a binding protein such as 
alpha2-M might have been promising parameters to measure 
in previous publications. Excessive copper accumulation
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appears to be one of the hazards when sheep are 
maintained indoors for prolonged periods (Todd, 1969) or 
grazing pastures with high copper content. Contamination 
of feeds with copper compounds from horticultural sources 
has been the cause of excess copper intake. Losses of 
sheep from dietary excess of copper, with haemolysis, 
icterus and haemoglobinuria as characteristic signs, have 
been reported from many parts of the world (Lafenetre et 
al, 1935; Gracey and Todd, 1960). In some cases the 
excess copper has come from the ingestion of herbage in 
orchards and vineyards previously sprayed with copper 
compounds (Lafenetre et al, 1935).
Rats appeared to be extremely tolerant of high copper 
intakes. Normal growth and health was maintained on diets 
containing 500 mg Cu/kg of diet, which was 100 times the 
normal concentration of the diet, despite a fourteen 
fould increase in liver copper (Boyden et al, 1938).
It has been demonstrated that excessive copper 
concentrations are toxic to sheep (National Research 
Council, 1977; Mahoney et al, 1955; Bremner, 1974; 
Ishmael et al, 1971; Gopinath et al, 1974; Todd and 
Thompson, 1963; Todd et al, 1962), to ruminants (Todd, 
1969; National Research Council, 1977; Bremner, 1974; 
Shand and Lewis, 1957; Weiss and Baur, 1968). The copper 
accumulates primarily in liver, where the storage 
capacity varies with the species (Sternlieb, 1980). In
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sheep, the phase of copper accumulation or the 
prehaemolytic phase may take place over a period of 6 to 
10 weeks or longer. During this time liver copper levels 
increase (on a dry weight basis) gradually from a normal 
range of 6 to 279 mg Cu/kg weight of liver,to a range of 
1000 to 3000 mg Cu/kg weight of liver (McCosker, 1968). 
However, the whole blood copper concentration remains 
within normal limits of 70 to 120 pg Cu/100 ml blood for 
the first half of the prehaemolytic period. During the 
second half of the prehaemolytic period concentration of 
copper attains twice their normal value and then suddenly 
increases by 8 to 10 times the normal value coinciding 
with the haemolytic crisis. During the same period a rise 
in serum glutamic oxalacetic transaminase (SGOT) values 
have been observed (Thompson and Todd, 1974).
An early clinical symptom of copper toxicity in sheep 
during the prehaemolytic period is gradual loss in 
weight. Luke and Marquering (1972) showed that 100 p g Cu 
increase per kg liver results in an 8.5 g loss in daily 
weight gain.
It has become apparent in recent years that when sheep 
are kept indoors for extended periods, chronic copper 
poisoning is one of the possible hazards. Evidence to 
this effect was produced by Bracewell (1958), who showed 
24 out of 720 ewes housed for periods of upto 16 months, 
died of haemolytic jaundice. A mineral supplement
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containing 43 mg Cu/kg of diet Has fed for the first & 
months, but at this point first cases of copper poisoning 
occured and the supplement was withdrawn thereafter. 
Despite this, further cases appeared during the following 
11 months. This was also observed by Senior (1959). 
However, Hemmingway and MacPherson (1967) pointed out 
that the possibility of copper poisoning is not great 
under normal feeding system, with no supplementary copper 
added to the diet of lambs. They stressed the existence 
of great variability between individual animals in their 
ability to accumulate copper, but stress could 
precipitate the toxic syndrome.
Studies by van der Berg et al (1983) showed significant 
increases in copper accumulation in the livers of four 
breeds of sheep fed on high copper diet (35 mg Cu/kg of 
diet). Though the copper level of diet given to the sheep 
was the same, copper accumulation in the four breeds 
varied.
Cases of chronic copper poisoning occurred in sheep where 
excessive copper intakes in the feed could not be 
demonstrated, which led to the investigation of other 
factors involved. There is evidence to show a 
relationship between feed protein intake and copper 
accumulation in the liver. McCall et al (1961) reported 
that symptoms of toxicity, after feeding 750 mg Cu/kg 
diet, decreased after raising the concentration of
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protein in the diet. McCall and Davis (1961) observed no 
significant increase in liver copper in rats fed 1000 mg 
Cu/kg diet when protein intake was increased by 25%; with 
only 10% protein intake there was a highly significant 
increase in liver copper accumulation. Similarly, 
MacPherson and Hemingway (1965) observed no accumulation 
of copper in livers of sheep fed on low copper intakes 
and an increased crude protein content, however, at high 
copper intakes (1 g copper sulphate/sheep/day) in the 
diet with high crude protein content did apparently have 
an effect and decreased the incidence of copper 
accumulation in the animals. This latter evidence 
indicates that the higher protein intake buffers the 
higher intake of Cu in some way. It is regretable that 
previous workers did not measure the blood proteins such 
as alpha2-M.
Smith and Larson (1946) first recognized a biological 
antagonism between copper and zinc, when they used 
dietary supplementation with copper to alleviate certain 
symptoms of zinc toxicity in rats. Later studies of 
Grant-Frost and Underwood (1958) observed the signs of 
copper deficiency in rats fed on diet containing 5000 mg 
Zn/kg of diet.
It is well recognized that copper metabolism in ewes and 
lambs is affected by increasing dietary zinc 
concentrations (Bremner et al, 1976; Campbell and Mills,
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1979; Parry and Al-Mukhtar, 1980; Saylor et al, 1980). 
Bremner et al (1976) examined the possibility of dealing 
with copper poisoning in intensive sheep rearing by 
increasing their dietary sine intake. Sheep were 
protected substantially by increasing the dietary zinc 
concentration to 420 mg Zn/kg of diet. This 
supplementation prevented the onset of haemolytic crisis 
and also decreased the amount of liver deunage which 
normally occurs with Cu toxicity. Further evidence by 
Parry et al (1984) confirmed the protective effect of 
feeding zinc upto 352 mg Zn/kg diet. Although the 
biochemical explanation for this has not been worked out, 
it would seem reasonable to assume that Zn could have 
been involved in stimulating the biosynthesis of 
metallothionein which in turn could have bound excess Cu 
ions, thus rendering them unavailable for liver 
metabolism. Occurence of metallothionein in the liver of 
ruminants (Bremner and Marshall, 1974b) is dependent on 
zinc status. The detoxification and storage of copper 
have been linked with metallothionein by Bremner and 
Marshall (1974b).
Contrary to this evidence and views that zinc increase in 
the diet can decrease liver copper studies by Saylor and 
Leach (1980) and Reynolds (1978) showed that 
supplementation of the sheep diet with 500 mg Zn/kg of 
diet did not decrease the copper concentration of the 
liver. However, lambs in experiments by Bremner et al,
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(1976) were 12 weeks of age whilst those used by Saylor 
and Leach (1980) included newborn lambs up to 60 days 
old. Hence, Saylor and Leach (1980) suggested that the 
age at which sine supplementation took affect was more 
important than the duration of feeding a zinc 
supplemented diet.
Parry et al (1984) showed in three breeds of pregnant 
sheep, kept indoors that a ratio of 1:4 between dietary 
Cu and Zn could reduce the effect of toxic levels of 
copper. They used commercially available diet, with 
copper varying from 20 mg to 82 mg Cu/kg and zinc from 80 
to 352 mg Zn/kg, for maintaining dietary ratios of 1:4 
for Cu:Zn. In their binding studies on plasma protein 
using Dorset sheep it was shown that plasma protein bound 
more copper during the first 21 days but this was not 
apparent after a total of 105 days. These studies 
supported earlier results by Bremner et al (1976) in 
showing the significance of dietary zinc supplementation 
in dealing with copper toxicity.
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ABSORPTION OF ZINC
A number of studies have shown that sine metabolism is 
under the control of a homeostatic mechanism (Miller, 
1969; Evans , 1973). Some investigators suggested a
role for low molecular weight proteins, possibly such as 
metallothionein making a contribution to the absorption 
process (Starcher, 1969; Van Campen and Kowalski, 1971; 
Suso and Edwards, 1971). However, there is no unifying 
concept regarding zinc absorption and transport.
Hahn and Evans (1973) identified a low molecular weight 
Zn-binding ligand in the intestinal lumen and mucosa of 
rats. Later, Evans et al (1975) showed that a similar 
ligand is present in dog and rat pancreatic secretions. 
The Zn-binding ligands have not been characterised, in 
any of these species and there is certainly a scarcity of 
studies on these processes in sheep.
Evans et al (1975) proposed the following sequence for 
zinc absorption based on their observations in rats: 1. a 
Zn-binding ligand is secreted in pancreas and released 
into the intestinal lumen, 2. in the lumen zinc binds to 
the ligand, 3.complexed with ligand, zinc is transported 
through the intestinal microvillus and into the 
epithelial cell, 4. in the epithelial cell Zn is 
transported to binding sites on the baso lateral plasma 
membrane, and 5. metal free albumin interacts with the
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plasma membrane and removes Zn from the receptor sites. 
The quantity of metal free albumin available at the 
basolateral plasma membrane determines the amount of Zn 
removed from the intestinal epithelial cell and thus 
regulates the quantity of Zn that enters the body.
Although 30-40% of serum Zn is associated with alpha2-M 
(Parisi and Vallee, 1970), this protein was suggested to 
play a minor role in Zn absorption. This was based on the 
observations of Parisi and Vallee (1970) indicating that 
alpha2-M does not take up or exchange readily with Zn 
isotope.
ABSORPTION OF COPPER
Studies of Evans (1979) showed that intestinal cytosol Cu 
binds to metallothionein. When the quantity of Cu that 
enters the intestinal cell does not exceed the capacity 
of the mucosal transport mechanism, probably occupies 
binding sites on metallothionein and Cu is released from 
metallothionein as the Cu is transported across the 
basement membrane into the lamina propria. However, when 
the quantity of incoming copper exceeds the capacity of 
the intestinal transport mechanism, the pre-existing 
binding sites on metallothionein become saturated and 
leads to metallothionein synthesis.
Stuydies in ruminants have shown that increased molydenum 
content of the diet above 1 mg Ho/kg diet causes copper
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deficiency. This is further enhanced by the dietary 
content of inorganic sources of sulphur or sulphur amino 
acids (Mills, 1980). The interaction between Cu,Mo and S 
takes place predominantly in the gut (Suttle, 1974) and 
suggested that it may involve the formation of an 
unavailable compound containing Cu and Mo which might 
limit the utilisation of dietary Cu by sheep.
ZINC BINDING TO ALPHA2-M AND ZINC TRANSPORT BY ALPHA2-M 
Zimmerman et al (1984) suggested that zinc bound to 
alpha2-M may be involved in providing readily available 
zinc in plasma for transport towards rapid cell growth 
and differentiation. While accepting albumin as the 
principal zinc transporting protein among tissues for 
rapid zinc change (to gut, liver and placenta), they 
suggested that alpha2-M interacts with cells to transfer 
zinc for complex metabolic needs such as DNA synthesis in 
the fetus. This view supports the rapid transport 
requirement role of alpha2-M to meet the increased zinc 
requirements during pregnancy.
Evidence to show that alpha2-M may have an important 
transport role comes from Laemmli (1970) who showed that 
metalloproteins require divalent cations i.e. Zn, Co, Mn, 
Mg and Ca for their activity. Later, Barrett and Starkey 
(1973) suggested that alpha2-M serves as a means of 
removal of activated proteases, which have bound metal
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ions, from the circulation by forming complexes. Such 
studies therefore indicate that alpha2-M can be involved 
in transport. However, despite the evidence, that 
alpha2-M could have an important role for metal ions in 
this way there are no studies published which have 
investigated whether bound Zn can be released and become 
available for example in faetal tissue where the demand 
for Zn is high.
There is no agreement on the zinc transporting proteins 
either in human plasma or ruminant plasma. In the plasma 
of most species approximately two thirds of the zinc 
present has been found to be loosely bound and one third 
very firmly bound to alpha2-M (Himmelhock et al, 1966; 
Parisi and Vallee, 1970; Giroux, 1975). In addition a 
small proportion of zinc 2-8% in an ultrafilterable form 
is bound to the amino acids:- histidine, glutamine, 
threonine, cystine and lysine (Prasad and Oberleas, 
1970). Although Scott and Bradwell (1983) showed in vitro 
binding of zinc to albumin and 12 other proteins in human 
serum, there was no evidence that binding to alpha2-M was 
as prominant. This could be due to the methodology used.
Studies of Boyett and Sullivan (1970) showed zinc binding 
consistently to transferrin and alpha2-M (these two 
proteins were measured together as Tf-alpha2-H). The 
total amount bound to these two proteins in normal and 
cirrhotic patients was remarkably constant (11.5 + 2.4
31
pg/100 ml normal serum and 11.0 + 5.1 ^ig/100 ml cirrhotic 
serum). However, transferrin bound sine concentration 
varied in normal and cirrhotic serum samples. Hence, they 
implied a reciprocal relationship between the amount of 
zinc bound to transferrin and that bound to alpha2-M. The 
total zinc bound to Tf-alpha2-M remained constant even 
though total zinc in serum zinc decreased to as low as 12 
^ig/100 ml. Boyett and Sullivan (1970) predicted that 
Tf-alpha2-M bound zinc does not change until serum zinc 
levels reach below 8 p.g/100 ml. More experimental
evidence is needed to clarify these predictions.
In vitro studies by Prasad and Oberleas (1970) showed 
that amino acids: histidine, glutamine, threonine,
cystine and lysine competed effectively with haptoglobin 
for binding of zinc, a tighter affinity for binding zinc 
with ceruloplasmin and alpha2-M. Other proteins such as 
IgG, transferrin, and albumin showed no such phenomena, 
which indicated that ceruloplasmin and alpha2-M showed 
special binding property with respect to zinc in vitro.
Charlwood (1979) reported complete in vitro transfer of 
zinc from transferrin to albumin at equilibrium. There 
are no studies so far as to whether this transfer of zinc 
does take place in vivo and also whether alpha2-M and 
amino acids are involved in transfer of zinc from one to 
the other either in human or in ovine species.
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Very interesting observations on alpha2-M were made by 
Pratt and Pizzo (1984), who showed correlated decreases 
in human plasma alpha2-M activity (trypsin binding 
activity) with apparent dissociation of the alpha2-M 
tetramer on polyacrylamide gel electrophoresis in the 
presence of zinc above 25 i^M. They also observed no
change in the activity of alpha2-M after treatment with
EDTA, which supported the view that reaction with
proteinase and the resulting change in conformation of 
alpha2-M does not involve zinc binding sites.
Pratt and Pizzo (1984) also demonstrated that alpha2-M
activity decreased in the presence of 50 Cu or Zn.
Evaluating the biochemical methodology which has been 
used for studying alpha2-M especially in binding studies 
is an important consideration. The same workers above 
found that BDS polyacrylamide gel electrophoresis of 
alpha2-M in 400 /iM CuS04 or 400 /iM of ZnCl2 did not 
disrupt the covalently bound alpha2-M subunits. All
alpha2-M-trypsin complexes incubated with CuS04 or ZnCl2 
showed that each of the above metal ions migrated as
single bands with a mobility higher than that of
untreated alpha2-M (Pratt and Pizzo, 1984).
Parisi and Vallee (1970) observed no exchange of 65Zn 
during isolation of alpha2-M, which suggests that zinc
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was bound with a high stability constant, a feature of 
other metalloproteins (Vallee and Wacker, 1970). However, 
a direct role for sine in the activity of alpha2~M is not 
recognized (Adham et al, 1977; Pratt and Pizzo, 1984).
Human alpha2-M has been studied by Adham et al (1977). 
They found evidence to show some heterogenous binding; 
this was attributed to two classes of binding sites. At 
pH 7.9 the site with strong affinity for zinc (site 1) 
showed an apparent stoichiometry of nearly 12 g atoms 
Zn/mol of alpha2-M and an apparent association constant 
of 3.06.107 . The second binding site (site 2) had 60 g 
atoms Zn/roonomer and an apparent association constant 
(K2) of 1.32.105 . For the third site (site 3) the 
calculated stiochiometry amounted to 40 g atoms Zn/mol of 
alpha2-M and K3 was equal to 7.33.105 . However, they 
indicated that the third binding site was an artefact. 
Binding constant estimated for the first of these sites 
by Pratt and Pizzo (1984) was 8 . 10*7 H and zinc binding 
site number of 20. Pratt and Pizzo (1984) reported the 
existence of low affinity binding sites as suggested by 
Adham et al (1977), although the upper limit for site 
number and the binding affinity were not accurately 
estimated due to the problem of protein aggregation and 
precipitation. They suggested that these numbers should 
be best considered as limiting values for a class of 
high-affinity zinc binding sites on human alpha2-M.
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Later, Qettins and Cunningham (1986) investigated the 
metal binding properties of human alpha2-M and detected a 
unique pair of high affinity sine sites in the alpha2-M 
tetramer that differ markedly from other weaker 
sites.They also obtained data with manganese binding to
apo-alpha2-M which was very similar to that of zinc and
concluded that manganese had similar relative affinities 
for the two types of site as with zinc.
Though it is recognized that trypsin binding activity of
alpha2-M does not depend on the presence of zinc in
alpha2-M (Adham et al, 1977; Parisi and Vallee, 1970; 
Pratt and Pizzo, 1984), however, Adham et al (1977) 
showed that at 20 g atoms Zn/mol, 25% of trypsin binding 
activity was lost and when the concentration of zinc was 
increased to 70 g-atoms Zn/mol alpha2-M, there was
disappearance of all trypsin binding activity. The
activity was not restored after removal of excess zinc 
from alpha2-M by dialysis, suggesting that the occupation 
of the second binding site of alpha2-M by zinc initiated 
irreversible conformational changes in the molecule 
interfering with enzyme binding activity.
Pratt and Pizzo (1984) observed a reduction in
reassociation of the subunits in the presence of zinc
(ranging from 0 to 1 mM) on polyacrylamide gel
electrophoresis, after the reaction of alpha2-M with 
trypsin.
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There is strong evidence to claim that human alpha2-M has 
a plasma Zn transport role. The studies by Parisi and 
Vallee (1970) showed that alpha2-M has a concentration 
range of 320-770 i^g Zn/g of alpha2-M, this corresponds to 
3.3-7.9 g-atoms Zn/mol of alpha2-M (molecular weight of 
alpha2-M:- approximately 840,000 - Schonenberger et al, 
1968). They indicated a role of transport for alpha2-M on 
the basis of variations in zinc concentration in several 
disorders and due to 30-40% zinc in alpha2-M. Pratt and 
Pizzo also support the role in zinc transport,in view of 
the absence of any effect on alpha2-M structure and 
function at physiological zinc concentration. Alpha2-M 
has the capacity to bind 20 mol zinc/mol at physiological 
concentration, but this does not mean saturation of one 
class of 20 binding sites because the limit of zinc 
binding in serum can be upto 40%. However, the actual 
zinc bound to alpha2-M may be less than total binding 
capacity. Pratt and Pizzo also state that the reversible 
binding capacity of alpha2-M is consistent with the 
existence of many zinc binding sites.
According to Pratt and Pizzo (1984), though the 
structural and functional implications of zinc binding to 
alpha2-M at high concentrations of zinc is not 
physiologically relevant,but it is useful to consider the 
problem in this way to try and understand the 
protein-metal interactions,particularly with regard to
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subunit association.
Song and Adham (1979) showed that approximately 80-100 jag 
Zn/g of protein and the molar ratio between zinc and 
alpha2-M as approximately l.This ratio was also 
maintained in hypo and hyperzincemic sera obtained from 
patients with multiple myeloma and lymphocytic lymphoma.
The stability of alpha2-M bound Zn concentration in 
healthy human adults was reported by Foote and Delves 
(1984). They observed 2.4 + 0.6 ^unol Zn/1 in human
alpha2-M. These observations were in close agreement with 
Giroux et al (1976) who showed a mean Zn concentration of
2.5 ± 0.5 junol/1. However, higher Zn concentration of 3.3 
+ 0.1 jimol/1 was reported by Song and Adham (1979) in
alpha2-M which was obtained after sucrose density 
centrifugation. Foote and Delves (1984) also reported a 
poor correlation between the concentration of alpha2-M 
and bound Zn due to a fourfould variation in the binding 
ratio between the two respectively (0.5 to 2.2). They 
suggested that alpha2-M bound Zn is subject to metabolic 
control. However,they were unable to offer any 
explanation to this obscure behaviour or the importance 
of it.
Little has been mentioned in this review on zinc bound to 
albumin; it is important to consider this. Foot*, and 
Delves (1984) further reported that the variations in
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human serum Zn concentrations were entirely due to
variation in albumin Zn. However, further investigations 
are needed to provide evidence and studies on Zn-binding 
to alpha2-M might help in clearer understanding of the 
nature of Zn variation in serum.
The above review of literature has shown the areas of 
work carried out on human alpha2-M, essential requirement 
of copper, zinc in deficiency and excess, also the
interrelationships between copper and zinc and the mutual 
antagonism between the two metals. Despite this, there 
are hardly any reports of studies showing the influence 
of one element on the binding of the other. From the 
review of literature it appears that mutual antagonism 
between copper and zinc could be used in preventing 
copper poisoning in sheep (Bremner et al, 1976). One of 
the ways in which zinc affected the toxicity of copper 
was by promoting the formation of relatively non-toxic 
forms of copper in the liver such as metallothionein. 
However, it is not clear whether concentration of one of 
these two metals could influence the binding of the other 
to plasma proteins and interfere with transport. It is 
beyond the scope of this thesis to investigate the 
influence on all proteins. Hence, this thesis confined 
the investigation of the influence of copper on 
Zn-binding to alpha2-M, and evidence is presented to show
that it is a Zn-binding protein with a role in the
transport of zinc.
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AIM OF THE INVESTIGATION
The main aim of this work was to attempt a quantitative 
assessment of Zn-binding to alpha2-M and how this is 
influenced by dietary copper. The hypothesis to be tested 
proposes that dietary copper influences Zn-binding to 
alpha2-M in ovine plasma and is dependent on the ratio of 
dietary concentrations between Cu and Zn.
The individual aims of this work are therefore summarized 
below and will be a guide to the general direction of the 
experimental design.
a. Purification of alpha2-M from sheep plasma. This is an 
essential first step before it can be used to test 
whether ovine alpha2-M is different in character and zinc 
binding properties from human alpha2-M as mentioned in 
this thesis.
b. It is then necessary to test whether there is a 
binding relationship between plasma alpha2-M and Zn in 
sheep plasma which in turn is sensitive to various 
parameters summarized as follows:
i. influence of dietary copper, firstly copper 
deficient on Zn-binding to alpha2-M, with possible 
competiton between the two elements for binding 
sites;
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ii.secondly,the possible influence of high dietary 
copper on Zn-binding to alpha2-M with a similar 
possibility of competition between the two elements 
as in (i) above.
c.Finally it is necessary to study whether Zn-binding to 
alpha2-M is different in different breeds of sheep and 
whether dietary copper can influence this Zn-binding.
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smiQN... .n
METHODS AND EXPERIMENTAL DESIGN 
1•(a). GENERAL EXPERIMENTAL DESIGN AND TREATMENTS
(i). Clun Forest wethered male lambs were used to obtain 
blood samples from sheep fed copper deficient diet (<1.0 
mg Cu/kg and 50 mg Zn/kg diet) and high-Cu diet (250 mg 
Cu/kg and 200 mg Zn/kg diet) fed sheep. Male lambs of 12 
weeks old were used in both the above experiments.
(ii). Samples of blood were also obtained from three 
other experiments carried out at the Department of 
Clinical Veterinary Medicine, Cambridge. In these 
experiments three breeds of pregnant sheep (Dorset, Clun 
and Finn) were used. These sheep were maintained indoors 
on a variable Cu diet (20 to 82 mg Cu/kg diet 
supplemented with 80 to 352 mg Zn/kg diet respectively 
with a ratio Cu:Zn of 1:4.
(iii). Animal house and pens
At Bristol Polytechnic, sheep were housed in individual 
pens throughout the experiments; the pens were made of 
stainless steel bars covered with plastic sheet so that 
sheep could not lick them. The floors of the pens were 
plastic trays and plastic mats were provided to serve as 
bedding. The pens were washed and cleaned three times a 
week. Temperature of the animal house was maintained at
200 c +1.
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(iv). The sheep at the Department of Clinical Veterinary 
Medicine, Cambridge were accommodated and managed in a 
polypen (thick polythene sheeting draped over and fixed 
to a steel frame). Three breeds of sheep, Dorset, Clun 
and Finn were separated in three respective groups of 10 
pregnant ewes in each. Immediately before housing these 
ewes were grazing a paddock with a previous history of 
copper toxicity causing deaths amongst each of the three 
breeds.
(b).DIETARY TREATMENTS
In the experiments conducted at Bristol Polytechnic and 
at Cambridge three types of diet were used:-high-Cu diet 
and varying copper-zinc diets were supplied by Dalgety 
Spillers, Clifton, Bristol. Cu and Zn concentrations in 
these diets were analysed prior to the start of each 
experiment.
Copper deficient diets were mixed at University of 
Bristol, Veterinary School, Langford, using the 
ingredients supplied by Dalgety Spillers. The diet was 
based on the composition used at the Rowett Research 
Institute, Aberdeen, Scotland.
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MgS04 .7H2 0 
CaHPCU .2H2 0
Trace elements 
FeS04 .7H2 0 
MnS04 .4H2 0 
C0CI2 .6H2O 
KI03
ZnS04 . 7H2 0
Fat soluble vitamins 
A (1000 i.u./kg);
D (360 i.u./kg) 
and E (10 i.u./kg)



















B group vitamins 0.036
(B group vitamins-biotin separated from others; 
naphthoquinone, pyridoxine, folic acid, thiamin HC1, 
riboflavin, DL-calcium pantothenate (45%), vitamin B12, 
ascorbic acid and inositol.)
(c). COPPER AND ZINC ANALYSIS
(i).Diet
Copper and zinc analysis were made on a Varian Techtron 
AA6 atomic absorption spectrophotometer.
A steel heating block was used for the digestion of diet 
samples. The steel block could accommodate 10 boiling 
tubes and was of the same size as the hot plate. The 
steel block was placed on the hot plate for digestion as 
mentioned below.
2 g of powdered diet was added to each of the boiling 
tubes except one and then 10 ml of concentrated Analar 
nitric acid (Analar) was added, followed by three drops 
of octan-l-ol and two drops of perchloric acid. A one 
inch diameter glass marble was placed on top of each 
tube, to reduce evaporative loss. Thermal contact with 
the block was aided by few drops of liquid paraffin 
between the block and glass tube. A tenth tube with 2 ml 
liquid paraffin and a thermometer in it was used to 
monitor the temperature. The block with the tubes was
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placed on the hot plate in a fume cupboard and was warmed 
gently until frothing was observed. When the frothing 
ceased the temperature was increased to 105°C. The 
samples were kept at this temperature for 48 hours and 
when they were completely dissolved, the solutions were 
diluted to a known volume and the zinc and copper content 
were measured by atomic absorption spectrophotometer.
(ii).Preparation of plasma samples
10 to 20 ml of blood from the animals jugular vein was 
collected into tubes containing lithium heparin. Plasma 
was separated by centrifuging at 3000 rpm for 15 minutes 
and subsequently stored in a freezer at -20° C.
When needed the plasma samples were diluted 1 in 5 with 
deionised water for measuring copper and zinc.
(iii).Chromatography fractions
Fractions from chromatographic separation were directly 
used for measuring copper and zinc.
(d).REAGENTS
(i) .Stock copper-1000 jUg Cu/ml
1 g of copper metal strip (Analar) was dissolved in a 
minimum volume of 1:1 nitric acid (Analar) and diluted to 
1 litre with deionised water to give 1000 jig Cu/ml and 
stored in a polythene bottle.
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Calibration standards
Suitable dilutions of the stock copper solution were made 
with deionised water, usually to give 10 jig Cu/ml 
solution first and then 0.05, 0.1, 0.2, 0.5 and 1.0 p.g 
Cu/ml standards.
(ii).Stock zinc-1000 ps Zn/ml
1 g of zinc metal, granulated (Analar) dissolved in 40 ml 
1:1 hydrochloric acid (Analar) and diluted to 1 litre 
with deionised water to give 1000 jig Zn/ml and stored in 
a polythene bottle.
Calibration standards
Suitable dilution of the stock zinc solution was made 
with deionised water, usually 10 }xg Zn/ml. From this 
diluted stock 0.1, 0.2, 0.5, 1.0 and 2.0 i^g Zn/ml
standards were made.
(e).CONTAMINATION BY EXOGENOUS COPPER AND ZINC 
Precautions were taken in all experiments to prevent 
copper and zinc contamination from external sources. All 
glassware was first cleaned by immersion in 35% W/V 
nitric acid, washed in distilled water and then rinsed 
with deionised water. All chemicals used were of Analar 
grade and all solutions were made up in deionised water 
and stored in polythene containers.
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(f).RADIOACTIVITY COUNT
A Scaler Ratemeter SR7, Nuclear Enterprises Ltd. was used 
for radioactivity determination of fi5Zn from fractions 
collected from mini columns used in the binding studies. 
The counting time was always for one minute.
A Rackbeta II(LKB Liquid Scintillation Counter) was used 
for ®5Zn count of polyacrylamide gel slices from both rod 
gel and vertical gel electrophoresis. In both cases 5 mm 
sections of gels were placed in scintillation vials and 5 
ml of liquid scintillator (Unisolve E, Koch Light Ltd.) 
was dispensed into each vial with an automatic dispenser. 
Precautions were taken by using liquid scintillator only 
as blank and also ®5Zn with liquid scintillator to 
monitor 65Zn count for comparison. The vials were left in 
the rack for 6 hours to allow the gel slices to dissolve 
completely, after which time each vial was shaken 
thoroughly and then counted. This procedure gave 
consistently reliable counts and on recounting showed 
reproducibility ( 5%).
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2.PURIFICATION OF ALPHA2-M FROM SHEEP PLASMA 
There are a number of methods available, as mentioned in 
the review of literature, for the purification of 
alpha2-M from plasma. No previously described method has 
been used specifically to purify alpha2-M from sheep 
plasma. However, due to strong immunological cross 
reaction between sheep and human alpha2-M (James, 1965), 
previously described methods for human plasma 
purification were adapted for use in this study to purify 
sheep alpha2-M.
Alpha2-M is easily inactivated either by reaction with 
proteinases or by the procedures adopted in protein 
purification, hence, the risk was reduced working with 
plasma rather than serum. Since complex and long 
procedures tend to inactivate alpha2-M, it was necessary 
to compromise between obtaining alpha2-M free from all 
contaminants and in retaining the active alpha2-M.
Two published methods of preparation were prefered:
(a). A large scale purification method (Song et al, 1975) 
using precipitation with polyethylene glycol, 
centrifugation and gel filtration ,
(b). Immunoadsorbent chromatography (IAC) (McEntire, 
1978) using specific anti-serum (anti-human alpha2-M)
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coupled to CNBr-Sepharose 4B and eluting alpha2-M with pH
2.5 acetate buffer.
The first method offered the possibility of sufficient 
yield of alpha2-M for both preliminary studies and 
material for raising anti-sheep alpha2-M antibodies in 
rabbits. The latter were needed for the second method,
immunoadsorbent chromatography (McEntire, 1978). These
two methods are convenient for use with both large and 
small samples of plasma. The immunoadsorbent 
chromatography method was extremely convenient for 
routine use and was economical.
The methods are described below in detail.
(a).LARGE SCALE PURIFICATION OF ALPHA2-M FROM 
SHEEP PLASMA(Song et al. 1975)
Materials required
Polyethylene glycol 300 (PEG-300), Rivanol
(2-ethoxy-6,9-diaminoacridine lactate) (Sigma Chemical 
Co., Poole, Dorset). Sephadex G-200 (Pharmacia, Milton 
Keynes). Fresh sheep blood was obtained from an abattoir 
in polythene container with heparin in it.
Preparation of alpha2-M
(i).Polyethylene glycol precipitation
All preparations were carried out at 4° C. To 300 ml of 
fresh sheep plasma, 120 g of PEG-300 was added with 
stirring. The mixture was allowed to stand for 1 hour at
4° C and then centrifuged for 2 hours at 3000 g. The 
precipitate was discarded. Another 120 g of PEG-300 was 
added to the supernatant. The mixture was stirred, 
allowed to stand for an hour and centrifuged at 3000 g 
for 2 hours. The precipitate was dissolved in 100 ml
saline and treated as below.
(ii).Removal of beta-lipoprotein and fibrinogen by 
Rivanol precipitation
30 ml of 0.5% Rivanol in distilled water was added to the 
crude alpha2-M solution in saline mixture was stirred for 
10 minutes and centrifuged at 3000 g for 30 minutes. An 
additional 20 mis of 0.5% Rivanol was added to the
supernatant. After standing for a further hour, the 
mixture was centrifuged for 1 hour at 3000 g. The pellet 
obtained was dissolved in 3% NaCl (50 ml) and clarified 
by centrifugation. Finally, this supernatant was passed 
through a Sephadex G-200 column (5 x 80 cms.) which had 
been equilibrated with 5 mM tris-HCl buffer, pH 7.4
containing 0.9% NaCl and 0.02% sodium aside. The flow
rate of the column was 24 ml/hr and the absorbance was 
monitored at 280nm. A total of 100 fractions (each of 10 
ml) were collected.
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Three distinct protein peaks will be seen in Fig.7 in 
Section-Ill. Peak I was in the region of the void volume 
and'thus high molecular weight protein material. Prior to 
the chromatography of alpha2-M, the void volume of the 
column was determined passing 10 ml of Blue Dextran 2000 
(Pharmacia) (2 mg/ml) and molecular weight markers 
(details in Section-II, 13) were applied to determine the 
molecular weight of Peak I.
Human plasma alpha2-M was also purified following the 
same procedure (Fig.9, Section-Ill).
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f1111-ALPHA 2-MACROGLOBULIN PURIFICATION 
Sheep plesma (300 ml)
4120 g (40% w/v) PEG-300
Centrifuged at 3000 g for 2 hours
Precipitate Supernatant
I
discarded +120g (40%) PEG-300
I
Centrifuged at 3,000 g for 2 hours
Precipitate redissolved Supernatant
in 100 ml saline 4 30 ml discarded
of 0.5% Rivanol




420 ml of 0.5% Rivanol
Centrifuged at 
3,000 g for 1 hour
Precipitate Supernatant
reconstituted in 50 ml discarded
of 3% NaCl




Flow chart of purification of sheep plasma alpha2-M.
Precipitate
discarded
A typical elution pattern from this G-200 column is shown in 
Fig.7 (Section-Ill). 52
(b).IMMUNOADSORBENT CHROMATOGRAPHY (McEntire. 19181
(i).Materials required
Antihuman alpha2-M raised in rabbits from Behring
Diagnostic Reagents, Hoechst Pharmaceuticals, Hounslow; 
anti-sheep alpha2-H was raised in rabbits for use in this 
procedure (details in Section-II, 5); Sepharose 4B (CNBr 
activated) from Pharmacia (Great Britain) Ltd., Hilton 
Keynes; 0.1 M borate buffer, pH 8.0 in 0.5 M NaCl; 1 M 
ethanolamine, pH 8.0; 0.1 M acetate buffer, pH 4.0,
containing 0.5 M NaCl and 0.1 M acetate buffer, pH 2.5.
(ii).Preparation of anti-alpha2-M immunoadsorbent column 
Cyanogen bromide-activated Sepharose 4B (CNBr-Sepharose 
4B) was prepared according to the manufacturers 
instructions as follows.
2.0 g of freeze-dried powder was swollen for 15 minutes 
in 1 mM HC1 and washed on a sintered glass filter
(porosity G3) with the same solution. A total of
approximately 200 ml per gram dry gel was added in 
several aliquots, the supernatant removed between 
successive additions. 1 g of freeze-dried powder has 
given approximately a gel volume of 3.5 ml. The use of 
HC1 preserved the activity of the reactive groups which 
hydrolyse at high pH. The gel was then washed thoroughly 
with coupling buffer (0.1 M borate buffer, pH 8.0, in 0.5 
M NaCl) and 4 ml of anti-human alpha2-M or anti-sheep
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alpha2-M (previously dialysed against coupling buffer, 
overnight) was added to the Sepharose and tumble mixed 
slowly for 2 hours at room temperature on a rotary mixer. 
After washing with coupling buffer, a number of residual 
active groups will still remain on the gel. These groups 
were blocked by adding an excess of a small primary 
amine, 1.0 M ethanolamine, pH 8.0 to the
Sepharose-antibody mixture. The mixing was continued for 
two hours. At the end of this period, the coupled 
Sepharose was decanted into a small Whatman column (1.0 x
12.0 cms.) and washed thoroughly with alternating 
aliquots (50 ml) of coupling buffer and 0.1 M sodium
acetate buffer, pH 4.0, containing 0.5 M NaCl.
Normally for the purification of alpha2-M from
experimental sheep plasma, whole procedure was scaled up 
5 times.
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(iii).Purification of alpha2-M from sheep plasma on IAC 
Sheep plasma (20 mis) was dialysed overnight against 
coupling buffer (pH 8.0) and then run into the prepared 
Sepharose column (approximately half way). Dialysed 
plasma was incubated for 30 minutes at room temperature. 
After which time the column was washed with coupling 
buffer, usually 250 ml, until the 280 nm absorbance of 
the effluent reached less than 0.01 absorbance. The bound 
alpha2-M was eluted with 0.1 H sodium acetate buffer, pH 
2.5, containing 0.5 M NaCl. Fractions of 5.0 ml were 
collected. The elution profile was monitored by using a 
Uvicord S (LKB Instruments Ltd.) at 280 nm. After this 
elution the column was washed thoroughly with the elution 
buffer and re-equilibrated with coupling buffer before 
applying a further sample. Re-equilibration was always 
started after the elution buffer absorbance dropped to 
less than 0.01 A 280.
Typical profiles of this immunoadsorbent chromatography 
using both anti-human alpha2-M and anti-sheep alpha2-M 
are presented later in Figs.13 and 14 (Section-Ill). 
Fractions were pooled and concentrated.
(c ).CONCENTRATION OF PROTEIN FRACTIONS
The protein fractions from both large scale purification 
and immunoadsorbent chromatography were pooled and 
concentrated against 403& solution of carbowax
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(Polyethylene glycol 6000, Sigma) at 4° C.
(d).CONFIRMATION THAT THE PROTEIN IS ALPHA2-M 
It was necessary to identify the protein in each of the 
fractions in Peak I from the large scale purification 
method. Once it was confirmed that they contained 
alpha2-M the fractions were pooled.
In immunoadsorbent chromatography all the protein 
fractions obtained after the sodium acetate buffer wash 
pooled.
( e K ALPHA2-M ANALYSIS
(i). Double immunodiffusion analysis
(ii). Immunoelectrophoresis
(iii). Polyacrylamide gel electrophoresis (PAGE). 
Materials required
Anti-human alpha2-M raised in rabbits was obtained from 
Behring Diagnostic Reagents, Hoechst Pharmaceuticals, 
Hounslow; anti-whole sheep serum was obtained from 
Bristol Polytechnic; and agarose, Coomassie Brilliant 
Blue R-250 were obtained from Sigma.
(i).Double immunodiffusion analysis(Ouchterlony)
This method allows several antigens or antibodies to be 
compared directly around a single well of antigen or 
antibody. Antibody (antihuman alpha2-M) was placed in the
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central well and the antigens (diluted protein fractions 
or undiluted protein fractions) were placed in the 
equidistant peripheral wells, containing either the same 
volume as antiserum or less. Antigen and antibody diffuse 
towards each other and a sharp line of precipitation 
occurs where the two are in optimal concentration. 
Multiple lines of precipitation appear if the antigen 
contains several molecular species.
The method was as follows:
A solution of 1.5% agarose in barbitone buffer, pH 8.6, I 
= 0.1 was prepared and the bottle was left in a boiling
water bath continuously (when in use).
Glass slides (26 x 76 mm) were precoated with two drops 
of agarose and 3 ml of liquid agarose (1.5%) was poured 
onto each slide and allowed to set. After the gel was 
set, holes were punched as shown in Fig.l with a gel 
puncher and antiserum was placed in the central well and 
either the fractions from column or concentrated sample 
were placed in the outer wells. The diffusion was allowed 
to take place in a moist chamber at room temperature for 
24 hours. After which time, precipitation lines appeared 
which were visualized by staining as mentioned below.
Staining of agarose gels
The slide was placed on the bench and covered with a 
filter paper (smooth side down) soaked with distilled
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Central wells (fo^ anti-serum)
Outer wells (for antigen)
Glass slide showing the position of central well 
for anti-serum and outer wells for antigen (test 
solution).
Well for antigen
Immunoelectrophoresis slide showing two wells on 
either side of central (cut portion of gel) lines 
indicating the position of trough before 
electrophoresis.
water. A thick wad of paper tissue was placed on top of 
the filter paper which was covered with a thick glass 
plate. On this a weight (usually a winchester bottle 
filled with water) was placed for 20 minutes.Then the 
weight, wad of tissue paper and filter paper were 
carefully dismantled after making the filter paper wet, 
to avoid splitting the gel. A petri dish was half filled 
with distilled water and the slide was immersed and left 
for 20 minutes. This procedure of pressing with tissue 
paper and washing was repeated four times. After which
time a petri dish was half filled with saline (0.9% NaCl) 
and left immersed for 20 minutes. Once again pressing and 
washing was repeated with saline instead of distilled 
water. Then the slide was dried completely with a hair 
dryer untill it was transparent and the slide was 
immersed in Coomasie Blue stain (1 g Coomasie Brilliant 
Blue R-250, 90 ml ethanol, 20 ml acetic acid and 90 ml 
distilled water) and stained for 5 minutes. The staining 
solution was used several times. After this staining the 
gels were rinsed with water and destained for about 10
minutes using destaining solution containing ethanol, 
acetic acid and water in the ratio,9:2:9.
When glass plates (84 x 94 mm) were used, 12 ml of liquid 
agarose (1.5%) was poured onto glass plate. The procedure 
used was essentially similar to slides except gel
punchers (LKB Instruments Ltd.) used were different.
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(ii).Immunoelectrophoresis
Principle:This technique was carried out in two steps.
The antigen solution was placed in a well in the agarose 
gel and separated electrophoretically as shown in Fig.2.
After completion of electrophoresis, a trough was cut out 
of the agarose gel parallel to the direction of migration 
(Fig.3 ). The trough was then filled with the appropriate 
antiserum (antihuman alpha2-M or antisheep alpha2-M or 
antiwhole sheep serum). The antigens and antiserum 
diffused and formed precipitates. This was purely a 
qualitative technique.
Immunoelectrophoresis method for slides
A microscope slide was precoated with two drops of 1.5% 
agarose in barbitone buffer, pH 8.6, I = 0.05 and 3 ml of 
agarose was poured onto glass slide (26 x 76 mm)(a 
levelling table was used).
The gel was allowed to set and a trough was cut using a 
Shandon gel cutter. Two holes were cut 27 mm from one end 
of the slide and 5 mm from the trough as shown in Fig.2.
Electrophoresis
5 pi of the antigen for investigation was added to each 






Immunoelectrophoresis slide with central trough 
filled with anti-serum after electrophoresis. 




Glass plate for immunoelectrophoresis, showing
the position of wells punched with LKB gel puncher
and the troughs for anti-serum.
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This dye indicated the approximate migration of the
antigen. As this dye binds to albumin it was more useful 
when serum was used to monitor the migration of proteins. 
However, it was necessary to have a trial run in the
presence of dye to estimate the correct time needed for 
the sample applied. In general 1 hour was sufficient for 
electrophoresis to achieve good separation.
The slide was placed across the bridge in electrophoresis 
tank (Shandon Southern) and separated the proteins using 
a potential difference of 50 volts/slide.
Diffusion
After electrophoresis the gel was carefully removed from 
the trough and 50 jil of the appropriate antiserum was 
added to the trough. Then the slide was placed in a moist
diffusion chamber at room temperature for at least 24
hours. The gel was stained and destained to visualise the 
precipitation lines as described under double diffusion 
technique.
Immunoelectrophoresis on glass plates (84 x 94 x 1 mm) 
was performed when more than two samples were tested 
under the same conditions as described below.
Immunoelectrophoresis on glass plates (84 x 94 x 1 
mm)- Grabar and Williams (1953)
Principle: The principle was same for microscope slide or
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the gla&s plates as described above.
Procedure: The procedure followed was as described in the 
LKB Application Note 249.
In order to keep the distance between antibody and 
antigen and to facilitate application of more than two 
samples the template was used to punch up to five holes. 
The troughs were cut with scalpel before the sample was 
applied (Fig.4). However, the gel was not removed before 
electrophoresis. Electrophoresis was carried at 200 volts 
for 45 to 60 minutes depending on the number of plates 
used at a time.
After electrophoresis the gel was removed from the 
troughs using the projection on the handle of the scalpel 
(LKB). The troughs were then filled with 50 to 100 ;il 
antibodies (anti-human alpha2-M or anti-sheep alpha2-M or 
anti-whole sheep serum or anti-IgG) as necessary. The 
plate was placed in a humidity chamber at room
temperature and allowed to diffuse for at least 15 hours. 
The pressing, drying and staining procedures were the 
same as those described above for slides. However, it was 
necessary to wash the plate for a longer time (6 times) 




The high resolution achieved by PAGE is due to separation 
on the basis of charge and size. The method of Hendrick 
and Smith (1968) emphasised the importance of maintaining 
a constant bis/acrylamide monomer ratio, since small 
changes in this ratio dramatically change the 
crosslinking and thus the seiving characteristics of gels 
of different acrylamide concentration.
Materials and equipment used
Acrylamide, bis-acrylamide (N,N’-methylene-bis-acrylamide 
and TEMED (N,N,N*,N*-tetramethylethylenediamine) were 
obtained from Sigma. Tris (tris
(hydroxymethyl)aminoethane, Analar sucrose and
bromophenol blue were obtained from BDH, Bristol. Shandon 
PAGE equipment for rod gels and LKB2001, vertical 
electrophoresis unit for vertical gels were used.
Solutions reauired
Solution A: 0.5 M tris-HCl (pH 8.9) containing 0.46% of








* bis is N,N’-methylenebisacrylamide 
Solution C:
Ammonium persulphate (10%) - made fresh in distilled
water.
To make the electrophoresis gel the following solutions 
were mixed in the proportions mentioned:
The mixture was poured into small glass tubes (5 x 120 
mm) or large plastic tubes (10 x 250 mm) for rod gels. It 
was also used to make the vertical gels. After pouring 
the mixture, water was layered on top.
Solution A 2.5 ml
Solution B 5.0 ml
Water 2.5 ml
Solution C 0.05 ml
Polymerisation took place in about 40 minutes but the 
gels were normally left for 2 to 4 hours before they were 
used.
Stacking gel was used in both small tubes and the 
vertical gel electrophoresis system to improve resolution 
of the protein bands.
Stacking gel solutions
Solution A:
0.5 M tris-HCl (pH 8.3) containing 0.46% of
N,N,N*,N*-tetramethylethylenediamine (TEMED).
Solution B:
Final acrylamide concentration of 3% in distilled water.
The mixture was mixed in the same proportion as
electrophorsis gel.
Solution A 2.5 ml
Solution B 5.0 ml
Water 2.5 ml
Solution C 0.05 ml
The stacking gel was usually 10 mm in height.
When polymerised and loaded into the apparatus large rod
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gels (10 x 250 mm) were ran at 1.5 mA/tube, small rod 
gels (5 x 120 mm) at 3 mA/tube and vertical gels at a 
total of 50 mA.
Before the sample was applied to the gel in 10% sucrose, 
bromophenol blue (a small grain of dye to give some blue 
colour) was added so that the migration could be 
monitored.
Electrophoresis buffer: 0.05 M tris-HCl, pH 8.9.
Staining of the electrophoresed gels (rod and vertical) 
Two stains were used in staining polyacrylamide gels:
Rapid staining was achieved by immersing the gels in 
rapid stain (0.40 g Coomasie Blue G-250 dissolved in a 
litre of 7% perchloric acid in distilled water) for 10 
minutes.
Slow staining was carried out by immersing in Coomasie 
Blue R-250 (0.1% Coomasie Blue R-250 in 25% methanol, 10% 
acetic acid, 65% water (v/v/v) and filtered before use). 
The gels were left in this stain for one hour.
De taining
After immersion of gels in rapid stain for 10 minutes, 
stain was poured back into the bottle and gels were 
immersed in 7% acetic acid for 10 minutes after which
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time the protein bands became visible.
After immersion in slow stain the stain was poured back 
into the bottle and the gels were washed several times 
with 5% acetic acid in 20% methanol and left in the same 
destaining solution until the background was clear.
(f ).DETERMINATION OF PROTEIN CONCENTRATION (Spector, 
1978; Sedmak and Grossberg, 1977).
(i).Coomassle Blue Binding Reagent
60 mg Coomassie Brilliant Blue G-250 (obtained from 
Sigma) was dissolved in 1 litre 3% perchloric acid, and 
filtered to remove undissolved material. The absorbance 
at 465 nm was between 1.3 and 1.5. This solution was 
stable indefinitely.
Prpgedurs
To 1.5 ml of sample containing up to 50 ug protein, 1.5 
ml Coomassie Blue reagent was added and absorbance was 
read at 595 nm after 2-30 minutes (Sedmak and Grossberg, 
1977).
(ii).Protein measurement with the Folin Phenol Reagent 
(Lowry et al.1951)
Reagent A : 0.5 g copper sulphate (CuS04. 5HaO) and 1.0 g 
sodium citrate (Nascitrate) were dissolved in 100 ml
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water.
Reagent B : 20 g Sodium carbonate (Na2C0*) and 4 g sodium 
hydroxide were dissolved in 1 liter water.
Reagent C : Reagents A and B were mixed in 1:1 just before 
use.
Reagent D : Folin-Ciocalteau reagent (obtained from BDH, 
Bristol) was diluted 1:1 just before use.
Procedure
Standard curve was prepared with protein concentration 
ranging from 0.05 mg to 0.5 mg protein using bovine serum 
albumin (B.S.A. obtained from Sigma) as follows:
To 0.5 ml of each protein solution 2.5 ml Reagent C was 
added and after thorough mixing on a vortex mixer allowed 
to stand at room temperature for 5-10 minutes.To this
mixture 0.25 ml Reagent D was added and mixed well and 
let it stand 20-30 minutes to develop colour and then
read the absorbance at 700 nm.
When unknown samples were used various dilutions were 
used to suit the standard proteins range. 0.5 ml of
unknown solution replaced standard protein solution and 
reagents were added as above for standards.
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A blank was also used as control (usually water).
3.PREPARATIVE ISOELECTRIC FOCUSING AND DETERMINATION OF 
ISOELECTRIC POINT OF SHEEP ALPHA2-MACROGLOBULIN
Isoelectric focusing was carried out using LKB 6100 
Ampholine Electrofocusing Equipment.
(a).PRINCIPLE
When a mixture of low molecular weight carrier ampholites 
are exposed to a voltage in a convection-free water 
solution, a pH gradient is formed. Large molecular weight 
ampholites, such as proteins, will, given these 
conditions, concentrate in narrow zones. The 
concentration will occur at the isoelectric point of the 
protein. The isoelectric point represents a pH value at 
which an ampholytic substance has net zero charge and 
does not migrate. This value is individual to each 
protein species.
(b).COLUMN USED FOR ELECTROFOCUSING: LKB 8101, 110 ml 
glass column.
(c).SOLUTIONS REQUIRED
Dense electrode solution: Anode at bottom of column
Electrode solution was made up mixing as follows:
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Phosphoric acid 0.2 ml
Distilled water 14.0 ml
Sucrose 12.0 g
Light electrode solution: Cathode at top of column
Electrode solution was made up mixing as follows:
Sodium hydroxide 0.1 g
Distilled water 10.0 ml
Solutions for density gradient 
Dense solution
LKB carrier ampholytes (3/4 of the total volume to give 
1% or 2% concentration) were made upto 42 ml with 
distilled water and 28 g of sucrose dissolved in this 
solution.
Light solution
1/4 of the ampholytes remaining were made upto 60 ml with 
distilled water.
Ampholyte concentration
Concentration of ampholines was chosen as 1% and 2% using 
40% ampholines. Total volume required to give the % 




i. Ampholines pH 3.5 - 10.0 2.5 ml to give 1% conc.
ii. Ampholines pH 3.5 - 10.0 0.5 ml
Ampholines pH 4.0 - 6.0 4.5 ml to give 2% conc.
(d).SAMPLE
5 ml solution of alpha2-M (concentrated Peak I fractions 
from Sephadex G-200 column) was mixed with 1/4 of the 
total volume of ampholytes and the total volume was made 
upto 60 ml with distilled water.
(e).STARTING THE ELECTROFOCUSING
The power supply (LKB 3371) was turned on and the voltage 
was set to 300. Electrofocusing was carried out for 36
hours. At the end of electrofocusing run the current was
constant.
(f).EMPTYING THE COLUMN
The power supply was turned off. Electrode solution from 
central tube was sucked off to avoid the risk of mixing 
with the effluent during the emptying process.
Column was emptied by pumping water from the top of the
column to force out the contents. 5 ml fractions were
collected using Ultrorac II (LKB). Uvicord S was used to 
monitor the absorbance at 280 nm and pH in each fraction
72
was measred on a pH meter (Hodel 291, Pye Unicam).
4.TESTING THE PERMEABILITY OF DIALYSIS MEMBRANE TO ZINC
Dialysis membranes were (obtained from Medicell 
International Ltd., London) boiled three times in 
deionised water before use to remove any contaminants 
present.
Seven dialysis tubes, each containing 2 ml zinc chloride 
(100 /ig Zn/ml) were dialysed against 4 litres of 1 mM 
tris-HCl buffer, pH 7.4 for 24 hours. One dialysis tube 
was taken out of the container every 4 hours and zinc was 
assayed using the atomic absorption spectrophotometer,
AA6.
Time of dialysis Amount of Zn present







This experiment showed that the dialysis membrane is 
permeable to zinc and 96% of the zinc in the dialysis
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tubes passed through in 24 hours.
5.RAISING RABBIT ANTI-SHEEP ALPHA2-M ANTIBODIES
Three rabbits were obtained from the Veterinary School,
University of Bristol, Langford.
Rabbits numbered 64, 65 and 66 were used to raise the 
antiserum.
Purified sheep alpha2-M (1 mg/ml) (from large scale 
method) was diluted in the ratio of 1:3 with Freund’s 
complete adjuvant (Sigma). Initially, 1 ml of this 
mixture was injected into all four limbs.
Booster injections were carried out with the same 
protein/adjuvant mixture at 4 week intervals to increase 
the production of antiserum as following: The amounts
used are outlined below.
1st booster injection 1 ml/limb - (only hind limbs)
2nd booster injection 1 ml/limb - (only fore limbs)
3rd booster injection 1 ml/limb - (only hind limbs)
Usually the rabbits were bled 10-14 days after the 3rd 
booster injection and the plasma was separated for 
antibody testing.
Following the above bleeding, rabbits were rested for 6
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weeks and then 0.5 ml alpha2-M/adjuvant was injected as 
further boosters as described above. This ensured that 
the rabbits continued to produce antibodies.
Testing of rabbit Plasma for antibodies to sheep alpha£-M 
The rabbit antisheep alpha2-M plasma was tested with 
antigen (sheep plasma alpha2-M). All three (Nos. 64, 65 
and 66) plasma samples were tested separately for their 
antibody specificity by double immunodiffusion technique 
and immunoelectrophoresis. The procedure adopted was 
similar to that for testing alpha2-M from purification 
methods (Section-II,2e).
The two protein peaks from IAC were not separated into 
two clear peaks and there was an overlapping. Pooled 
concentrated proteins were a mixture of alpha2-M and IgG.
It is possible to separate this mixture into pure 
alpha2-M and IgG by using affinity chromatography on 
Protein A-Sepharose CL-4B (Pharmacia). However, the high 
cost of the material made it impossible to use. Instead, 
an IAC method was prefered, as anti-sheep IgG was 
available in this laboratory for use in IAC. The 
anti-sheep IgG was coupled to CNBr-Sepharose 4B to purify 
alpha2-M by separating IgG.
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6.IMMUNOAPSORBENT CHROMATOGRAPHY OF IgG
This method was essentially as described for alpha2-M 
purification in Section-II, 2b. Using methods outlined in 
Section-II, 2b anti-sheep IgG (raised in Bristol 
Polytechnic) was coupled to CNBr-Sepharose 4B and
concentrated protein (all fractions from IAC of sheep 
plasma, combining Peaks I and II) was applied on the 
column. Protein fractions were collected at pH 8.0 
contained pure alpha2-M due to IgG retention on the 
column. IgG was eluted with acetate buffer, pH 2.5. 
Results are shown in Figs.20 & 21 in Section-Ill, Expt.l.
The above technique demonstrated that sheep alpha2-M can 
be purified further. However, presence of IgG along with 
alpha2-M was in no way a hinderance in studying
Zn-binding to alpha2-M. It was shown by Prasad (1970) 
that Zn-binding to IgG appeared to be electrostatic in 
nature and &5Zn incubated with human IgG the 
radioactivity did not migrate with the protein peak. The 
Zn-binding to IgG was tested in this study and no 
detectable Zn was bound to IgG as shown in Section-11,7.
Hence, the above method was not used to further purify
alpha2-M. Instead, both IgG and alpha2-M concentrations 
were determined and the difference in concentration 
between total protein and IgG gave alpha2-M concentration 
in the experimental samples.
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7.Zn-BINDING TO IgG
(a). Gel electrophoretic analysis
(b). Gel filtration analysis
(a).GEL ELECTROPHORETIC ANALYSIS
Zn-binding to alpha2-M and IgG were tested using sample 
obtained from IAC on PAGE.
5% polyacrylamide gels were prepared (as described in 
Section-II,2e,iii) in gel tubes. The following samples 
were applied mixed with 20% sucrose.
(i). Concentrated sample from IAC (containing sheep 
alpha2-M and IgG)
(ii). 500 ul concentrated sample (i) mixed with 0.1 uCi
65Zn (0.1 uCi = 0.35 ug Zn) and incubated for 2 hours.
Both (i) and (ii) were mixed with equal volume of 20% 
sucrose solution in distilled water and 10, 20, 30, 40, 
50, 100 and 200 ul were applied to the gels.
After 3 1/2 hours electrophoresis the gel with sample (i) 
was stained with rapid stain (Section-II,p.67) to fix the 
position of alpha2-M and IgG bands. The position of these 
bands were used to locate the protein bands in other 
gels. These were cut out and their radioactive content 
measured in a well type Scaler Ratemeter, SR7 (Nuclear
77
Enterprises).
Results are presented in Appendix-I.
(b).GEL FILTRATION ANALYSIS 
Procedure
Zn-binding to IgG using gel filtration consisted four 
stages of procedure:
(i). Elution of®5Zn
(ii). Elution of IgG
(iii). Elution of IgG incubated with 6$Zn
(iv). Calculations
(i).Elution of s^Zn
A concentration of 1500 jig Zn was used to test the 
Zn-binding to IgG. ®5Zn (obtained from Radiochemical 
Centre, Amersham.) was mixed with cold Zn to obtain final 
concentration of 1500 p g Zn. This Zn concentration was 
made upto 200 p  1 final volume with tris-HCl buffer, pH
7.4 and applied to the columns (Amicon, mini column, 8 x 
60 mm) packed with Sephadex G-200 in 5 mM tris-HCl 
buffer, pH 7.4, containing 0.9% NaCl and 0.02% sodium 
azide, equilibrated and eluted with the same buffer. A
total of 15 fractions of 10 drops (400 pi) collected.
Radiactivity count was taken before sample application
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and after application in each of the fractions. 
Percentage count of radiactivity in each fraction was 
taken and used as blank as explained in (iv).
(ii).Elution of IgG
Stock IgG (Sheep IgG, Product No.15131: obtained from 
Sigma); 7.5 mg IgG in 3 ml tris-HCl buffer (i)) was used 
to obtain 12.5, 25, 50, 75 and 100 i^g IgG concentration 
when made upto 200 u^l with tris-HCl buffer as follows:








Each sample was applied to the column (as in (i)) 
separately. After elution, protein in each fraction was 
monitored using Coomassie Blue Reagent (Spector, 1978; 
Sedmak and Grossberg, 1977).
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(iii).Elution of IgG incubated with «szn
Each IgG solution (as in (ii)) was mixed with each level 
of Zn (as mentioned below)
IgG Stock 65Zn Buffer Final IgG
(pi) (pi) (pi) concentration
(pg/200 ul)
5 50 145 12.5
10 50 140 25.0
20 50 130 50.0
30 50 120 75.0
40 50 110 100.0
and incubated for a period between 10-30 minutes 
(Section-11,10), after which time the sample was applied 
to the column and eluted with tris-HCl buffer.
The radioactivity was determined before application of 
the incubated sample and after elution of the sample, in 




Zn bound to IgG was calculated as follows:
Total counts per minute (C.P.M.) upto the elution volume 
of sample = A
Total C.P.M. when 65Zn alone was applied (upto the
elution volume of sample) = Blank = y
Total C.P.M. of bound 65Zn (B) = A-y
C.P.M. of 50 i^l 65Zn used in incubation = Z
Z counts per minute = micrograms (C) Zn
B counts per minute = B x C/Z ^ ig Zn
Results are presented in Appendix-I.
8.Zn-BINDING TO ALPHA2-M
Zn-binding to alpha2-M was studied using:
(a). Gel electrophoresis analysis
(i). Rod gels, 5% (1 x 25 cms)
(ii). Vertical gel, 5% (0.5 mm thickness)
(b). Gel filtration analysis
(a )ROD GELS. 5%
Rod gel electrophoresis was used to study the influence 
of 50-400 ug of alpha2-M on Zn-binding to alpha2-M (as 
shown in Table-Ill, Expt.2, Section-Ill).
The method is described in Section-IIe, (PAGE). Rod gels 
were of bigger size (1 x 25 cms) and gels were run for 24
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hours in Buchler PAGE apparatus.
Alpha2-M with a concentration of 1 mg/ml was used as 
stock and each sample was incubated for 24 hours with 0.1 
i^Ci 6*Zn (equivalent to 2.0 pg Zn) . Each sample was mixed 
with 20% sucrose before application to the gel as 
follows:






After locating alpha2-M on the gel with rapid stain 
mentioned in Section-II, p.67), gels were cut and count 
was taken on Rackgamma 1270 (LKB) and 65Zn bound to 
alpha2-M was calculated.
(a).VERTICAL GEL. 5%
This technique was used for the following three 
experiments:
(i). Expt.2 (Table-I) in Section-Ill, Zn-binding to 
25-200 fig of alpha2-M:
Alpha2-M with a concentration of 1 mg/ml was used as 
stock from which 25, 50, 100, 200 pi were removed and
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incubated with 0.1 /iCi ®6Zn (equivalent to 0.2 ^ ig Zn) for 
24 hours. After which time 20% sucrose solution was added 
to each sample before application to the gel (&% gel was 
prepared as described in Section-II,2e).
Electrophoresis was carried out at 200V and 45 mA for 10 
hours. After electrophoresis alpha2-M was located using 
rapid stain (Section-II, 2e) and gel was cut and
radioactivity count was taken using Rackbeta II(LKB).
(ii). Expt.2 (Table-II) in Section-Ill, Zn-binding to 
50-500 }ig of alpha2-M:
5% gel was prepared as described in Section-II,2e. From 
alpha2-M stock (concentration 1 mg/ml), 50, 100, 200, 
300, 500 jliI volumes were removed and incubated with 0.1 
/iCi ®5Zn (equivalent to 0.2 p.g Zn) for 24 hours. 40% 
sucrose was added to give a final concentration of
approximately 10% sucrose in samples. This was necessary 
due to limitation of sample slot which could only
accommodate 300 jjlI total volume. However, by using 
modified spacers it was made possible to accommodate 
larger volumes. Electrophoresis conditions were similar 
to the above experiment. Radioactivity count was taken as 
in (i).
(iii). Expt.4 (Table-VI) in Section-Ill, combined effect 
of incubation period and the level of in vitro Cu on in 
vitro Zn-binding to alpha2-M from sheep plasma.
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Alpha2-M was mixed with Cu stock and ®6Zn and incubated 
for 24, 72, 108 and 216 hours. After which time 40%
sucrose and distilled water were added and the volumes 
made upto 200 pi before application to the gel (5% gel 
was prepared as described in Section-II,2e). Volumes of 
solutions were as follows:
Alpha2-M Cu stock 6 5 Zn D.W. 40% sucrose
(pi) (pi) (pi) (pi) (pi)
100 10 10 40 40
100 20 10 30 40
100 30 10 20 40
100 40 10 10 40
100 50 10 _ 40
Alpha2-M concentration = 1 mg/ml 
Cu stock = 1000 fig/ml 
65Zn = O.lpCi = 0.2 fig Zn
Electrophoresis was carried out at 200V, 45 mA for 10 
hours. Radioactivity count was taken as in (i).
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(b).GEL FILTRATION ANALYSIS
Gel filtration technique was used in the following 
experiments to study Zn-binding to alpha2-M.
(i). Influence of increasing amounts of alpha2-M on 
Zn-binding to alpha2-M (Section-Ill, Expt.2, Table-IV) in 
sheep plasma.
(ii). Influence of variable amounts of Zn on Zn-binding 
to alpha2-M (Section-Ill, Expt.3, Table-V) in sheep 
plasma.
(iii). Effect of in vitro Cu levels on in vitro 
Zn-binding to alpha2-M in sheep plasma (Section-Ill, 
Expt.4, Tables-VI & VII).
(iv). Zn-binding to alpha2-M from Cu-deficient sheep 
plasma (Section-Ill, Expt.5).
(v). Zn-binding to alpha2-M from high-Cu sheep plasma 
(Section-Ill, Expt.6).
(vi). In vitro Zn-binding to alpha2-M from the plasma of 
three breeds of pregnant ewes maintained indoors on 




Amicon, mini columns (8 x 60 mm) were packed with 
Sephadex G-200 in 5 mM tris-HCl buffer, pH 7.4, 
containing 0.9% NaCl and 0.02% sodium azide and 
equilibrated with the same buffer. The column rested on 
fraction collector (Redirac, LKB) arm directly above drop 
counter.
Zn-binding to alpha2-M was studied at two levels of Zn 
(150 and 1500 yug). These Zn concentrations were obtained 
by mixing radioactive Zn (obtained from The Radiochemical 
Centre, Amersham.) and cold Zn (non-radioactive Zn).
There were four stages of procedure involved as follows:
(i). Elution of 65Zn (both levels),
(ii). Elution of alpha2-M,
(iii). Elution of alpha2-M incubated with 65Zn,
(iv). Calculations.
(i).Elution of 6*Zn
50 jul 65Zn of each level was made upto 200 pi with 
tris-HCl buffer and after radioactivity count was taken 
using Scaler Ratemeter SR7 (Nuclear Enterprises Ltd.) 
before application to the gel. After application, sample 
was eluted with tris-HCl buffer and a total of 15 
fractions of 10 drops collected. Counts per minute were 
calculated for each fraction as a percentage of counts
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before application. For each elution a separate column 
was used to avoid time wastage.
(ii).Elution of alpha2-M
Each sample of alpha2-M was made upto 200 i^l with the 
addition of tris-HCl buffer and applied on an Amicon, 
mini column packed with Sephadex G-200 and eluted (as in 
(i)). Elution volume of each sample was measured by 
monitoring protein absorbance using Coomassie Brilliant 
Blue reagent (details of the reagent mentioned in 
Section-II, 2f).
(iii).Elution of alpha2-M incubated with 6 5Zn
100 i^l of each sample was mixed with 50 pi of 65Zn (150 
pg Zn and 1500 pg Zn separately) and the volume was made 
upto 200 pi with tris-HCl buffer. This mixture was 
incubated for a period between 10-30 minutes at room 
temperature by shaking gently on a flask shaker. After 
the radiactivity count was taken the sample mixture was 
applied to the gel and eluted with tris-HCl buffer. A 
total of 15 fractions of 10 drops (400 pi) collected. 
Only the volume equivalent to elution volume of the 
sample (as in ii) was measured for radioactivity.
(iv).Calculations
The calculations are similar to Section-11,7. However, in 
experiments iv to vi the concentration of alpha2-M 
differed and consideration of IgG in the sample was
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essential. For this, total protein concentration and IgO 
concentration were measured first. The difference between 
total protein and IgG gave the concentration of alpha2-M 
in the samples from experiments iv to vi. Total protein 
concentration was determined by Coomassie Blue binding 
method (Sedmak and Grossberg, 1977). The IgG 
concentration was determined by single radial 
immunodiffusion (details in Section-II, 11).
Zinc bound was calculated as p.g Zn bound/100 fig alpha2-M, 
after calculating bound Zn as in Section-11,7.
9.IN VITRO COPPER INFLUENCE ON ZINC BINDING TO ALPHA2-M
The following procedure was used in Expt.4 (Table-VII), 
Section-Ill.
Sample incubation procedure
1 ml alpha2-M (1 mg alpha2-M/ml) solution was added to 
each one of five plastic test tubes and 100, 200, 300, 
400 and 500 jil of copper sulphate (500 fig Cu/ml) solution 
respectively was added to tubes 1 to 5. The tubes were 
left shaking for 24 hours incubation in cold room at 4° 
C. After incubation, 110, 120, 130, 140 and 150 ;ul of the 
mixture was transfered from 1, 2, 3, 4, and 5 tubes
respectively. These volumes of the mixture were 
equivalent to 100 fig alpha2-M. These volumes were 
sufficient for 5 incubations each with both levels of Zn.
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To each of these tubes 150 and 1500 jig Zn (®5Zn + cold 
Zn) were added separately and after 10*30 minute 
incubation period at room temperature applied on Sephadex 
G-200 columns (8 x 60 mm.) and eluted as described in 
Section-11,7. Zinc bound to alpha2-M was calculated as in 
Section-II,7.
10.INFLUENCE OF INCUBATION TIME ON ZINC BINDING TO 
ALPHA2-M
To a fixed volume (100 /il) of alpha2-M, variable 
quantities of ®5Zn (equivalent to 0.7, 1.4, 2.1, 2.8 and
3.5 jig Zn) were added and incubated at room temperature 
for 10, 20, 30, 40, 50 and 60 minutes. After incubation
samples were applied on Sephadex G-200 (8 x 60 cms.)
columns, separately, equilibrated with 5 mM tris-HCl 
buffer, pH 7.4, containing 0.9% NaCl and eluted with the 
same buffer. Zinc bound to alpha2-M was calculated as 




Mancini et al (1965) modified Oudins original technique 
by incorporating the antiserum into thin layer of gel and 
placing the antigen into wells cut into the gel.
The antigen diffuses radially and a ring of precipitation
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forms and moves outwards, becoming stationary at 
equivalence. The diameter of the ring is a function of 
the antigen concentration in the well and can be compared 
to a calibration curve of standard antigens.
IgG (Product No.15131) was obtained from Sigma Chemical 
Company, Poole.
(b).PROCEDURE
A glass plate (10 x 20 cms.) was precoated with few drops 
of agarose (1.5%) solution and placed on a plate 
leveller. 50 ml of molten 1.5% agarose solution was 
dispensed into a small test tube in a 56® C water bath.
When the agarose solution reached 56° C, 200 a^l of
anti-sheep IgG (raised in rabbits at Bristol Polytechnic) 
was added and mixed well. The mixture was poured onto the 
precoated glass plate and allowed to set.
After the agarose was set, wells were punched using a 20 
pi gel puncher (LKB) and a template.
Stock IgG (1 mg/ml) was diluted to give 5 p g  IgG/100 pi
and 5, 10, 15, 20 volumes (standards) were dispensed
into 4 wells and in other wells unknown samples were 
dispensed in volumes between 5 to 20 ^ ul and the volumes 
added were made upto 20 ul with saline when less than 20 
pi were added in all cases.
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The glass plate was placed in a diffusing chamber for at 
least 48 hours. After which time pressing, drying and 
staining was carried out as described in 
Section-II,2e(i).
The diameter (d) of each ring was measured on the stained 
plate and d2 of standards was plotted against the 
concentration of the standards used and the concentration 
of unknowns were derived by interpolation from the 
standard curve or specific computer programme.
A typical plate showing single radial immunodiffusion 
analysis of standards is presented in Fig.5.
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Sheep IgG concentration (pg)
Single radial immunodiffusion of IgG standards
12.DETERMINATION OF MOLECULAR WEIGHT OF ALPHA2-M BY
POLYACRYLAMIDE GEL ELECTROPHORESIS
Molecular weight of nondenatured protein was determined 
using Sigma Chemical Co.Ltd. kit no. M.W. ND-500.
(a).PREPARATION OF REAGENTS 
Separating gel buffer
36.3 g tris(hydroxymethyl) methylamine (tris) and 0.23 ml 
N,N,N*,N’-tetramethylethylenediamine (TEMED) were
dissolved in water. The pH was adjusted to 8.9 at 25° C 
with concentrated HC1 and the solution was made upto 100 
ml with water.
Stacking gel buffer
5.98 g tris and 0.46 ml TEMED were dissolved in water and 
pH adjusted to 6.7 at 25° C with concentrated HC1 and 
made upto 100 ml with water.
Acrylamide solution for separating gel
28 g acrylamide and 0.74 g N,N’-methylenebisacrylamide 
were dissolved in water and diluted to 100 ml.
Acrylamide solution for stacking gel
10 g acrylamide and 2.5 g N,N’-methylenebisacrylamide 
were dissolved in water and diluted to 100 ml.
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4 mg riboflavin was dissolved in 100 ml of water. 
(Suitable for use in absence of visible microbial 
growth).
Sucrose solution
5 g sucrose was dissolved in 100 ml of water.
Ammonium persulphate solution
40 mg of ammonium persulphate was dissolved in 5 ml of 
water. (Prepared fresh).
Electrode buffer
1.2 g tris and 5.76 g glycine were dissolved in water and 
diluted to 2 litres. The pH was approximately 8.3 at 25° 
C.
Stored tightly capped at 0-5° C.
Fixative solution 
Mixed:
400 ml methanol 
70 ml acetic acid 
530 ml water
Staining reagent
0.5 g Coomassie Brilliant Blue R-250 was dissolved in 500 




1.0 ml stacking gel buffer, 1.0 ml glycerol and 1.0 ml 
water containing 0.25 mg bromophenol blue were mixed.
(b).PREPARATION OF SAMPLE
The unknown protein (sheep plasma alpha2-M) was prepared 
so that the concentration was about 1 mg protein per ml 
in 5 mM tris-HCl buffer, pH 7.4. The sample was diluted 
with an equal volume of sample buffer.
(c).PREPARATION OF MOLECULAR WEIGHT MARKERS 
Reconstituted each of the protein standard vials with 1.0 
ml of 50 mM NaCl-1 mM sodium phosphate buffer, pH 7.0, 
except urease which was dissolved in 5 ml of water.
Solutions were frozen at -20° C.
Immediately before use, diluted standards with an equal 
volume of sample buffer.
Standards
Urease , Jack bean 480,000 (tetramer)
240,000 (dimer)
Albumin, bovine serum 132,000 (dimer)
66,000 (monomer)
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(d).PREPARATION OF ELECTROPHORESIS GELS
The dimensions of gel tube were, 0.5 cm inner diameter 
and 12.0 cms length. Gels were formed in 20-30 minutes.
(e).PREPARATION OF SEPARATING GELS
Mixed separating gel buffer, acrylamide solution for 
separating gel, ammonium persulphate and sucrose solution 
according to the following Table. The mixture was 
deaerated for one minute with a water pump.
%Gel conc. 4.5 5.0 5.5 6.0 7.0
ml of reagent
Separating gel 1.5 1.5 1.5 1.5 1.5
buffer
Acrylamide sol.1.93 2.15 2.36 2.57 3.0 
for separating 
gel
Sucrose sol. 7.82 7.64 7.40 7.17 6.75
Ammonium 0.75 0.75 0.75 0.75 0.75
persulphate
Solutions were mixed carefully to avoid introducing air
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and then carefully dispensed 1.75 ml of the mixture into 
each gel tube as follows:






Approximately 0.05 ml of water was layered on top of gel 
solution, taking care not to disturb the surface of the 
gel solution and allowed 30 minutes for complete 
polymerisation.
( f K PREPARATION OF STACKING GEL
To prepare the stacking gel solution, the following 
solutions were mixed:
2 ml stacking gel buffer 
4 ml acrylamide solution for 
stacking gel 
2 ml riboflavin solution 
8 ml sucrose solution 
Above mixture was deaerated for one minute using water 
pump. The water layer was removed from polymerised 
separating gels and top of each of the separating gels 
was washed twice with approximately 0.2 ml of stacking
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gel solution. 0.2 ml of stacking gel solution was 
carefully dispensed into each tube. After which, 
approximately 0.05 ml of water was layered carefully on 
top of the gel solution. The gels were polymerised on the 
bench in approximately 30 minutes. After polymerisation 
the gels were used immediately or stored overnight (no 
longer than 24 hours) at 0-5°C, immersed in water.
(g).ELECTROPHORESIS
Water from the top of gel was decanted and the top of gel 
was rinsed with 0.2 ml of electrode buffer twice. After 
which layered electrode buffer on top of each gel to fill 
tube. Samples were underlayed on gels according to 
amounts listed below.
Albumin, bovine serum 15 ^ ul
Urease 100 jil
Unknown (alpha2-M) 100 yul
Compartments of electrophoresis apparatus were filled 
with electrode buffer and electrophoresis was started. A 
constant current of 1 milliamp per gel was applied until 
marker dye (bromophenol blue) was completely through the 
stacking gel (about 1/2 to 1 hour); then increased to 2 
milliamps per gel until the marker dye was one centimeter 
from the anodic end of the gel (about 3 hours).After 
which time power supply was switched off. The gels were 
removed from tubes by injecting water between the gel and
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the glass wall with a syringe, then exerted pressure at 
the end of the tube with a pipette bulb. The migration of 
bromophenol blue dye (centre of the band) was measured 
and noted.
(h).STAINING AND DESTAGING
The gels were immersed in fixative for about 2 hours, 
after which time the gels were left in staining solution 
overnight. The gels were destained in fixative solution 
by diffusion against several changes of fixative solution 
(no longer than 24 hours). Then the gels were transfered 
into 1% acetic acid solution for storage. The gels were 
allowed to stand in acetic acid solution for at least 
three hours before migration distances were read. The 
migration distances of the tracking dye and of the blue 
protein bands were recorded from top of the separating 
gel.
(1).RESULTS
To determine the Relative Mobility (Rf) of a protein, 
divided its migration distance from top of the separating 
gel to the centre of the protein band by the migration 
distance of the bromophenol blue tracking dye from the 
top of the separating gel.
distance of protein migration
Rf =-- - ------------------------------


















Fig.6 Plot of slopes of standard proteins (Urease,Jack bean
(tetramer), 480,000; Urease,Jack bean (dimer), 240,000; 
albumin,bovine serum (dimer), 132,000 and albumin,bovine 
serum (monomer), 66,000 daltons) obtained after non-denatured 
protein PAGE) against molecular weights.
100
100(log(Rf x 100)) values (ordinate) were plotted against 
the gel concentration as percent (abscissa) on standard 
graph paper for each protein. The negetive slopes from 
these graphs (ordinate) were plotted against the known 
molecular weights of the standards (abscissa) on 2 cycle 
log-log paper. The molecular weight of the unknown 
protein (sheep alpha2-M) was determined from the graph 
(Fig.6).
13.DETERMINATION OF MOLECULAR WEIGHT OF ALPHA2-M BY GEL 
FILTRATION ON SEPHADEX 0-200
Procedure
Sephadex G-200 column was equilibrated with 5 mM tris-HCl 
buffer, pH 7.4 and then 10 ml of Blue Dextran solution 
was applied on the column. 10 ml fractions were collected 
and the absorbance was monitored at 280 nm with 
Pharmacia, UV-2 monitor.
After the determination of void volume from Blue Dextran 
elution, 10 ml solution of molecular weight markers 
(Thyroglobulin, 669,000; apoferretin, 443,000;
beta-amylase, 200,000; alcohol dehydrogenase, 150,000;
and bovine albumin, 66,000 were obtained from Sigma 
Chemical Co.,Poole.) mixture was applied on the same 
column and they were eluted with tris-HCl buffer, pH 7.4 
and 10 ml fractions were collected. Calibration curve of
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log molecular weight against Ve/Vo was drawn as shown in 
Fig.8 in Section-Ill.
Protein from large scale purification procedure (after 
centrifugation) was passed through the above Sephadex 
G-200 column and after calculating Ve-VO, the molecular 
weight was read from the calibration curve as shown in 
Fig.8, Section-Ill.




Affi-Gel Blue, 50-100 mesh (Bio-Rad Laboratories 
Ltd.),Whatman column (1 x 10 cms.), 0.02 M phosphate 
buffer, pH 7.1 (Buffer A), Dialysis tubing, 1.4 M NaCl in 
buffer A (Buffer B) and 8M urea in buffer A.
Affi-Gel Blue (Bio-Rad Laboratories, Ltd.) selectively 
adsorbs albumin from serum or plasma. This binding is so 
strong that a high concentration of salt or chaotropic 
reagent is required to desorb the albumin. An Affi-Gel 
Blue column thus provides a simple first step in the 
purification of serum proteins by removing the major 
serum constituent, albumin. This specific property of the 
gel was used to separate zinc bound to albumin and zinc 
bound to alpha2-M pool in plasma of experimental samples.
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The review of literature has shown that sine is bound to 
albumin and alpha2-M in significant amounts and a minor 
proportion to amino acids. All the sine bound to alpha2-M 
pool proteins was mainly considered as alpha2-M bound 
sine. Copper deficient and copper excess sheep plasma 
were subjected to chromatography on Affi-Gel Blue.
Procedure for removing albumin from sheep plasma 
Plasma sample was dialysed overnight against Buffer A. A 
Whatman column was packed with Affi-Gel Blue, with a 
total bed volume of 5 ml per millilitre of plasma. The 
column was washed with 2 bed volumes of Buffer A and then 
dialysed plasma sample(4 ml) was applied on the column. 
Once again the column was washed with 2 bed volumes of 
Buffer A. The effluent from this wash contained the serum 
proteins without most of the albumin (Pool-I). The 
albumin (Pool-II) was eluted with Buffer B. The column 
was regenerated with 2 bedvolumes of 8H urea in Buffer A.
Wash and elution were monitored for protein absorbance at 
280 nm. Only when the absorbance was less than 0.1, 
buffer was changed after wash to elute albumin. 
Similarly, when the absorbance was nearer less than 0.1, 
regeneration of the column was started.
Pool-I and Pool-II fractions were pooled separately and 
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PURIFICATION OF ALPHA 2-MACROGLOBULIN FROM SHEEP PLASMA 
INTRODUCTION
Methods are available for the purification of alpha2-M 
from human plasma, but none are reported for the 
purification of alpha2-M from sheep plasma. However, 
Tunstall and James (1974) indicated compatability of 
anti-human alpha2-M, showing a strong reaction against 
sheep alpha2-M. This offered an opportunity to adapt the 
methods used for human alpha2-M purification to sheep 
alpha2-M purification.
PURIFICATION OF ALPHA2-M
Alpha2-M was purified using two methods, large scale 
purification method (Section-II, 2a) and immunoadsorbent 
chromatography method (Section-II, 2b).
A. RESULTS OF LARGE SCALE PURIFICATION
a. GEL EXCLUSION CHROMATOGRAPHY ON SEPHADEX G-200 
Elution profile of purified sheep alpha2-M is presented 
in Fig.7. Chromatography of the final 50 ml extract 
(Section-II, 2a) showed three distinct peaks and Peak I 

























Fig.7 Elution profile of sheep plasma extract (obtained after centrifugation; details in 
Section-II,2a) on Sephadex G-200 column (5 x 80 cms.); absorbance (smooth line) at 
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Fig.9 Elution profile of human plasma extract (obtained after centrifugation; 
details in Section-II,2a) on Sephadex G-200 column (5 x 80 cms.); 
absorbance at 280 nm. 10 ml fractions were collected.
volume) indicating apparent high molecular weight of the 
protein. The determination of apparent molecular weights 
showed Peaks I, II and III as 700,000; 103,000; 45,000
daltons respectively (Fig.8).
Alpha2-M from human plasma was also purified and elution 
profile (Fig.9) of the final 50 ml extract (Section-II, 
2a) showed three peaks with similar molecular weights as 
above.
b. CHARACTERISATION AND PURITY OF ALPHA2-M 
Three methods were employed for this purpose, double 
immunodiffusion analysis, immunoelectrophoresis and 
polyacrylamide gel electrophoresis.
These methods are described in Section-II, 2e.
i. Double immunodiffusion analysis
All the eight fractions (Fig.7, fr.37-44) from Peak I 
showed a single precipitation line (Fig.10) when tested 
against both anti-human alpha2-M and anti-whole sheep 
serum confirming the presence of alpha2-M.
The use of anti-whole sheep serum to examine the 
fractions from Peak I for any protein other than 
alpha2-M, also confirmed that Peak I consisted of only 
alpha2-M.
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A n t i - s h e e p  s e r u m
Fig,10 Double diffusion analysis of fractions 37-40 
(in positions, 1-4) and fractions 41-44 (in 
positions 5-8) from Peak I (Fig.7) showing 
single precipitation lines when anti-human 
or anti-whole sheep serum was used.
no
Precipitation line
Anti-human alpha2-M or 
Anti-whole sheep serum
Fig.11 A typical immunoelectrophoresis of fractions
from Peak I (Fig.7) showing a single precipita­
tion line when tested against anti-human alpha2-M 
or anti-whole sheep serum.
Positions 1 & 2 fractions from Peak I (Fig.7)
ill
ii. Immunoelectrophoresis
Immunoelectrophoresis of fractions from Peak I against 
both anti-human alpha2-M and anti-whole sheep serum 
confirmed the presence of alpha2-M only (Fig.11).
iii. Polyacrylamide gel electrophoresis
Polyacrylamide gel electrophoresis of pooled and 
concentrated fractions from Peak I (gel filtration on 
Sephadex G-200, Fig.7) on 5% gel, showed a single protein 
band (Fig.12).
All the three tests above strongly suggested that the 
fractions from Peak I contained alpha2-M and no other 
protein, which confirmed that alpha2-M obtained was pure.
c. PRESENCE OF ZINC IN THE PURIFIED ALPHA2-M 
Fractions from Sephadex G-200 column (Fig.7) were 
subjected to atomic absorption to test for the presence 
of zinc. Peak I fractions and some fractions in Peak II 
showed the presence of zinc as in Fig.7. Peak I fractions 
showed up to 0.1 /ig Zn/ml in the peak area which 
gradually reduced towards the end of Peak II. The 
presence of Zn coincided with alpha2-M. Despite the 
presence of Zn and alpha2-M in Peak II, due to the 
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Fig.12 Polyacrylamide gel electrophoresis of
concentrated Peak I (Fig.7) on 5% rod gel 
showing a single protein band which was 
identified as alpha2-M.
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B. IMMUNOAPSORBENT CHROMATOGRAPHY (IAC)
I AC was carried out using both anti-human alpha2-M and 
anti-sheep alpha2-M.
The elution profile presented in Fig.13 shows
purification of alpha2-M from sheep plasma using
anti-human alpha2-M coupled immunoadsorbent column 
(Section-II, 2b). Elution with borate buffer, pH 8.0 
removed most of the plasma proteins except alpha2-M. 
Elution with acetate buffer, pH 2.5 yielded a single peak 
of protein, which was characterised as alpha2-M. These 
results were similar to the results reported by McEntire 
(1978) using human plasma. However, alpha2-M purified on 
anti-human alpha2-M-IAC yielded a single peak first 
(Fig.13), but after using the column for two or three 
times two peaks appeared instead of a single peak. The 
presence of two peaks after IAC, suggested two proteins.
IAC of sheep plasma using the anti-sheep alpha2-M 
(Section-II, 5) coupled to CNBr-Sepharose 4B showed two 
protein peaks as shown in Fig.14.
Fractions from IAC were pooled, concentrated and tested 
to confirm the presence of alpha2-M and the second 
protein using double diffusion analysis,
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Fig.13 Immunoadsorbent chromatography of sheep plasma on CNBr-Sepharose 4B coupled 
to anti-human alpha2-M. Sample volume 4 ml.
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(mmunoadsorbent chromatography of sheep plasma on CNBr-Sepharose 4B coupled 
to anti-sheep alpha2-M, showing two protein peaks after elution with acetate 
buffer pH 2.S.
i. Double immunodiffusion analysis
Pooled and concentrated protein fractions from IAC 
columns (a.anti-human alpha2-M coupled, b.anti-sheep 
alpha2-M coupled) showed a single precipitation line on 
double diffusion against anti-human alpha2-M (Fig.15) 
indicating the presence of alpha2-M. However, using 
antisera against sheep serum showed two precipitation 
lines (Fig.16) confirming the results obtained on IAC 
(Fig.14).
ii. Immunoelectrophoresis
Immunoelectrophoresis of pooled and concentrated 
fractions from sheep plasma IAC also confirmed the 
presence of two proteins (Fig.17).
iii. PAGE
IAC peaks I and II (Fig.14) were combined and 
concentrated and then 50 /il of this was applied on 5% 
PAGE. Results showed two distinct protein bands 
(Fig.18).
Alpha2-M obtained from gel filtration (Song et al, 1975; 
Methods, Chapter, Ila) used in raising antiserum was 
probably contaminated. Among the proteins which were 
likely to be associated with alpha2-M in sheep plasma , 
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Fig.15 Double diffusion analysis of concentrated
fractions,obtained after IAC of sheep plasma 




Fig.16 Double diffusion analysis of concentrated
fractions,obtained after IAC of sheep plasma 





Fig.17 Immunoelectrophoresis of pooled and
concentrated fractions from sheep plasma 
IAC (anti-sheep alpha2-M coupled column) 
against anti-whole sheep serum, showing 
two precipitation lines.
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Fig.18 Polyacrylamide gel electrophoresis of pooled 
and concentrated fractions from sheep plasma 
IAC (anti-sheep alpha2-M coupled column) on 
5% rod gels,showing two protein bands.
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The presence of contaminant was observed in concentrated 
fractions suggested the contaminant present in trace 
amounts. Hence, concentrated alpha2-M from gel filtration 
and IAC methods were tested and tests confirmed the 
presence of a contaminant protein.
IDENTIFICATION OF PROTEIN CONTAMINANT IN ALPHA2-M 
On double diffusion and immunoelectrophoresis of 
concentrated IAC fractions and gel filtration Peak I 
against anti-human transferrin, there was no reaction 
with the contaminant confirming that the contaminant was 
not transferrin.
Double diffusion of concentrated fractions of IAC and gel 
filtration Peak I against anti-sheep IgG (raised in 
rabbits,at Bristol Polytechnic) showed a positive 
reaction (Fig.19). These tests confirmed the contaminant 
(2nd protein) in concentrated IAC fractions and Peak I 
(Fig.7) as IgG.
PURIFICATION OF ALPHA2-M FROM IgG
Contaminated alpha2-M after IAC on an anti-sheep IgG 
coupled CNBr-Sepharose 4B column yielded alpha2-M in pure 
form at pH 8.0 and IgG at pH 2.5. Fractions from these 
peaks were pooled, concentrated and tested against 
anti-whole sheep serum, anti-human alpha2-M and 
anti-sheep IgG. Purified alpha2-M and purified IgG showed
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Anti-sheep IgG
Fig.19 Double diffusion analysis of pooled fractions 
from IAC and gel filtration, Peak I (Fig.7) 
against anti-sheep IgG. Antigen in positions 
as follows:
Unconcentrated, IAC fr. 1 & 5
Unconcentrated, Peak I 2 & 6
Concentrated, IAC fr. 4 & 8
Concentrated, Peak I 3 & 7
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A.W.S.S.
Fig.20 a Immunoelectrophoresis of purified sheep
alpha2-M (position 2) and purified IgG
(position 1) against anti-whole sheep serum 
(A.W.S.S.) .
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Fig.20b Photograph showing immunoelectrophoresis of sheep





Fig.21 Immunoelectrophoresis of purified sheep 
alpha2-M (position 1) and purified IgG 
(position 2) against anti-human alpha2-M (A.H .A.) 
and anti-sheep IgG (A.s.IgG).
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a single precipitation line against each of the anti-sera 
(Figs.20a and 21). Fig.20b shows a single IgG 
precipitation line against anti-whole sheep serum 
compared to several plasma proteins with sheep plasma.
Further purification of alpha2-M using an anti-IgG 
coupled CNBr-Sepharose 4B was a new modification 
(Section-II, 6) resulting from these studies to remove 
IgG when it is present as contaminant associated with 
sheep plasma alpha2-M.
FURTHER PURIFICATION OF ALPHA2-M BY PREPARATIVE 
ISOELECTRIC FOCUSING AND DETERMINATION OF ISOELECTRIC 
POINT \
Isoelectric focusing (Section-II, 3) yielded 4 peaks 
(Fig.22). Peak III was identified as alpha2-M after 
imrounoelectrophoresis (Fig.23a). Peak III from 
electrofocusing was also subjected to
Immunoelectrophoresis against anti-whole sheep serum to 
test the purity of alpha2-M. Results shown in Fig.23b 
confirmed that alpha2-M was pure.
Isoelectric point of 4.8, was obtained (Fig.22) using two 
different mixtures of Ampholines (pH 3.5-10 and a mixture 






















Fig.22 Preparative Isoelectric focusing in 110 ml column
(LKB). 1% Ampholines (3.5 - 10.0) were used. Voltage 












Fig.23a Immunoelectrophoresis of Peaks I, II, III and






Fig.23b Immunoelectrophoresis of Peak III (Fig.22)
against anti-whole sheep serum (A.w.s .s.).
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DISCUSSION
Sheep plasma alpha2-M was purified successfully following 
two methods used for obtaining pure alpha2-M from human 
plasma (Song et al, 1975; McEntire, 1978).
Adaptation of large scale method (Song et al, 1975) 
yielded sheep plasma alpha2-M nearer to 100% purity in 
agreement with Song et al (1975) as in human plasma. 
However, trace amounts of IgG in association with sheep 
alpha2-M were discovered only after raising antiserum to 
sheep alpha2-M, using alpha2-M purified as above (Song et 
al, 1975).
The presence of transferrin (Boyett and Sullivan, 1970) 
and beta-globulin (Song et al, 1975) were reported in 
human plasma alpha2-M. However, association of 
transferrin with alpha2-M was observed in crude 
preparations of alpha2-M (Boyett and Sullivan, 1970) from 
normal and cirrhotic serum. Song et al (1975) reported 
beta-globulin on immunoelectrophoresis of purified human 
alpha2-M preparations but not on double diffusion and 
stressed the importance of immunoelectrophoresis in 
detecting the presence of contaminants. In this study 
presence of IgG as a contaminant in purified sheep 
alpha2-M may be due to the existence of species 
differences.
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In this study alpha2-M purified from both sheep plasma 
and human plasma showed three protein peaks (Figs.7 & 9). 
Whereas, Song et al (1975) observed a single protein peak 
when human plasma was subjected to the same method. Their 
observations failed to report the appearance of three 
protein peaks after gel filtration of human plasma 
extract. These three peaks in human plasma extract 
differed from sheep. Peak I was dominant in human plasma 
extract compared to the other two peaks. Whereas, in 
sheep plasma extract Peak II was dominant followed by 
Peak I and Peak III was much smaller.
Appearance of IgG as a contaminant in sheep alpha2-M 
preparations was not reported before. IgG presence in 
association with alpha2-M suggests stronger attachment in 
sheep plasma than in human plasma. In view of this it is 
necessary to take precautions to remove IgG during 
purification of sheep alpha2-M, particularly with the 
method of Song et al (1975). However, the presence of IgG 
could be ignored in Zn-binding studies due to lack of 
Zn-binding to IgG as shown in Appendix-I.
Among the methods used for the purification of human 
alpha2-M, the method described by Barrett (1981) dealt 
with contaminants more thoroughly than other techniques. 
According to Barrett (1981) a 95% pure human alpha2-M is 
suitable for many purposes and non-denatured PAGE or 
immunoelectrophoresis against anti-human serum proteins,
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scarcely detects contamination. Barrett (1981) 
used,immunoadsorbents (CNbr-Sepharose 4B) coupled to all 
human immunoglobulins, immunoglobulin A,
alpha2-pregnoglobulin,haptoglobulin and fibrinogen to 
remove the remaining 5% other proteins to obtain 100% 
pure human alpha2-M. However, this is too expensive and 
in most cases this high purity may not be required.
In this study sheep alpha2-M fractions demonstrated 
presence of up to 0.1 jig Zn/ml (Fig.7). Song et al (1975) 
did not measure Zn in the fractions.
Trypsin binding activity of alpha2-M was studied during 
purification stages by Song et al (1975), but in this 
study, their method was used primarily to obtain starting 
material in pure form to raise antibodies to sheep 
alpha2-M and for preliminary investigations.
Preparative isoelectric focusing was used successfully as 
a final step for further purification.
In this study electrofocusing of sheep alpha2-M using two 
different mixtures of ampholines yielded the same pi 4.8. 
Barrett et al (1979) showed electrofocusing an equal 
mixture of S and F-forms of human alpha2-M, that both 
showed the same isoelectric point, 5.2. However, Ohlsson 
and Skude (1976) reported a large change in pi of human 
alpha2-M (from 5.0 to 6.0) associated with the complexing
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of a proteinase. The differences in isoelectric point 




ZINC BINDING TO ALPHA 2-MACROGLOBULIN IN SHEEP PLASMA 
INTRODUCTION
Parisi and Vallee (1970) were the first to report that 
alpha2-M was a Zn-binding protein.
The concentration of alpha2-M is known to vary between 
men and women (James et al, 1966a), infants and adults 
(Ganrot and Schersten (1967), during pregnancy (Ganrot 
and Bjerre, 1967) and in ataxia telangiectasia, atopic 
dermatatis, mongolism and diabetes mellitus (James et al, 
1966a).
Despite observing variable concentrations of the 
Zn-binding alpha2-M (Parisi and Vallee, 1970), no 
published reports have been found which show a 
relationship between variable concentrations of alpha2-M 
and Zn-binding.
Therefore studies were carried out to examine the 
relationship of variable concentrations of sheep plasma 
alpha2-M on Zn-binding using the techniques as follows:
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i. PAGE in 5% vertical gel,
ii. PAGE in 5% rod gels,
iii. Gel filtration on Sephadex G-200.
Details of Zn-binding to alpha2-M using 5% rod gels, 5% 
vertical gel and gel filtration on Sephadex G-200 are 
described in Section 11,8.
RESULTS
i. Zn-binding to alpha2-M (Table-I and Fig.24) was
considered in three stages a. alpha2-M concentrations
between 25-200 jug, b. alpha2-M concentrations between 
25-50 jig and c. alpha2-M concentrations between 50-200
/ig-
Zn-bound to alpha2-M increased from 0.00156 to 0.0110 pg 
Zn, which was 605% increase (Table-I) corresponding to an 
increase in alpha2-M concentration from 25 to 200 pg 
(700% increase), . A 13.0% decrease in g-atoms Zn/mol of 
alpha2-M was observed during the same change in the 
concentration of alpha2-M.
Zn-bound to alpha2-M increased by 143.6% when the 
concentration of alpha2-M was increased from 25 to 50 pg 
(100%). g-atoms Zn/mol of alpha2-M increased by 21.7% 















25 535 0.00156 0.69
50 1293 0.00380 0.84
100 1697 0.00490 0.55
200 3712 0.01100 0.60
65
Zn added *  0.1 pCi = 0.2 pg Zn
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ALPHA2-M (pg)
Fig.24 Zn-binding (Counts per minute of 65Z n ) to alpha2-M on 5 per cent PAGE 
(Vertical gel). Constant current, 50 mA;for 10 hours. 65Zn added, 0.1 
pCi * 0.2 ug Zn. Alpha2-M incubated with 65Zn for 24 hours at 4° C before 
application.
Zn-bound to alpha2-M increased by 189.5% in response to 
an increase in alpha2-M concentration from 50 to 200 jig 
(300%). Whereas, for this increase in alpha2-M, showed a 
28.6% decrease in g-atoms Zn/mol alpha2-M.
Fig.l shows Zn-binding to alpha2-M increased in a linear 
fashion from 0.00156 to 0.0110 jig Zn corresponding to 
alpha2-M increase from 25-200 jig.
At 200 jig of alpha2-M concentration (Table-I), 55 jig of 
Zn was bound to 1 g of alpha2-M, which was equivalent to 
1 g-atom Zn/mol of alpha2-M.
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Results in Table-II and Fig.25 showed an increase in jig 
*5Zn bound, from 0.0136 to 0.0298 (119% increase),
corresponding to an increase in alpha2-M from 50 to 200 
jig respectively. Corresponding g-atom Zn/mol alpha2-M 
showed a drop of 45%. This decrease was even more, 89% 
(from 3.02 to 0.32 g-atoms Zn/mol of alpha2-M) when 
alpha2-M concentration increased from from 50 to 500 jig. 
The Zn bound to 500 jig of alpha2-M was only 7.3% higher 
than that of 50 jig of alpha2-M.
Fig.25 showed that at alpha2-M concentration of 200 jjg, 
maximum concentration of Zn was bound. At this point 149 
p.g Zn was bound to 1 g of alpha2-M.
At 50 jig of alpha2-M concentration 3.02 g-atoms Zn/mol 














50 5908 0.0136 3.02
100 9993 0.0230 2.55
200 12887 0.0298 1.65
300 8706 0.0201 0.74
500 6331 0.0146 0.32
65
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ALPHA2-M (jjg)
65Fig.25 Zn-binding (Counts per minute of Zn) to alpha2-M on
5% PAGE (Vertical gel). Constant current, 50 mA; run 
for 10 hours.
65
Zn added = 0.1 juCi = 0.2 j i g  Zn
65 OAlpha2-M incubated with Zn for 24 hours at 4 C
before application.
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ii. Maximum *5Zn binding (Table-Ill) in rod gels was 
observed at at 200 jig concentration of alpha2-M. Increase 
in alpha2-M concentration from 50 to 400 jig (700% 
increase) showed 38.8% increase in jig 65Zn bound (0.85 to 
1.18 jag Zn), but g-atom Zn/mol of alpha2-M showed a 
decrease of 82.7%. At the point of maximum Zn binding 
(Table-Ill & Fig.26) 5.9 mg of Zn was bound to 1 g of 
alpha2-M. It appears that from 200 to 400 jig alpha2-M 
concentration a steady state of Zn binding or equilibrium 
was achieved.
The results in Table-Ill demonstrate increased Zn-binding 
to alpha2-M with increase in alpha2-M concentration. 
However, at molar level, g-atoms Zn/mol of alpha2-M 
decreased from 188.70 to 32.70, when alpha2-M was 
increased from 50 to 400 jig, indicating distribution of 
Zn to all available Zn-binding sites.
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Table-Ill










50 6685 0.85 188.70
100 8147 1.04 115.35
200 9267 1.18 65.44
400 9271 1.18 32.70
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ALPHA2-M ( j i g )
Fig.26 Zn-binding (Counts per minute of ^ Z n )  to
alpha2-M on 5 per cent (rod gels, 1 x 25 cms. ) 
PAGE for 24 hours at constant current, 1.5 mA/ 
tube. Zn added, 1.0 j i C i = 2.0 ug Z n . Alpha2-M 
incubated with 65Zn for 24 hiurs at 4° C before 
application.
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ill. A STUDY OF INCREASING ALPHA2-M CONCENTRATION ON
Zn-BINDING (GEL FILTRATION)
Results presented in Table-lV and Fig.27 indicated a 
significant (P<0.001) decrease throughout in Zn-binding 
to alpha2-M as the concentration of alpha2-M incresed 
from 50 to 250 jig. From a mean of 200.30 jig Zn bound/100 
jig alpha2-M reduced to a mean of 7.20 pg Zn/100 fig 
alpha2-M. On a weight basis g-atoms Zn/mol of alpha2-M 
reduced from 222.16.102to 7.98.102.
Comparison of Zn-bound to 50 and 250 fig of alpha2-M 
(Table-IV), showed a decrease of 96.4% at 250 i^g alpha2-M 
and most of the decrease observed (78%) was at 100 fig 
alpha2-M concentration. Percentage decreases between 




Zn- binding to 50- 250 pg of a!pha2-M incubated 
with 1500 pg Zn.
pg Zn Bound / 100 pg alpha2-M
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(fig) Mean S.E.M.
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F ig  .27 Mean Zn-binding to alpha2-M obtained Irom sheep plasma 
incubated with 1500 pQ Zn.
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DISCUSSION
The most interesting observation from the polyacrylamide 
gel electrophoresis studies (Tables-I, II & III) was that 
in all three experiments, maximum concentration of 65Zn 
was bound to 200 pg of alpha2-M. In Tables-I, II & III 
the concentrations of 0.0110, 0.0298 and 1.18 p g 65Zn
bound respectively to 200 p g alpha2-M. The wide variation 
in the concentration of Zn bound to 200 pg of alpha2-M 
could be due to (i) binding of Zn to different binding 
sites varying in their affinity towards Zn, (i i) 
differences in the concentration of 65Zn added to 
alpha2-M. The existence of binding sites with varying 
affinities is supported by the studies of Adham et al 
(1977) who reported two classes of binding sites for Zn 
on alpha2-M, one with greatest affinity for Zn had an 
apparent stoichiometry (nlin g-atoms/mol of alpha2-M 
monomer) of 12 and an apparent association constant (Kl) 
of 3.06.107 . The second binding site had an n2of 60 and 
K2 of 1.32.105, with much less affinity. Presence of two 
classes of Zn-binding sites, a pair of sites per alpha2-M 
tetramer with highest affinity for Zn and a second class 
of Zn-binding sites with much lower affinity for Zn were 
also reported recently by Gettins and Cunningham (1986). 
Foote and Delves (1984) reported a poor correlationship 
between the concentration of alpha2-M and its associated 
zinc was subject to considerable variation. Even with a 
fourfould difference between the highest and the lowest
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points obtained (ratio of alpha2-H to Zn,0.5 to 2.2). 
Foot and Delves (1984) suggested that the alpha2-M bound 
Zn fraction is itself subject to metabolic control. This 
metabolic control could be excercised by dietary 
concentrations of Zn and Cu and subsequently the liver, 
which was shown to respond to alterations of Zn and Cu in 
the diet (Bremner et al,1976).
Despite agreement with Foot and Delves (1984) in 
observing considerable variations in Zn-binding to 
alpha2-M, their in vivo observations were in human serum 
and in this study Zn-binding was studied in vitro. The 
differences were not only in animal species but also in 
the technique used.
In Tables-I, II and III g-atoms Zn/mol alpha2-M decreased 
reflecting the ratio of Zn (conc. of Zn was kept 
constant) to alpha2-M by weight. As the concentration of 
alpha2-M increased the concentration of Zn which was 
maintained at a single level, in each of the experiments 
was bound to all the available Zn-binding sites.
In Tables-I, II and III initially, more Zn was bound upto 
200 pg concentration of alpha2-M and it appeared to reach 
an equilibrium for the level of Zn available in each of 
the experiments. Above 200 fig concentration of alpha2-M 
there was no increase observed in bound Zn compared to 
200 pg concentration of alpha2-M. The overall trend of
150
decrease in Zn-binding was more clearly observed in 
g-atoms Zn/mol of alpha2-M in Tables-II, III and IV.
Results in this study demonstrated and confirmed that 
electrophoretic disruption of protein metal interaction 
did not take place contrary to suggestions made by Song 
and Adham (1979) and PAGE was used successfully. In this 
study 5% polyacrylamide gels were used in studying 
Zn-binding to alpha2-M and the results show similar trend 
in vertical as well as rod gels. There was no indication 
of gel percentage used in the work of Song and Adham 
(1979) and the use of gel with higher percentage could 
easyly be a factor rather than the technique. However, it 
is possible to encounter problems particularly when using 
vertical gel electrophoresis. Despite an advantage, where 
all samples were subjected to similar electrophoretic 
conditions, it is possible for samples and radioactivity 
to overlap. This problem was overcome in this study by 
leaving a blank sample slot or two, between two samples.
Pratt and Pizzo (1984) showed that on non-denatured 
polyacrylamide gel electrophoresis of alpha2-M, subunit 
dissociation was promoted by the presence of metal ions 
(not all divalent metal ions) of the same oxidation state 
or orbital structure. Alpha2-M in the presence of 400 u^M 
concentrations of Cu, Hg and Zn showed a marked decrease 
in the activity of alpha2-M, and this was due to 
reduction in the stability of intersubunit noncovalent
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interactions (Pratt and Pizzo, 1984). However, there is 
no evidence to suggest that Zn-binding is effected when 
non-denaturing PAGE was used.
Alpha2-M incubated with low concentration of Zn (Tables-I 
and II) showed lower Zn-binding than at higher 
concentration of Zn (Tables-III and IV) and only a part 
of the total Zn was bound to alpha2-M. These results 
indicated that alpha2-M has greater Zn-binding capacity. 
When, the capacity of Zn-binding was more than the 
utilisable Zn, bound Zn decreased as in Tables-II and III 
after 200 yug concentration of alpha2-M. It is apparent 
that irrespective of the concentration of Zn added 
alpha2-M can only utilise part of the total Zn available.
Maintaining a constant concentration of Zn (1500 yug) and 
varying the concentration of alpha2-M from 50 to 250/*j has 
shown that alpha2-M has the capacity to bind more zinc 
and the available zinc was shared by the binding sites 
available and increasing the alpha2-M concentration has 
decreased the concentration of Zn bound to alpha2-M. 
Whether, a similar response to increased Zn levels 
against a constant concentration of alpha2-M was possible 
will be investigated in the next experiment.
Results in Table-IV showed that when more Zn was 
available alpha2-M appeared to have the capacity to bind
152




INFLUENCE OF VARIABLE AMOUNTS OF Zn ON Zn-BINDING TO 
ALPHA2-M
INTRODUCTION
In the earlier experiments it was shown that the capacity of 
alpha2-M to bind Zn depends upon the level of Zn with which it 
is associated. It was also shown that only a proportion of the 
available Zn is bound to increasing concentrations of 
alpha2-M.
Further study of Zn-binding properties of alpha2-M was carried 
out to examine whether a relationship exists between variable 
Zn concentration and alpha2-M.
RESULTS
Results presented in Table-V and Fig.28 showed a linear 
relationship between the amount of Zn added to that of 
alpha2-M, which was kept constant at 100 pg. As the Zn 
concentration increased from 150 pg Zn to 3000 pg Zn, the 
uptake of Zn increased from 14.45 to 293.41 mean p g Zn 
bound/100 pg of alpha2-M. Twenty times more Zn was bound to 
alpha2-M during an increase in added Zn from 150 to 3000 p g  Zn 
(20 times increase). These results are highly significant 
(P<0.001).
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The g-atoms Zn/mol of alpha2-M increased from 16.03.102 to 
325.44.102 consistent with the increase in Zn concentration.
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Iablfc-¥
Zn- binding to 100 pg of alpha2-M on varying incubated
Zn from 150- 3000 pg.
pg Zn Bound/100 pg alpha2-M
Zn added 
(MS) No. Mean S.EM.
g-atoms Zn/ 
mol alpha2-M
150 5 14.45 ±0.03
2
16.03.10
300 5 28.06 *>•»■ 4 1.03
2
31.12.10
450 5 45 21 a™ 4 1.47
2
50.14.10
750 5 74.55 ± 0.61
2
82.69.10
1500 5 150.90 *** ±1.84
2
167.37.10
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F ig .28 Mean Zn-blndlng to 100 pg of atpha2-M ebtafotd from shtap 
platma.on varying incubatad Zn from 150 to 3000 pg.
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DISCUSSION
Increased Zn concentration in the incubation mixture with 
alpha2-M has shown a linear relation ship (Table-V, Fig.28) 
when the concentration of alpha2-M was constant (100 jig). 
These results confirmed the earlier observations that alpha2-M 
has the capacity to bind Zn possibly far in excess of the 
concentrations reported.
The studies of Adham et al (1977) showed that saturation of 
Zn-binding site 1 with Zn did not have any effect. However,at 
20 g-atoms Zn/mol alpha2-M, 25% of trypsin binding activity 
was lost and at 70 g-atoms Zn/mol alpha2-M practically lost 
all trypsin binding activity. Alpha2-M dialysed against EDTA 
buffer did not restore the activity. On the basis of these 
observations they concluded, that the occupation of the second 
binding site by Zn, initiated an irreversible conformational 
changes in the molcule interfering with trypsin binding 
activity. They suggested that each mol of alpha2-M may bind 
upto 70 g-atoms Zn before all of these sites are saturated. 
Gonias et al (1984) are in agreement with this.
Gonias et al (1984) showed that incubation of human alpha2-M 
with 5 fiH to 1.0 mM ZnCl2 solutions did not precipitate. 
However, alpha2-M-trypsin and alpha2-M-methylamine
precipitated (80%) in concentrations over 0.2 mM ZnCl2. They 
showed that these precipitated proteins contained fast forms 
of alpha2-M and involved metal ion-induced conformational 
changes in the alpha2-M as reported by Adham et al (1977). No
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precipitation of alpha2-M was observed in this study using 
upto 3000 jig Zn in vitro (230 mM), which suggests absence of 
fast-form of alpha2-M. These studies indicate the possibility 
of higher Zn-binding values and results in this study 
confirmed these high values subject to the availability of Zn.
In their dialysis studies Adham et al (1977) showed 50% 
higher Zn concentration in human alpha2-M than that of the 
albumin based on the weight of protein . In terms of g-atoms 
Zn/mol of protein,the Zn content of alpha2-M was 20 times 
higher than that of albumin (Adham et al,1977). In subsequent 
experiments sheep alpha2-M and albumin will be examined for 
their binding affinities.
Evidence from these in vitro experiments show that the 
alpha2-M has a greater Zn-binding capacity than has been 
previously accounted for from in vivo observations. Pratt and 
Pizzo (1984) suggested that the 30-40% of zinc bound to human 
alpha2-M claimed by Parisi and Vallee (1970) is more likely to 
reflect a maximum proportion of zinc bound to alpha2-M, which 
is not normallyfound in normal in vivo states.
The results in Table-V showed the g-atoms Zn/mol of alpha2-M 
far in excess of 70 g-atoms Zn for human alpha2-M (Adham et 
al, 1977), which strongly suggests the possibility of 
conformational changes occuring in sheep alpha2-M in response 
to higher Zn concentrations, as oberved by Adham et al (1977) 
in human plasma alpha2-M. In sheep the possibility of higher 
Zn concentrations, particularly through ingestion of diets or
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dietary imbalances created by Cu antagonism, though remote, 
should be considered. In the subsequent studies experimental 
evidence will be presented .in support of the hypothesis that 
dietary Cu concentration influences Zn-binding to alpha2-M in 
sheep plasma and is dependent on the ratio of dietary 
concentrations of Cu and Zn.
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EXPERIMENT-4
AN IN VITRO STUDY OF THE COMPETITIVE BINDING BETWEEN
COPPER AND ZINC FOR ALPHA 2-MACROGLOBULIN 
INTRODUCTION
In this experiment the influence of Cu on Zn-binding to 
alpha2-M was examined and was related to the 
concentration of Cu and Zn in the diet.
Two techniques of study were used for this, PAGE and gel 
filtration on Sephadex G-200. Details of these methods 
are described in Section-II.
RESULTS
Results are presented in Table-VI and Fig.29. When the 
effect of Cu upon Zn-binding was studied using the gel 
filtration binding method (Section-II, 8b) there was a 
significant (P<0.001) decrease in Zn-binding to alpha2-M 
at level-I (150 p g Zn), when the Cu concentration was 
increased from 5 to 25 fig Cu. Increasing the 
concentration from 5 to 10 p g  Cu does demonstrate a 
significant (P<0.001) increase in Zn-binding. Higher 
concentration of Cu, however, has decreased the affinity 
of Zn to alpha2-M, resulting in 55.8% reduction with 25 
pg Cu, compared to the Zn-binding at 5 p g  Cu level. This 
effect was also seen with level-II Zn (1500 p g Zn) and 5
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Table-.-VI
Effect of in vitro Cu (5-25 pg) and in vitro Zn 




Cu added No. of Zn/ mol





















25 5 8.11ftftfc ±0.52
2
8.99.10
ftftft p < o.OOl
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Table-VII
Effect of In vitro Cu (5*25 pg) and In vitro Zn 
(1500pg) on Zn-binding to alpha2*M in sheep plasma.
Cu added No. of




(pg) assays Mean S.E.M. a!pha2*M
5 5 170 .55*** ±0.84
2
198.16.10
10 5 158.98 66* ±3.19
2
176.33.10
15 5 113.47*66 ±4.96
2
125.85.10
20 5 126.98 *6* ±2.82
2
140.84.10
25 5 98.98*** ± 2.24 109.78.10*
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Pig.29 The effect of in vitro Cu (5-25 ug) and two
(150 and 1500 ug) on Zn-binding to alpha2-M 
sheep plasma using gel filtration method.
levels of Zn 
obtained from
to 25 pg Cu (Table-VII, Fig.29). There was a 42% decrease 
in Zn-binding. A significant (P<0.001) decrease was 
observed at each Cu level compared to binding in the 
presence of 5 pg Cu.
In contrast there was no clear relationship between Cu 
and Zn-binding when 5% PAGE was used. There was a trend 
to decreased Zn-binding with concentrations of 10-30 p g  
Cu but this was reversed with 50 p g  Cu. This effect of Cu 
was less marked at 72 hours when the binding of Zn was 
with the exception of the 30 p g sample, similar.
Results presented in Table-FIII and Fig.30 show a similar 
trend in percent 6$Zn bound, p g 65Zn bound and g-atoms 
Zn/mol of alpha2-M.
Although the following results are those of single values 
for increases in copper concentration,they do however 
reflect a trend of importance which needs further 
confirmation.
When the influence of each Cu concentration was assessed 
different trends emerged. The effectiveness of Cu level 
in the incubation mixture was assessed by increase and 
decrease in p g 65Zn bound and g-atoms Zn/mol of alpha2-M 
in all.









TABLE- V1H Effect of in vitro Cu ranging from 10 to 50 jj.g and 
Zn, incubated for 24 to 216 hours on Zn-binding to 
alpha2-M in sheep plasma.
Hours of Incubation
■ ............  ' 24 72 108 216
_ _ ___ %R57n hnnnd 5.4 8.7 4.3 3.6
10 ua65 Zn bound 0.0110 0.0174 0.0086 0.0073
q-atoms Zn/mol alDha2-M 1.22 1.93 0.95 0.81
. ............%65Zn .hound.. 3,4 ..7 ,5 ............ 2.1 2.6
2 0 fig65 Zn bound 0.0068 0.0152 0.0041 0.0052
g-atoms Zn/mol alpha2-M 0.75 1.68 0.45 0.58
............%657n hni ind__ __2.6...... 3.7 . . . .  2*7.— . 4.5
3 0 fig bound 0.0053 0.0073 0.0054 0.0090
g-atoms Zn/mol alpha2-M 0.59 0.81 0.60 1.00
%657n hnnnri 2.96 7.57 2.25 7.2
4 0 uq65 Zn bound 0.0059 0.0151 0.0045 0.0144
g-atoms Zn/mol alpha2-M 0.65 1.67 0.50 1.60
............ .%65Zrtbound__ 7.0 8.4 3.94 3.8 .
5 0 pg 65 Zn bound 0.0141 0.0168 0.0079 0.0076
q-atoms Zn/mol alDha2-M 1.56 1.86 1 0.87 0.84
65
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20 ug Cu ▲ 
30 ug Cu •
50 ug Cu ■
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INCUBATION PERIOD (1IOURS) X I 0
Fig.30 Effect of Cu CIO-50 ug) and incubation period 
(24-216 hours) on Zn-binding to alpha2-M using
5 per cent PAGE (vertical gel).
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effective at 72 hours and most effective at 216 hours 
(Table-VIII, Fig.30).
Concentration 20 fig Cu with alpha2-M was least effective 
after 72 hours and most effective after 108 hours 
(Table-VIII, Fig.30).
Incubation of alpha2-M with 30 fig Cu was least effective 
after 216 hours and was most effective after 24 hours 
(Table-VIII, Fig.30).
Alpha2-M incubated with 40 fig Cu was most effective after 
108 hours and least effective after 72 hours (Table-VIII, 
Figs.30).
Cu concentration of 50 fig was most effective after 216 




Two experiments have essentially been carried out under 
the title for Expt.4; these differed in technique and 
method in the study of the competition between Cu and Zn 
for alpha2-M binding.
The differences between these two were: 1.Cu was
presented to alpha2-M before the two levels (150 /ig and 
1500 pg Zn) of Zn were added; gel filtration was then 
used.
2.Cu was presented with Zn simultaneously to alpha2-M; 
PAGE was then used.
The essential result from these approaches showed 
evidence that whilst Cu (in vitro) can compete with Zn 
for binding to alpha2-M, the time of exposure (or 
incubation) of both these elements to alpha2-M was 
important. This became obvious when the in vitro Cu was 
incubated alone for 24 hours with alpha2-M because the 
first experiment using the gel filtration technique 
showed less alpha2-M bound Zn than when Cu with Zn were 
incubated together for periods between 24-216 hours with 
alpha2-M when the second experiment using the PAGE 
technique showed more Zn bound to alpha2-M.
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The first experiment:
1. EFFECT OF IN VITRO Cu ON IN VITRO Zn-BINDING TO 
ALPHA2-M IN SHEEP PLASMA
Results in Tables-VI & VII (Fig.29) showed significantly 
(P<0.001) decreased Zn-binding to alpha2-M after 24 hours 
incubation with Cu concentrations between 5 to 25 pg. 
This result was shown at both levels of in vitro Zn, viz. 
150 and 1500 pg Zn (Fig.29). This supported the results 
during 24-216 hours in Table-VIII using the PAGE 
technique. Thus demonstrating clear evidence of in vitro 
Cu decreasing Zn-binding to alpha2-M.
65Zn was added 10-30 minutes before application on gel 
filtration column to assay the bound Zn. Thus the 
alpha2-M incubated Cu was probably occupying a weaker 
class of Zn-binding site on alpha2-M prior to exposure to 
150 pg Zn and 1500 ^ ig Zn as shown in Tables-VI & VII, 
Fig.29. Hence, despite increase in Zn-binding at 10 u^g Cu 
concentration the over all trend showed a decrease in 
Zn-binding to alpha2-M at both levels of Zn.
Adham et al (1977) further supported by Pratt and Pizzo 
(1984), Gettins and Cunningham (1986) classified 
Zn-binding sites on human alpha2-M into two, sites 1 and
2, strong Zn-binding and weaker Zn-binding respectively. 
It would appear from these results assuming sheep
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alpha2-M have similar binding properties that the Cu 
competing and partially replacing bound Zn has taken 
place on sites 2 (Adham et al, 1977) on alpha2-M.
The second experiment:
2.COMBINED INFLUENCE OF IN VITRO Cu. Zn AND INCUBATION 
PERIOD ON Zn-BINDING TO ALPHA2-M
Results of Zn-binding to alpha2-M (Table-VIII, Fig.30) 
showed two clear phases. During the first phase, upto 72 
hours, alpha2-M bound Zn increased with 10-50 fig of in 
vitro Cu. During the second phase, from 72 to 216 hours, 
the alpha2-M bound Zn decreased at all levels of in vitro 
Cu (10, 20, 40 and 50 fig), except at 30 fig Cu level. The 
rise in Zn-binding during the first phase was probably 
due to the availability of Zn-binding sites which were 
demonstrating greater affinity, as in Adham1s et al 
(1977) sites 1, for Zn than Cu. Support for this view is 
. available from the studies of Pratt and Pizzo (1984). 
They showed that under electrophoretic conditions 
employed in their study, some subunit dissociation took 
place. Thus Zn could have become bound to the available 
Zn-binding sites on such subunits.
The results in the current study demonstrated and 
confirmed that Zn-binding was influenced by Cu and the 
differences in the concentrations of Zn, Cu and the
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period of incubation appeared to be responsible for the 
decrease in Zn-binding to alpha2-M. The differences 
observed could be due to competition for the sites 
between Cu and Zn at both high and low affinity (strong 
and weaker) sites.
During an incubation period of 216 hours the variation in 
Zn-binding reduced by over 40% for most of the incubation 
times with the different Cu concentrations used. Thus 
possibly demonstrating the importance of adequate 
incubation time to allow this decreased effect when both 
Cu and Zn are in the incubation medium. The influence of 
Cu in this competition is further supported on comparison 
of the results in Table-VIII with Table-V (Expt.3) where 
the results were obtained in the absence of Cu.
It is possible that there may be stereochemical factors, 
shown by Banaszak et al (1965) in human myoglobin with 
two specific binding sites, one for Cu and another for 
Zn, similar factors may be responsible in sheep plasma 
alpha2-M which can influence Zn-binding in preference to 
Cu during the first phase. Such stereochemical factors 
could influence binding affinities of Cu and Zn. Though 
the situation is different in sheep alpha2-M with only 
Zn-binding sites with high and low affinities for Zn, 
these stereochemical factors need further investigation 
in sheep plasma alpha2-M.
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Zn-binding to alpha2-M during the first phase could be 
under homeostatic control. However, the a f f i n i t y  for Zn 
was not apparent during second phase and thus no evidence 
of homeostatic control; this was probably due to 
replacement of Zn by Cu at weaker Zn-binding sites.
It is equally worth noting that the concentration of 65Zn 
added (equivalent to 0.2 or 2.0 yug Zn) to the mixture 
containing alpha2-M and Cu was far less than Cu 
concentration (10 to 50 jig) to exhibit sufficient 
influence at the weaker binding sites. Excess Cu in the 
incubation mixture may be responsible for the breakdown 
of homeostatic mechanism.
During the second phase, the longer incubation period 
combined with the effect of Cu and electrophoresis might 
have caused dissociation of alpha2-M. This would make the 
weaker Zn-binding sites available for excess Cu in the 
incubation mixture and unavailable for Zn by giving 
preference to Cu due to greater affinity of this element 




EFFECT OF DIETARY COPPER DEFICIENCY ON ZINC BINDING TO 
ALPHA 2-MACROGLOBULIN
INTRODUCTION
In vitro experiments have supported a role of Cu in 
modifying the Zn-binding of alpha2-M. In this study a 
Cu-deficient diet was fed to sheep to investigate the in 
vivo influence of Cu-deficiency on in vitro Zn-binding to 
alpha2-M.
RESULTS
Mean plasma Zn concentrations (Table-IX, Fig.31) in 
Cu-deficient sheep decreased significantly (P<0.001) and 
remained low for a period of 9 weeks compared to the mean 
concentrations at the begining of the experiment. Despite 
providing a diet supplemented with 5 mg Cu/kg diet after 
week 7 the mean Zn concentrations remained lower. During 
the 7 weeks on a Cu-deficient diet and during weeks 8 and 
9 on Cu-supplemented diet, the mean Zn concentrations of 
plasma were variable.
The mean Cu concentrations (Table-IX, Fig.31) in 
Cu-deficient sheep plasma remained low even after 
supplementing the diet with 5 mg Cu/kg diet.
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Mean Zn and Cu concentrations of Cu-deficient sheep plasma.
pg Zn/ml plasma pg Cu/ml plasma
Week No Mean S.EM Mean S.EM.
0 5 1.14 * * * ±0,09 1.19 ** ±0.19
1 5 0.90 *** ±0.07 0.74*** ±0.09
2 5 0.85 *** ±0.05 0.79*** ±0.08
3 5 0.94 *** ±0.08 0.81*** ±0.06
4 5 0.87*** ±0.07 0.71*** ±0.05
5 5 0.85*** ±0.06 0.74*** ±0.05
6 5 0.98*** ±0.09 0.83*** ±0.08
7 5 1.12*** ±0.04 0 .88*** ±0.07
8 5 0.76*** ±0.05 0.85 * * * ±0.09
9 5 0.88*** ± 0.02 0.82 ...ftft ± 0.05



















Fig.31 Mean Zn and Cu concentrations of Cu-deficient sheep plasma.
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Results of Zn-binding to alpha2-M in Cu-deficient sheep 
plasma are presented in Tables-X & XI and Fig.32. It is 
interesting to observe a pattern of variation of 
Zn-binding to alpha2-M. This variation in the Zn-binding 
seems to have a cyclic effect every 2 to 3 weeks.
In vitro Zn-binding to alpha2-M was studied at two levels 
of Zn incubation, level-I, 150 yug Zn;and level-II, 1500 
pg Zn.
In Cu-deficient sheep alpha2-M incubated with level-I Zn, 
first showed significantly (P<0.001) decreased Zn-binding 
after one week and then increased Zn-binding to alpha2-M 
from 40.10 to 67.26 yug Zn/100 pg alpha2-M during the 
first four weeks, which was equivalent to 44.48 . 102and
74.60 .102respectively. After 3 weeks on Cu-deficient
diet Zn-binding to alpha2-M was at maximum, 112.27 yug 
Zn/100 pg alpha2-M (124.52 .102 g-atoms Zn/mol alpha2-M), 
2.8 times or 180% increase when compared to Zn-binding at 
the begining of the experiment. Despite observing 1.7 
times Zn-binding to alpha2-M (67.7%) after 4 weeks, by 
week 5 Zn-binding to alpha2-M decreased and was nearly 
58% lower than at the start of the experiment. When 
Cu-supplemented diet (5 mg Cu/kg diet) was fed after week 
7 Zn-binding to alpha2-M showed a trend of increased 
Zn-binding in weeks 8 and 9, which were 55.02 and 51.85 
jug Zn/100 jig alpha2-M respectively.
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Tablei_X
Zn- binding to a!pha2-M obtained from Cu-deficient sheep
plasma incubated with 150 pg Zn (level-I).





Week No. Mean S.EM.






2 5 69.95 ±2.05 77.58.102
3 5 112.27 ±3.23
2
124.52.10























Zn-binding to alpha2-M obtained from Cu-deficient sheep plasma 
incubated with 1500 pg Zn (Level-I).
pg Zn bound/ 100 pg
alpha2-M g-atoms
No of Zn/ mol
Week assays Mean S.EM. alpha2-M
0 5 349.2 ±11.90
3
38.73.10
1 5 456.5 ±19.10 50.63.103
2 5 974.7 ± 26.40 108.11.10 3
3 5 3249.9 ±72.10 360.46.103
4 5 827.6
A
± 30.30 91.79.10 3




7 5 201.8 ±16.10 22.38.103
8 5 1118.6
A  •*. A



















a Level-I Zn (150 Mg) 
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Fig. 32 Zn-bindi ng to alpha2-M obtained from Cu-deficient sheep
plasma incubated with two levels of Zn (150 and 1500 pg).
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In vitro Zn-binding to alpha2-M in Cu-deficient sheep 
plasma incubated with level-II Zn (1500 fig) significantly 
(P<0.001) increased upto 6 weeks (Table-XI, Fig.32). 
After 6 weeks 439% (5.4 times) increase in vitro
binding of Zn to alpha2-M was observed. At one point 
after week 3 maximum binding was 3249.9 fig Zn/100 fig 
alpha2-M (equivalent to 360.46 .10* g-atoms Zn/mol
alpha2-M, an increase of 830.7%). Despite the Zn-binding 
to alpha2-M decreasing in weeks 5 and 6 increased 
Zn-binding to alpha2-M was maintained at a higher level 
during weeks 5 and 6. Lowest Zn-binding to alpha2-M was 
after week 7, which was 201.8 fig Zn/100 fig alpha2-M, 
42.2% less than at the begining of the experiment. 
Feeding Cu supplemented diet (5 mg Cu/kg diet) maintained 
Zn-binding at higher level than at the begining, during 
weeks 8 and 9.
Zn concentration of Pool-I and Pool-II (Table-XII, 
Fig.33) showed reduction of Pool-II Zn as a consequence 
of this the ratio (ratio of Pool-I Zn compared to 
Pool-II) of Zn in Pool-I increased from week 3 and 
remained higher than Pool-II Zn. Though Zn concentration 
in both pools decreased Pool-II demonstrated greater 
reduction. In Pool-I after 7 weeks on Cu-deficient diet, 
sheep plasma alpha2-M Pool Zn (Pool-I) concentration 
increased by only 2%. On the other hand 34.5% decrease in 
Zn concentration of albumin Pool was observed. After
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Table- XII
Zn concentration of a!pha2-M pool (Pool-I) and albumin 
pool (Pool- II) in Cu- deficient sheep plasma.




1 0.405 0.516 0.78:1
2 0.360 0.485 0.74:1
3 0.498 0.460 1.08:1
4 0.482 0.380 1.27:1
5 0.440 0.425 1.03:1
6 0.546 0.430 1.27:1
7 0.612 0.524 1.17:1
8 0.408 0.372 1.10:1
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Fig.33 Zn concentration of alpha2-M pool (Pool-I) and albumin pool 
(Pool-II) in Cu-deficient sheep plasma.
feeding Cu-supplemented diet (5 mg Cu/kg diet) there was 
no increase in either Pool-I or Pool-II Zn concentration 
(Table-XII).
The Zn concentration of purified alpha2-M (Table-XIII, 
Fig.34) obtained from Cu-deficient sheep plasma showed 
reduction of Zn after one week and showed inreased Zn 
concentration of alpha2-M upto week 3. After which time 
showed lower Zn concentration than at the begining of the 
experiment. Dietary supplementation of Cu appeared to 
inrease Zn concentration during week 8.
There was no Cu present in purified alpha2-M in 
Cu-deficient sheep plasma.
The results of dialysis of alpha2-M and albumin mixed 
with 2000 pg Zn (Table-XIV, Fig.35) showed 4.55% Zn 
remained with alpha2-M and 2.37% Zn with albumin after 24 
hours. After 24 hours dialysis alpha2-M showed 50% higher 
bound Zn than that of albumin based on weight of the 
proteins and 350% higher than albumin after 7 days. In 
terms of g-atoms Zn/mol of protein, 50 times more Zn was 
bound to alpha2-M than albumin after 7 days.
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Table- XIII
Zn and Cu concentrations of alpha2-M obtained from Cu- deficient
sheep plasma.
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Dialysis of alpha2-M and albumin zinc
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bound Zn bound Zn




































7650 21 3 4
DAYS ON DIALYSIS
Fig.35 Comparison of Zn-binding to alpha2-M and albumin 
(B.S.A.) during dialysis for 7 days.
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DISCUSSION
Mean plama Zn and Cu concentrations in Cu-deficient sheep 
(Table-IX) were reduced significantly (P<0.001) as 
observed by Al-Mukhtar (1984)in Cu-deficient sheep. 
Reduction in plasma Cu was a direct response of dietary 
Cu-deficiency and absence of any homeostatic mechanism 
for Cu. Whereas, reduction of Zn in plasma could be due 
to impairment of absorption at intestinal level. Alfaro 
and Heaton (1974) suggested that a minimum level of Cu is 
necessary in the body to facilitate the absorption of Zn. 
They observed reduced liver Zn concentration in 
Cu-deficient rats.
In this study, Zn-binding to alpha2-M was studied at two 
levels of Zn:level-I (Table-X), 150 /ig Zn;level-II 
(Table-XI), 1500 i^g Zn. In Cu-deficient sheep alpha2-M 
incubated with both levels of Zn, showed significantly 
(P<0.001) increased in vitro Zn-binding over the first 4 
weeks. At Zn level-II (1500 fig Zn), the increased in 
vitro Zn-binding was maintained over the entire 6 weeks, 
whilst at Zn level-I (150 fig Zn) this increased 
Zn-binding to alpha2-M was subsequently lost after an 
initial period of 4 weeks. The reason for this is not 
clear but it may represent the existence of different 
binding sites on alpha2-M.
It may also indicate the possibility of altered Zn status
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of alpha2-M. This is well demonstrated by the results of 
Table-XII. Ratio of Zn, Pool-I:Pool-II indicates a shift 
in Zn from albumin to alpha2-M as the duration of 
Cu-deficiency was increased.This shift was not so 
pronounced upto week 3, however,from week 4 pool I Zn was 
greater than Pool-II even after feeding Cu-supplemented 
diet.These results suggest that in Cu-deficiency plasma 
Zn is exchanged from albumin to alpha2-M. As a result of 
this proposed exchange of Zn between alpha2-M and 
albumin.in vitro Zn-binding was effected at both levels 
of Zn.
Zn-binding to alpha2-M from sheep fed a Cu-deficient diet 
may also have been affected by the binding affinities of 
Zn-binding sites on alpha2-M compared to albumin. Thus 
when albumin and alpha2-M to which excess Zn (2000 jig Zn) 
had been added were dialysed against 1 mM tris,pH 7.4 
(Table-XIV), alpha2-M showed 50% higher bound Zn than 
that of albumin after 24 hours and 350% higher than 
albumin after 7 days of dialysis (Table-XIV, Fig.35). In 
terms of g-atoms Zn/mol of protein 50 times more Zn was 
bound to alpha2-M than albumin after 7 days. These 
results are in general agreement with those of Adham et 
al (1977) although the binding of Zn to alpha2-M was 150% 
higher in sheep plasma alpha2-M than in human plasma 
alpha2-M.
It is reasonable to speculate, in the absence of any
190
comparable work, that the metabolic stress created by 
dietary Cu-deficiency might contribute to an increased 
binding of Zn to alpha2-M. Results in this study, 
demonstrated significantly (P<0.001) increased Zn-binding 
for 4 weeks at level-I Zn, 6 weeks at level-II Zn and the 




EFFECT OF DIETARY HIGH COPPER ON ZINC-BINDING TO 
ALPHA2-MACROGLOBULIN
INTRODUCTION
The occurrence of chronic copper poisoning has been 
recognized for many years (Mallory, 1925; Beijers, 1932; 
Gracey and Todd, 1960; Todd and Thompson, 1963) as a
major hazard in the intensive rearing of sheep. High 
dietary Cu concentration may also cause conditioned
Zn-deficiency, e.g. Cu-induced Zn-deficiency of swine
(Suttle and Mills, 1966). It also causes accumulation of 
Cu in sheep liver (Todd, 1969). Bremner et al (1976) 
showed that Zn supplementation offers an effective 
protection against Cu-toxicosis. Similarly, Parry et al 
(1984) confirmed these findings and demonstrated that 
maintaining the dietary Cu to Zn ratio, 1:4 offered 
protection against Cu poisoning to three breeds of 
pregnant ewes maintained indoors.
In Experiment 5 dietary Cu-deficiency increased 
Zn-binding to alpha2-M from sheep plasma. In order to 
provide further evidence of the interference of dietary 
Cu level with Zn-binding to alpha2-M and its dependence 
on dietary concentration of Cu and Zn; high-Cu diet was
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fed to sheep. Zn-binding to alpha2-M in the plasma of 
sheep fed on high-Cu diet have not been reported so far.
Details of high-Cu diet, alpha2-M purification by IAC and 
Zn-binding to alpha2-M are described in Section-II.
RESULTS
Mean plasma Zn concentration in high-Cu sheep (Table-XV, 
Fig.36) decreased weekly starting from week 0. This low 
concentration of zinc was maintained even after giving 
Cu-supplemented diet (5mg Cu/kg diet and 50 mg Zn/kg 
diet) after week 7.
Plasma Zn concentration in this experiment (Table-XV) 
decreased from a mean of 2.10 p.g Zn/ml (at the begining 
of experiment) to 1.38 yug/ml after week 7. Lowest mean Zn 
concentration, 0.96 /ig Zn/ml was observed after week 4. 
Bremner et al (1976) observed reduced Zn concentration in 
sheep fed on a basal diet containing 29 mg Cu/kg diet. 
This diet was Cu-toxic, and the reduction in mean plasma 
Zn concentration was much less (9%) observed after 7 
weeks. In this study after one week, 22.8% reduction in 
plasma Zn was observed in high-Cu sheep (Table-XV). After 
7 weeks plasma Zn was 34.3% lower than week 0.
Mean plasma Cu concentration in high-Cu sheep increased 
from 0.73 p g Cu/ml to 3.18 p.g Cu/ml (Table-XV, Fig.36) in 
one week on experimental diet. Cu concentration reduced
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Table- XV
Mean Zn and Cu concentrations in high-Cu sheep plasma.
pg Zn/ ml plasma pg Cu/ ml plasma
Week No. Mean S.E.M. Mean S.E.M.
0 5 2.10 * * * ±0.18 0.73 it * ±0.04
1 5 1.62 *** ±0.04 3.18*** ±0.29
2 5 1.47**:: ± 0.02 1.65*** ±0.13
3 5 1 is * * * ±0.04 1.04*** ±0.09
4 5 0.96*** ±0.03 0.99*** ±0.13
5 5 1.40*** ±0.09 0.93*** ±0.08
6 5 1.35*** ± 0.11 0.12 ns ±0.05
7 5 1.38*** ± 0.12 0.08 * ± 0.02
8 5 1.32*** ±0.06 0
9 5 1.35 ** ±0.23 0
•
MS No t significant
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Fig .36 Mean Zn and Cu concentrations in high-Cu sheep plasma.
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in week 2 and continued to decrease significantly 
(P<0.001) until week 5. After 6 weeks on high-Cu diet, 2 
sheep showed no detectable Cu in their plasma and the 
other three contained only 0.2 p g Cu/ml plasma 
(Table-XV). Despite giving normal diet there was no Cu in 
plasma after weeks 8 and 9. After 9 weeks two sheep died 
within 24 hours after obtaining blood samples.
Mean plasma Cu concentration increased in one week by 
335.6% and after 7 weeks on high-Cu diet decreased by 89% 
(Table-XV). These results differed from Bremner et al 
(1976) who showed a gradual increase in Cu concentration 
from 1.0 /ig Cu/ml to about 1.7 p g  Cu/ml plasma in 16 
weeks. However, they did observe a transient increase in 
plasma Cu over 2.0 pg/ml.
Results presented in Table-XVI, Fig.37 showed at level Zn 
(150 pg) incubation, a 86.1% reduction in vitro 
Zn-binding to alpha2-M. One week after feeding high-Cu 
diet the Zn bound/100 p g alpha2-M was reduced from 43.10 
to 5.98 p g Zn, which was equivalent to 47.80 .102 and 6.63 
.102g-atoms Zn/mol alpha2-M respectively.
During 7 weeks on high-Cu diet (Table-XVI), sheep plasma 
alpha2-M exhibited a significant (P<0.001) reduction in 
vitro p g  Zn bound/100 p g alpha2-M. There was an 
improvement in Zn-binding after giving normal diet for a 
further period of 2 weeks to 72.66 p g Zn/100 p g  alpha2-M,
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Table- XVI
Zn-binding to alpha2-M obtained from high-Cu sheep plasma 
incubated with 150 pg Zn (Level-I).
No. of
pg Zn bound/ 100 pg 
alpha2-M g-atoms Zn/ mol
Week ■ assays Mean S.E.M. alpha2-M
0 5 43.10 ±7.08 47.80.1C?
1 5 05.98 ±0.52 6.63.102
2
2 5 10.55 ± 1.44 11.70.10
2
3 5 19.30 ± 1.66 21.41.10
2
















9 5 72.66ft ft * ±2.28 80.59.10















*  Level-1 Zn (150 pg)
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Fig .37 Zn-binding to aipha2-M obtained Irom high-Cu sheep plasma
incubated with two levels of Zn (150 and 1500 pg).
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Table- XVII
Zn- binding to alpha2-M obtained from high-Cu sheep plasma




pg Zn bound/ 10( 
Mean





0 5 688.7 * ** ±32.5 76.39.103
1 5 455.2*** ±17.7 50.49.103
2 5 63.5* * * ± 4.2 7.04.103
3 5 190.5.... ±13.4 21.13.103
4 5 284.7::::.: ± 9.4 31.58.10?
5 5 451.5 ±17.9 50.08.103
6 5 461.4*** ±18.0 51.18.103
7 5 1 27.1«: ± 6.7 14.10.103
8 5 196.8*** ± 12.0 21.83.103
9 5 675.6 ***




which was equivalent to 80.59.102 (Table-XVI, Fig.37).
At the end of 7 weeks on high-Cu diet (Table-XVI), there 
was a 49.5% reduction in vitro of Zn-binding to alpha2-M 
compared to week 0.
Sheep plasma incubated with level II Zn (1500 /ig) showed 
a 90.8% reduction in Zn-binding to alpha2-M after week 2, 
from 688.7 to 63.5 ^ ig Zn bound/100 u^g alpha2-M and in 
terms of g-atoms Zn/mol alpha2-M from 76.39.103 to 
7.04.103 (Table-XVII and Fig.37). Alpha2-M maintained a 
significantly (P<0.001) reduced in vitro Zn-binding 
throughout 7 weeks on high-Cu diet and at the end of 7 
weeks showed a reduction of 81.5% in Zn-binding to 
alpha2-M compared to that at the begining. Feeding normal 
diet for a period of further 2 weeks increased Zn-binding 
and attained nearly the same level as at the begining of 
the experiment, 688.7 and 675.6 ^ ig Zn/100 i^g alpha2-M 
respectively.
Plasma from sheep fed on high-Cu diet showed 
(Table-XVIII, Fig.38) decreased Zn concentration in 
alpha2-M pool (Pool-I) Zn and albumin pool (Pool-II) Zn 
throughout the experimental period including substituting 
normal diet during the weeks 8 and 9. Only exception to 
this was an increase of alpha2-M pool Zn after 6 weeks. 
Zn bound to Pool-II was maintained higher than Pool-I 
during the 7 weeks on high-Cu diet.
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Table- XVIII
Zn concentration of alpha2-M pool (Pool-I) and albumin 
pool (Pool-II) in high-Cu sheep plasma.
pg Zn/ ml plasma




1 0.512 1.182 0.43:1
2 0.470 1.040 0.45:1
3 0.310 0.835 0.37:1
4 0.320 0.650 0.49:1
5 0.240 0.932 0.26:1
6 0.580 0.908 0.63:1
7 0.530 0.915 0.58:1
8 0.450 0.950 0.47:1





W E E K S
Fig. 38 Zn concentration of alpha2-M pool (Pool-I) and albumin pool 
(Pool-II) in high-Cu sheep plasma.
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At the end of 7 weeks alpha2-M pool Zn was only 7% less 
than at the begining of week 0. However, albumin pool Zn 
reduced by 41% from week 0 (Table-XVIII).
At the start of the experiment purified alpha2-M Zn 
concentration was 0.440 mg/g alpha2-M and there was no 
detectable Cu present (Table-XIX, Fig.39). After one week 
on high-Cu diet, not only Cu was bound to alpha2-M but 
the Zn concentration increased nearly 2.4 times. During 
the period of 7 weeks on high-Cu diet, alpha2-M Cu varied 
between 0-0.400 mg/g alpha2-M and at the end of 7 weeks 
there was no Cu present in alpha2-M (Table-XIX, Fig.39).
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Table- XIX
Zn and Cu concentrations in alpha2-M obtained from
high-Cu sheep plasma.
































The most interesting results from this experiment are 
shown in Table-XIX. Firstly, alpha2-M in sheep fed a 
high-Cu diet, was binding Cu after one week on the 
feeding regime. Secondly, the amount of alpha2-M bound Cu 
increased from 0.2 mg to 0.4 mg Cu/g alpha2-M over a 
period of six weeks. Thirdly, whilst alpha2-M was showing 
increased quantity of bound Cu, the amount of bound Zn 
also increased over the six week period from 0.44 mg at 
week 0, to 1.3 mg Zn/g alpha2-M.
These results showed that alpha2-M could bind Cu in the 
presence of Zn; furthermore, as the ingested Zn was 
increased, a substantial quantity of Zn was 
correspondingly bound to alpha2-M as well as 
substantially increased bound Cu. Therefore, alpha2-M was 
shown to have a much greater capacity for binding Zn than 
has previouly been recorded as compared by control values 
at week 0, and this increased Zn-binding was occuring 
simultaneously with substantially increased Cu-binding; 
this was a surprising result, especially in the light of 
the fact that alpha2-M does not normally bind Cu as shown 
in week 0.
It is difficult to speculate on the molecular mechanism 
of accommodating the increased Cu-binding simultaneously 
with increased Zn. If the amount of bound Zn in alpha2-M
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had shown a quantitative decrease in the presence of the 
increased bound Cu, then it would have been reasonable to 
reflect on Zn-binding sites accommodating the Cu. 
However, until further work can be carried out to test 
the strength of binding and specificity of such binding 
sites for either Zn or Cu, it can only be suggested at 
this stage that more binding sites for Zn and Cu are 
available on alpha2-M than has previously been envisaged.
In contrast to results shown in Table-XVIII, which showed 
evidence of antagonism between dietary Cu and Zn in 
alpha2-M and albumin fractions, the results in Table-XIX 
do not immediately confirm this antagonism. It was 
expected that if such antagonism existed that the 
alpha2-M Zn in Table-XIX would have decreased at the 
expense of the increased alpha2-M Cu levels. However, it 
is reasonable that antagonism was present in the results 
of Table-XIX, but due to the substantial and abnormal 
quantities of ingested Zn, that such an antagonism 
between Cu and Zn in alpha2-M, was masked.
Significantly (P<0.001) reduced plasma Zn concentratios 
(Table-XV) were observed in high-Cu sheep plasma and the 
decreases were gradual. The greater Zn reduction (34.3%) 
after 7 weeks compared to 9% reduction of Zn after 9 
weeks in the studies of Bremner et al (1976) may be due 
to the differences in dietary Cu concentration of 250 mg
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Cu/kg diet in this study and 29 mg Cu/kg diet in their 
work. It may also reflect differences in the Cu to Zn 
ratio. In this study it was was 5:4 and in their 
experiments 1:1.5 (Cu:Zn). This may explain the fact that 
the inclusion of Zn at 200 mg/kg diet in this study was 
unable to protect against the effect of Cu-toxicosis. 
Bremner et al (1976) also used higher ratios of Cu:Zn, 
1:7.6 and 1:14.5 which offered greater and effective 
protection against Cu-toxicosis.
The Cu level rising fast during the first week from 0.73 
to 3.18 p g  Cu/ml plasma (a 335.6% increase). This effect 
was a consistent finding and has been shown in previous 
experiments from this laboratory (Al-Mukhtar, 1984). From 
week 2 the Cu concentration decreased gradually showing 
89% decrease after 7 weeks. There was no Cu present in 
plasma in weeks 8 and 9. The results in Table-XV differed 
from Bremner et al (1976). The ingested Cu was probably 
accumulated in liver as shown by Todd et al (1962 and 
1963), Ishmael et al (1971 and 1972). Liver Cu was not 
assayed in this study, but, when two sheep died after 
completion of the experiment, post-mortem confirmed the 
cause of death as copper poisoning and accumulation of Cu 
in the liver. Results in this study are in agreement with 
Todd et al (1962 and 1963), Ishmael et al (1971 and 1972) 
on the accumulation of Cu in liver in Cu-toxicosis. 
However, these studies did not report the concetration of 
Zn in their diets, which makes it difficult to compare
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the results. Dietary Zn concentration plays a vital role 
and the effects of dietary high-Cu depend upon the level 
of Zn in the diet as shown by Bremner et al (1976) and 
Parry et al (1984). This is supported by the differences 
observed in this study.
Zn-binding to alpha2-M in high-Cu sheep plasma decreased 
on incubation with both levels of Zn (150 and 1500 ,ug Zn) 
(Table-XVI & XVII). The decrease was rapid with level I 
Zn than with level II. This decrease in Zn-binding to 
alpha2-M may be due to the combined effect of dietary 
Cu-excess and greater affinity of Cu to binding sites on 
alpha2-M. Recent evidence presented by Gettins and 
Cunningham (1986) showed by NMR study, that manganese 
binds to human apo-alpha2-M analogously to Zn and this 
evidence showed the possibility of Cu replacing Zn on 
some weaker sites.
The results in this study indicated three main features 
of in vitro Zn-binding to alpha2-M in high-Cu sheep 
plasma. First, Zn-binding to alpha2-M decreased, this was 
followed by an increase, but after 7 weeks Zn-binding was 
significantly (P<0.001) decreased. Lastly, feeding a 
normal diet has shown increased Zn-binding to alpha2-M.
Cu has greater affinity than Zn for the available binding 
sites on proteins (Bremner et al, 1974; Williams, 1984). 
The combined effect of high dietary Cu and the greater
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affinity may be responsible for lowered Zn-binding to 
alpha2-M. Bremner et al (1974) stressed the importance of 
understanding the relatioship between Cu and Zn and their 
distribution among liver proteins to explain the mutual 
antagonism between Cu and Zn in animals. Similarly, 
Williams (1984) suggested that transfer of Cu cannot be 
entirely dependent on binding strengths and 
thermodynamics alone, since that of Cu is always greater 
than that of Zn. Suttle and Mills (1966) showed that high 
dietary Cu induced Zn-deficiency in swine. The combined 
effect of the above considerations and the evidence in 
support of these was provided by the results in this 
study and it can be explained as follows (Fig.40):
The influence of high-Cu diet was to increase the plasma 
Cu concentration and decrease both the plasma Zn 
concentration and the in vitro Zn-binding to alpha2-M. 
Although liver Cu was not measured in this study, there 
was accumulation of Cu in liver (as shown by postmortem 
indicating Cu poisoning and accumulation of Cu in liver). 
Accumulation of Cu in liver was due to transfer of Cu 
from plasma to liver. Occurrence of this event was 
supported by decreased Cu concentrations in plasma and 
increased in vitro Zn-binding to alpha2-M. However, this 
transfer of Cu to liver may be dependent on the rate of 
Cu accumulation in liver, which was supported by the 
evidence of varied Zn-binding to alpha2-M. On feeding a 
normal diet to sheep after 7 weeks Zn-binding to alpha2-M
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increased indicating lack of transfer of Cu to liver.
The results in Table-XVIII showed decreased Zn 
concentration in alpha2-M pool (Pool-I) and albumin pool 
(Pool-II). In comparison with Pool-II Zn decreae in 
Pool-I Zn after 7 weeks by only 7% to that on Week 0 
indictes the greater binding affinity for Zn by alpha2-M. 
Whereas, 41% reduction in Pool-II Zn after 7 weeks 
compared to Week 0 indicates weaker binding affinity than 
alpha2-M. However in both pools Zn was lowered as a 
direct response to high-Cu diet and probably diminished 
absorption of Zn at the intestine.
It is suggested (Evans, 1973) that chemical similarity of 
Cu and Zn leads to competition between these elements at 
various binding sites within specific metabolic systems, 
including intestinal absorption. Van Campen and Scaife 
(1967) demonstrated that Zn interacts with Cu at a site 
either in or on the intestinal mucosa. These studies 
support the possibility of interference of Zn-absorption 
by high dietary Cu concentration.
Recovery of Zn in both the pools may be dependent on the 
rate of accumulation of Cu in liver and limiting factors 
in the accumulation of Cu and the synthesis of 
metallothionein in liver as shown in Fig.40. In vitro 
Zn-binding to alpha2-M reflected any changes in Zn status 
of alpha2-M as shown in Fig.40.
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EXPERIMENT-7
EFFECT OF VARIABLE Cu AND Zn CONCENTRATIONS ON Zn-BINDING 
TO ALPHA2-MACROGLOBULIN IN THREE BREEDS OF PREGNANT EWES
INTRODUCTION
Copper toxicity has long been recognised as a major 
hazard in the intensive rearing of sheep (Bremner et 
al,1976). This syndrome is always associated with a high 
concentration of liver Cu concentration but no definite 
correlation has been achieved between Cu concentration in 
the diet and liver Cu. Van der Schee et al (1983) linked 
earlier evidence of Bremner et al (1976) of Zn as dietary 
antagonist to Cu,with the possibility that the effect of 
a ratio of these metals may differ between breeds.
In Experiments 5 and 6, in vivo Cu level has interfered 
with in vitro Zn-binding to alpha2-M and it was dependent 
on the level of Zn and Cu in the diet. In order to 
provide further evidence of the interference of Cu with 
Zn-binding to alpha2-M and its dependence on dietary 
concentration of Zn and Cu, samples of blood were 
obtained from three breeds of pregnant ewes fed on diet 
containing Cu,Zn,l:4 and kept indoors. This experiment 
was carried out to investigate the breed differences in 
vitro Zn-binding to alpha2-M.
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RESULTS
It is interesting to note from Table-XX that in Dorset 
ewes the mean plasma Cu concentration on Day-0, which was 
the first day of housing, was higher than at any 
subsequent sampling day. The mean plasma Cu value before 
housing took place for the Dorset group was 1.84 jig Cu/mi 
plasma significantly lower (P<0.001) than Day-0. This 
showed that the effect of housing on pregnant Dorset ewes 
increased the plasma Cu concentration.
The subsequent mean plasma Cu concentration in Dorset 
ewes decreased at first and was variable upto 86 days.
The mean plasma Zn concentration in Table-XX before 
housing was 1.26 ^ig/ml. On day-0 of housing showed a 
significant (P<0.001) decrease to 0.99 jig/ml plasma, and 
continued to decrease in pregnant Dorset ewes from 0.99 
jig/ml plasma on day-0 to 0.70 jig/ml plasma, signif icantly 
(P<0.001) upto 55 days. After which increased gradually 
upto 86 days, when the mean Zn was 1.13 ^ ig/ml plasma 
(Table-XX, Fig.41).
The mean plasma Cu concentration (1.43 pg/ml plasma) in 
pregnant Clun ewes in Table-XXl, Fig.42 showed 
significant (P<0.01) increase on Day-0 compared to Cu 
concentration (1.18 jig Cu/ml) prior to housing. The 
effect of housing pregnant Clun ewes increased the plasma 
Cu. At first Cu concentration indoors decreased
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Table- XX
Mean Cu and Zn concentrations in the plasma 
of pregnant Dorset ewes maintained indoors 
on variable Cu and Zn diet in the ratio 1:4.
pg Cu/ml plasma pg Zn/ml plasma
Days No. Mean S.E.M. Mean S.E.M.
0 10 2.31... ±0.13 0.99 ±0.07
35 10 1.55 ±0.09 0.82 ±0.05
42 10 1.22 ±0.07 0.75f t * ±0.03
55 10 1.15 ±0.06 0.70
* A i;
±0.03
69 10 1.31* * * ±0.06
COo ±0.03
74 10 1.20 ±0.06 0.90 ± 0.02
86 10 1.5?
fit':*!
±0.06 1.13*** ± 0.02









Mean Zn and Cu concentrations in the plasma of pregnant
Dorset ewes maintained indoors on variable Cu and Zn diet
in the ratio 1:4.
Table- XXI
Mean Cu and Zn concentrations in the plasma of 
pregnant Clun ewes maintained indoors on 
vairiable Cu and Zn diet in the ratio 1:4.
pg Cu/ml plasma pg Zn/ml plasma
Days No Mean S.E.M. Mean S.E.M.
0 10 1.43 ±0.08 0.66
*  *  *
± 0.01
14 10 1.17..... ±0.06 0.86* * ft ±0.03
21 10 1.21















*  *  *
±0.03
62 10 1.36
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Fig . 42 Mean Zn and Cu concentrations in the plasma of pregnant
Clun ewes maintained indoors on variable Cu and Zn diet
in the ratio 1:4.
significantly (P<0.001), but it was variable during the 
62 days (Table-XXI, Fig.42).
The mean Zn concentration in the plasma of pregnant Clun 
ewes was lowered (Table-XXI) significantly (P<0.001) 
after housing and remained variable and lower than the 
concentration observed prior to housing (0.92 jig Zn/ml 
plasma).
The mean plasma Cu concentration in the plasma of 
pregnant Finn ewes (Table-XXII, Fig.43) on day-0 (1.14 
jig/ml plasma) was not significantly different to that of 
the concentration (1.16 i^g Zn/ml plasma) prior to 
housing. However, a significant (P<0.001) reduction in 
the plasma concentration was observed following housing 
and feeding on the variable Cu and Zn diet. Subsequently, 
the Cu concentration increased during 62 days.
The mean Zn concentration in the plasma of pregnant ewes 
decreased significantly (P<0.001) after housing compared 
to the concentration prior to housing (1.3 u^g Zn/ml 
plasma) and remained variable during 62 days (Table-XXII, 
Fig.43).
In Table-XXIII, Fig.44 Zn-binding to alpha2-M (incubated 
with 150 jig Zn) from the plasma of pregnant Dorset ewes 
increased significantly (P<0.001) from 17.97 to 174.71 /ig 
Zn bound/100 jig alpha2-M or in g-atoms Zn/mol alpha2-M
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Table- XXII
Mean Cu and Zn concentrations in the plasma of 
pregnant Finn ewes maintained indoors on variable 
Cu and Zn diet in the ratio 1:4.
pg Cu/ml plasma pg Zn/ml plasma
Days No Mean S.E.M. Mean S.E.M.
0 10 1.14 ±0.16 0.98*** ±0.05
14 9 0.91 .* * * ±0.18 0.60ft ft ft ±0.04
40 10 0.89 ±0.09 0.97
* * ft
±0.03
48 10 ±0.08 0.77 ±0.04











Fig.43 Mean Zn and Cu concentrations in the plasma of pregnant
Finn ewes maintained indoors on variable Cu and Zn diet
in the ratio 1:4.
Tab le -X X III
In vitro Zn-binding to alpha2-M from the plasma 
of pregnant Dorset ewes maintained indoors on variable 
Cu and Zn diet with a ratio 1:4.
Aplha2-M incubated with 150pg Zn
pg Zn bound/ 
100pg Alpha2-M g-atoms
Days No Mean S.E.M. alpha2-M
0 5 17.97 ±3.14 19.93.102
35 5 174.71 ±11.06 193.78.10 2










86 5 16.80 ±3.68 18.63.102




a Level-1 Zn (150 pg)
■ Level-11 Zn (1500 pg)
10
DAYS X10
Zn-binding to alpha2-M obtained from the plasma of pregnant 
Dorset ewes maintained indoors on variable Cu and Zn diet in 
the ratio 1:4. Alpha2-M incubated with two levels of Zn (150 
and 1500 ug).
Table -X X IV
In vitro Zn-binding to alpha2-M from the plasmaof 
pregnant Dorset ewes maintained indoors on variable 
Cu and Zn diet with a ratio 1:4.
Alpha2-M incubated with 1500 pg Zn
pg Zn Bound/
100 pg alpha2-M g-atoms
Zn/mol
Days No Mean S.E.M. alpha2 -M
0 5 285.60 ±13.60 31.68.103
35 5 1068.30 ±63.0 118.49.103
42 5 646.80
f t  f t  s’ :
±24.5 71.74.103
55 5 517.00









f t  s’ :  s’ :
±24.70 25.95.103
*** P < O.OOl
v._______________________________________________)
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from 19.93 .102to 193.78 . 102during the first 35 days. 
However, during 86 days Zn-binding to alpha2-M was 
variable and after 86 days it was nearly the same as 
Day-0.
In Table-XXIV, Fig.44 alpha2-M incubated with 1500 ^ g Zn 
showed significantly (P<0.001) increased Zn-binding, from 
285.6 to 1068.3 i^g Zn bound/100 p g  alpha2-M or in terms 
of g-atoms Zn/mol alpha2-M increased from 31.68 .103to 
118.49 . 103after 35 days on variable Cu and Zn diet. 
Zn-binding to alpha2-M reduced significantly (P<0.001) 
during 86 days but was variable. However, at the end of 
86 days Zn-binding was lowered significantly (P<0.001) 
compared to Day-0.
In Table-XXV, Fig.45 in vitro Zn-binding to alpha2-M 
incubated with 150 p g  Zn decreased signif icantly 
(P<0.001) in pregnant Clun ewes, from 69.9 to 9.6 p g  Zn 
bound/100 p g alpha2-M or in terms of g-atoms Zn/mol 
alpha2-M from 77.53 .102to 10.65 .102during 48 days.
After 62 days the Zn-binding was significantly (P<0.05) 
lower than the Day-0.
In Table-XXVI, Fig.45 alpha2-M incubated with 1500 p g  Zn 
showed significantly (P<0.001) decreased Zn-binding in 
pregnant Clun ewes. Zn-binding to alpha2-M was variable 
during 62 days, however, after 62 days it was 313.8 




In vitro Zn-binding to alpha2-M from the plasma
of pregnant Clun ewes maintained indoors on variable
Cu and Zn with a ratio 1:4.
Alpha2-M incubated with 150 pg Zn
pg Zn bound/
100 pg alpha2-M g-atoms
Zn/mol
Days No Mean S.E.M. alpha2-M
0 5 69.90 ** ±14.10 77.53.102
14 5 24.60*** ±1.10 27.28.102
21 5 24.40*** ±0.70
2
27.06.10
35 5 21 .00*** ±1.60
2
23.29.10
40 5 10.00*** ±.0.90 11.09.102
48 5 9.60 *** ±0.70
2
10.65.10
62 5 14.10 * ±3.90 15.64.102













a Level-I Zn (150 pg)
■ Level-!I Zn (1500 pg)
» i *---  x » -«■-*------ L
2 3 4 5 6 7
DAYS X1°
Zn-binding to alpha2-M obtained from the plasma of pregnant 
Clun ewes maintained indoors on variable Cu and Zn diet in 
the ratio 1:4. Alpha2-M incubated with two levels of Zn (150 
and 1500 pg).
Table-XXVI
In vitro Zn binding to alpha2*M from the plasma 
of pregnant Clun ewes maintained indoors on 
variable Cu and Zn diet with a ratio 1:4. 









14 5 360.50 ±14.10 39.98.103
21 5 402.30 ±6.40 44.62.103
35 5 405.20ft ft ft ±5.60 44.94.103
40 5 120.50 ±7.50 13.36.103
48 5
* :*? A
160.80* * * ±6.80
3
17.83.10
62 5 313.82*** ±16.50 34.81.103
ftftft P <  O .O O l
 ^ >
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In terms of the g-atoms Zn/mol of alpha2-M decreased to 
34.81 .103 from 54.59 .103.
In Table-XXVII, Fig.46 in vitro Zn-binding to alpha2-M 
incubated with 150 i^g Zn in pregnant Finn ewes decreased 
during 62 days and showed variable binding with 
corresponding variable significance levels. After 62 days 
Zn-binding to alpha2-M was significantly (P<0.001) lower, 
19.93 compared to 31.38 p g  Zn bound/100 p g  alpha2-M on 
the Day-0. In terms of g-atoms Zn/mol alpha2-M decreased 
from 34.80 . 102to 22.10 .102 .
In Table-XXVIII, Fig.46 in vitro Zn-binding to alpha2-M 
incubated with 1500 p g  Zn,decreased significantly 
(P<0.001) in pregnant Finn ewes,from 349.0 to 93.3 p g Zn 
bound/100 p g  alpha2-M or in terms of g-atoms Zn/mol 
alpha2-M from 38.71 .103 to 18.04 .103 after 14 days on 
variable Cu and Zn diet. Zn-binding was variable during 




In vitro Zn-binding to alpha2-M from plasma of pregnant 
Finn ewes maintained indoors on variable Cu and Zn diet 
with a ratio 1:4.
Alpha2-M incubated with 150 pg Zn
pg Zn bound/
100 pg alpha2-M g-atoms
Zn/mol
Days No Mean S.E.M. alpha2-M
0 5 31.38*** ±3.99 34.80.102
14 5 11.56** ±1.95 12.82.102
40 5 20 .66 *** ±1.25 22.91.102
48 5 7.41 ** ±1.65 8 .22.102
62 5 19.93*** ± 1.15 22 .10.102










a Level-I Zn (150 pg)
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Fig.46 Zn-binding to alpha2-M obtained from the plasma of pregnant
Finn ewes maintained indoors on variable Cu and Zn diet in the 
ratio 1:4. Alpha2-M incubated with two levels of Zn (150 and
1500 pg).
Table-XXVIII
In vitro Zn-binding to alpha2-M from the plasma of 
pregnant Finn ewes maintained indoors on variable 
Cu and Zn diet with a ratio 1:4.
Alpha2-M incubated with 1500 pg Zn
pg Zn bound/
100 pg alpha2-M g-atoms
Zn/mol






14 5 93.30 ±6.40 10.35.103
40 5











The effect of housing on pregnant ewes increased the mean 
plasma Cu concentration in all breeds studied 
(Tables-XX-XXII), with a significantly (P<0.001) greater 
increase in Dorset ewes (Table-XX) than either Clun or
Finn ewes.On the first day of housing mean Zn
concentration in plasma of all breeds decreased 
significantly (P<0.001) as shown in Tables-XX-XXII. 
Decrease in Zn concentration may be directly related to
increased Cu in plasma similar to the effect of high-Cu
diet as observed by Saylor and Leach (1980) in sheep and 
Gipp et al (1974) in young pigs. Sheep fed on 47 mg Cu 
and 46 mg Zn/kg of diet showed decreased Zn concentration 
in plasma, but they were not significant (Saylor and 
Leach, 1980). However,in young pigs, dietary Cu of 240 
mg/kg showed significantly (P<0.01) decreased plasma Zn 
(Gipp et al, 1974).
Concentrations of both Cu and Zn varied in response to 
dietary variation of Cu and Zn levels, but maintaining 
the dietary ratio, 1:4 between these two elements. These 
variations in plasma Cu and Zn may be related to Cu 
accumulation in liver and the rate of accumulation may be 
the controling factor.
Weiner et al (1978) reported the importance of
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considering genetic variation in the Cu metabolism, and 
this was later supported by Woolliams et al (1982),who 
showed that Scotish Blackface and Welsh Mountain ewes 
differed significantly in their plasma Cu levels. They 
also reported a breed differences in the efficiency of 
absorption of Cu in liver.
Results in the present study confirmed the protective
effect of Zn supplementation against Cu toxicosis and the 
antagonism between Cu and Zn as shown by Bremner et al 
(1976) and Parry et al (1984).
Zn-binding to alpha2-M incubated with 150 p g Zn was 
significantly (P<0.001) lower in all three breeds as
shown in Tables XXIII-XXVIII compared to alpha2-M 
incubated with 1500 p g  Zn. However, the Zn-binding
response of pregnant Dorset ewes (Table-XXIII) was 
different to Clun (Table-XXV) and Finn ewes (Table-XXVII) 
on Day-0 at level-I Zn incubation (150 p g  Zn). Only 17.97 
p g  Zn/100 jig alpha2-M was bound compared to 69.90 and 
31.38 p g  Zn bound/100 p g alpha2-M in clun and Finn ewes 
respectively.
In Tables-XXIV, XXVI & XXVIII Zn-binding to alpha2-M 
incubated with 1500 p g  Zn showed breed differences on 
Day-0. Clun ewes (Table-XXVI) showed significantly 
(P<0.001) greater Zn-binding than either Dorset or Finn 
ewes. For a difference of 10 times Zn (between level-II &
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level-I) incubated with alpha2-M 16,7 and 11 times Zn was 
bound to alpha2-M in Dorset, Clun and Finn ewes 
respectively.
The existence of breed differences was clearly shown by 
Zn-binding to alpha2-M at both levels of Zn incubation. 
Dorset ewes showed more Zn-binding to alpha2-M at both 
levels of Zn (150 and 1500 pg Zn) incubation 
(Tables-XXIII & XXIV) than either Clun (Tables-XXV & 
XXVI) or Finn (Tables-XXVII & XXVIII) ewes. Finn ewes 
showed least Zn-binding among the three breeds and 
Zn-binding to alpha2-M reflected variations in plasma 
concentrations.
In vitro Zn-binding to alpha2-M responded to variations 
in plasma Cu suggested the dependence on the rate of Cu 
accumulation in the liver. In this study (Expt.7) the 
proportion of Zn bound to alpha2-M and albumin pool were 
not determined (due to lack of sufficient plasma from the 
experimental samples) which could have helped in 
explaining whether any transfer of Zn in vivo has taken 





The aim of this investigation was to make a quantitative 
assessment of Zn-binding to alpha2-M in sheep; no 
previous attempts are recorded. Dietary copper had some 
influence on this binding, but influence of the ratio of 
dietary Cu to Zn although inconclusive warrants further 
research.
The absence of methods for the purification of sheep 
plasma alpha2-M necessitated testing the methods used for 
human plasma alpha2-M. A great deal of the work was 
carried out in purification of alpha2-M from sheep plasma 
and the alpha2-M purification method published by Song et 
al (1975) was used. In contrast to Song’s et al (1975) 
findings who reported three protein peaks were observed 
compared with only one peak for a similar human plasma 
sample. Peak I contained alpha2-M and detectable amounts 
of IgG. When alpha2-M was purified by immunoadsorbent 
chromatography IgG was a contaminant. This IgG did not 
show any evidence of Zn-binding (Appendix-I) and its 
presence was ignored in binding studies.
Support for the hypothesis that Cu influences the binding 
of Zn to alpha2-M was obtained by showing the influence
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of in vitro Cu concentrations on Zn-binding to sheep 
alpha2-M. This was followed by the changes in Zn-binding 
to alpha2-M in the plasma of sheep fed a Cu-deficient and 
high-Cu diet. Finally, the influence of a diet containing 
variable amounts of Cu and Zn in the ratio 1:4 on 
Zn-binding to alpha2-M in the plasma from pregnant 
Dorset, Clun and Finn ewes maintained indoors was 
studied.
Sheep alpha2-M was found to bind large amounts of Zn;
this was shown in Expt. 3. Zn-binding to alpha2-M
increased in a linear fashion with each addition of Zn 
from 150 to 3000 jig to 100 jxg alpha2-M (Table-V and 
Fig.28). It was shown that 325.44 x 102 g-atoms Zn/mol 
alpha2-M was bound in vitro when 3000 p.g Zn was incubated 
with 100 i^g alpha2-M (Expt. 3). When 50,100,150,200 and
250 jig alpha2-M were each incubated separately with 1500
fig Zn, both, mean ug Zn bound/100 )ig alpha2-M and g-atoms 
Zn/mol alpha2-M showed a 96.4% reduction at 250 ug 
alpha2-M concentration compared to 50 /xg alpha2-M (Expt. 
2, Table-IV, Fig.27).
Before it was possible to test the influence of copper, 
either dietary related, or direct plasma copper increase, 
on the capacity of alpha2-M to bind Zn, it was necessary 
in Expt.2 to test whether there was a linear relationship 
between the amount of alpha2-M and its ability to bind a 
constant quantity of Zn. In Expt. 2, when added Zn
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concentration was kept constant and alpha2-M 
concentration increased, it was shown that the expected 
relationship existed. There have been no previous reports 
of similar studies in sheep or humans.
Recently Gonias et al (1984), Pratt and Pizzo (1984) 
reported Zn-binding capacity in excess of 100 g-atoms 
Zn/mol of human alpha2-M In this study, a higher
Zn-binding capacity was observed.
Evidence from the current studies with sheep alpha2-M and 
results on human alpha2-M by Gonias et al (1984), Pratt 
and Pizzo (1984), and Adham et al (1977) gives rise to 
the hypothesis that alpha2-M could have a homeostatic and 
transport function, controlling limited variation in 
plasma Cu and Zn in response to fluctuating dietary
levels of these elements. Evidence in support of the
above hypothesis was demonstrated in the current
experiments by using sheep plasma alpha2-M. Sheep
alpha2-M showed 4.5 times greater Zn-binding affinity 
than sheep albumin (Table-XIV, Expt.5); in terms of 
g-atoms Zn/mol alpha2-M, the Zn content of sheep alpha2-M 
was 50 times higher than that of albumin. These values 
are far higher than human alpha2-M, where, 50% higher 
affinity for Zn and 20 times higher Zn content than 
albumin were observed by Adham et al (1977) after 
dialysis. This suggests that not only alpha2-M has a role 
in the transport of Zn, but that has increased binding
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capacity is important.
The molar ratio of Zn to alpha2-M in vitrowas shown to be 
greater than the in vivo ratios reported so far in human 
plasma. Thus, a maximum of 222.16 x 102 ; 325.44 x 102 ;
198.16 x 102 ; 360.46 x 103 ; 76.39 x 103 g-atoms Zn/mol 
alpha2-M were observed. The highest concentration of Zn 
bound to alpha2-M (360.46 x 103 g-atoms Zn/mol alpha2-M) 
was in Cu-deficient sheep. Similarly, in pregnant ewes 
maintained indoors on a variable Cu and Zn (ratio 1:4) 
diet, 118.49.103 ; 54.59.103 ; 38.71.103 g-atoms Zn/mol
alpha2-M respectively were determined in Dorset, Clun and 
Finn ewes. There have been no similar studies in either 
human alpha2-M or in sheep alpha2-M. However, there are 
studies of Zn binding to native human plasma alpha2-M 
(Parisi and Vallee, 1970; Adham et al, 1977; Song and
Adham, 1979) and in hyperzincaemic and hypozincaemic 
human sera (Song and Adham, 1979). In both hypo and 
hyperzincemic sera obtained from patients with multiple 
myeloma and lymphocytic lymphoma, Song and Adham (1979) 
showed that the molar ratio between Zn and alpha2-M was 
maintained at approximately 1:1.
An investigation of the influence of Cu on Zn-binding to
sheep plasma alpha2-M showed that the Zn-binding to sheep
plasma alpha2-M in the presence of both Cu and Zn
(Table-VIII, Expt.4) was less effective than incubation
with Cu only (Tables-VI & VII, Expt.4). The effectiveness
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was judged on the basis of Zn bound to alpha2-M and the 
time taken to respond to the influence of Cu. A 
significant (P<0.001) decrease in Zn-binding to alpha2-M 
(Tables-VI & VII, Expt.4) was observed as a direct 
consequence of incubating alpha2-M first with Cu (5 to 25 
/ig) . The results in Table-VIII showed comparatively less 
bound Zn and slower response as both Cu and Zn were 
probably competing for the same sites on the alpha2-M. 
These results (Table-VI & VII, Expt.4) suggested that Cu 
occupied the Zn-binding sites. Comparison of Tables-VI, 
VII & VIII indicated that the levels of in vitro Cu and 
Zn are important considerations in assessing Zn-binding 
to alpha2-M; also, the incubation time or the period of 
association with the competing metals Cu and Zn is 
important.
The concentration of Cu and Zn in the incubation mixture 
appeared to guide the influence on Zn-binding to
alpha2-M. This was shown clearly in Tables-VI & VII 
(Expt.4), where alpha2-M incubated with 150 jig Zn and 
1500 jig Zn, the Zn-binding to alpha2-M decreased by 
55.8% and 42% respectively in response to in vitro Cu 
ranging from 5-25 jig. It appears that higher in vitro Zn 
(1500 ^ ig Zn) reduced the influence of Cu. This conclusion 
is supported by the results in Table-V (Expt.3), where a 
linear relationship between a constant concentration of 
alpha2-M and increasing concentrations of Zn was 
established in the absence of copper.
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Studies on human plasma alpha2-M established that there 
are two Zn-binding sites in human alpha2-M (Adham et al, 
1977; Pratt and Pizzo, 1984; Gettins and Cunningham, 
1986).
Sheep plasma alpha2-M may be similar to human plasma 
alpha2-M in possessing Zn-binding sites with different 
affinities. The results in Expts.2, 3 and 4 demonstrated 
this by showing altered Zn-binding to alpha2-M in the 
presence and absence of Cu. This suggests the possibility 
of the occupation of Zn-binding sites on alpha2-M by Cu 
ions. It can be speculated that sheep plasma alpha2-M 
might be similar to human alpha2-M and it is the weaker 
sites which might be susceptible to Cu.
Studies of human plasma alpha2-M (Gettins and Cunningham, 
1986) indirectly suggested the possibility of replacement 
of Zn in alpha2-M by Cu. They obtained similar data with 
Zn and Mn binding to human apo-alpha2-M and established 
that Mn has similar relative affinities for the two types 
of sites as Zn. Ions such as Mn(II) and Cu(II) have long 
electron-spin relaxation times and are therefore good NMR 
probes (Dwek, 1973). Thus supporting indirectly the 
replacement of Zn by Cu. Experimental evidence for this 
is offered by the results in Expts.4 (Tables-VI & VII) 
and 6 (Tables-XVI & XVII).
Feeding a Cu-deficient diet significantly (P<0.001)
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decreased plasma Cu and Zn concentrations (Table-IX). 
However, after 7 weeks mean Zn concentration reached 
nearly the same level observed at the beginning 
(Fig.31).This confirmed the results by Saylor and Leach 
(1980) and Al-Mukhtar (1984) who observed reduced plasma 
Cu concentrations in Cu-deficient sheep similar to the 
results in this study. While reduced mean plasma Cu 
concentration may be directly related to lack of dietary 
Cu, the reduction in plasma Zn was not so obvious and may 
have been due to interrelationships between Zn and Cu. 
There is evidence of redistribution of Zn from tissues to 
liver under stressful conditions (Vikbladh, 1951; Beisel
and Pekarek, 1972; Pekarek and Wannemacher, 1972;
Pekarek, 1972; Pekarek and Beisel, 1974. It is possible 
that the Cu-deficiency results in a redistribution of Zn
from tissues to liver. This would explain the lower
plasma Zn as observed in Table IX, Expt.5. However, 
greater affinity between alpha2-M and Zn and lack of Cu 
in the diet stimulated alpha2-M to bind Zn. Occurence of 
this event may be responsible for the increase in plasma 
Zn after 7 weeks as shown in Table-IX, Expt.5.
A high-Cu diet was fed to sheep in Expt.6 and 
observations made on plasma Zn and Cu concentrations as 
shown in Table-XV. The results showed a rise of plasma Cu 
after one week; the increased concentration of Cu 
although higher than normal for three weeks indicating 
some support for Saylor and Leach (1980) who found
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similar results and proposed that such an increase in 
plasma Cu was due to a lack of biliary control for Cu in 
sheep. However, after the first week, the plasma Cu 
concentration decreased, thus indicating that the Cu is 
leaving the plasma more rapidly and probably accumulating 
in the liver. There is no evidence that the biliary 
control has changed during these weeks of decreasing 
plasma Cu; however, after the ninth week, two of the 
sheep died; on post mortem examination showed liver Cu 
concentrations of toxic levels.
The mean plasma Zn concentration in high-Cu sheep fell by 
54% after 4 weeks and was 34.3% lower after 7 weeks 
compared to the mean concentration at the begining of the 
experiment (Expt. 6, Table-XV, Fig.36). The recovery of 
plasma Zn concentrations from their lowest concentrations 
may be due to 200 mg Zn/kg in the diet.
Comparison of results in Expt.6 with the results by 
Bremner et al (1976) highlights the influence of dietary 
high-Cu. Bremner et al (1976) showed that high dietary Zn 
effectively protects against Cu-toxicosis in sheep. Three 
dietary treatments were used in their studies, group A 
given the basal diet (29 mg Cu and 43 mg Zn/kg 
diet),groups B and C received additional supplements of 
Zn, made up to 220 and 420 mg Zn/kg diet respectively. 
After 9 weeks they found a 9% reduction in mean plasma Zn 
concentration in group A. In Expt. 6 (Table-XV) the
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reduction in Zn concentration was more pronounced. 
Similarly, in their (Bremner et al, 1976) study mean 
plasma Cu concentrations in all treatment groups 
increased up to 16 weeks and showed 72%, 58.4%, 58.6% 
increase in A,B and C groups respectively. After which 
time all groups showed reduction in plasma Zn but the 
concentrations were higher than at the start of the 
experiment. The pronounced influence of high-Cu diet in 
this study may be due to 250 mg Cu/kg diet compared to 29 
mg Cu/kg diet of Bremner et al (1976). The ratio of Cu to 
Zn in this study was 5:4 and in their diets, 29:43; 
29:220 and 29:420 in groups A, B and C respectively. 
These differences in Cu:Zn and the mutual antagonism 
between these two were responsible in this study for more 
pronounced rise and fall in mean plasma Cu 
concentrations. Similarly, higher Zn concentrations in 
A,B and C diets of Bremner et al (1976) were responsible, 
not only for maintaining higher plasma Zn concentrations 
but also offered effective protection against 
Cu-toxicosis. However, the precise concentrations of Cu, 
Zn required to offer protection against Cu toxicity is 
still not clear and in addition to Zn the effects of 
other elements such as molybdenum and iron could also be 
important.
Despite the recognition of dietary antagonism (Smith and 
Larson, 1946) between Cu and Zn in the diet of rats, with 
the exception of Bremner et al (1976) dietary levels of
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Zn were not specified in earlier studies. This makes 
comparisons of the present results in this thesis with 
other workers (Todd et al, 1962; Todd and Thompson, 1963; 
Ishmael et al, 1972) difficult.
Further evidence on the influence of Cu on Zn-binding to 
alpha2-M from Cu-deficient and high-Cu diet fed sheep was 
obtained in Expts.5 & 6. These results showed that
Zn-binding to alpha2-M obtained from Cu-deficient sheep 
plasma increased (Tables-X & XI, Expt.5) significantly 
(P<0.001). In contrast, significantly (P<0.001) decreased 
Zn-binding was observed in alpha2-M obtained from high-Cu 
sheep plasma (Tables-XVI & XVII, Expt.6).
Zn-binding to alpha2-M obtained from Cu-deficient sheep
plasma increased during 4 weeks, from 44.48 x 102 to
74.58 x 102 g-atoms Zn/mol alpha2-M when incubated with 
level-I Zn (150 pg) (Table-X, Expt.5). Maximum g-atoms 
Zn/mol alpha2-M was 124.52 x 102 observed after 3 weeks. 
After which time Zn-binding to alpha2-M varied.
Zn-binding to alpha2-M showed an increase after 7 weeks 
when Cu was supplemented in the diet (5 mg Cu/kg and 50 
mg Zn/kg diet). At 1500 p g Zn incubation Zn-binding to 
alpha2-M was significantly (P<0.001) higher than at the 
start of the experiment for 6 weeks (Table-XI, Expt.5). 
Level-II Zn concentration was 10 times higher than
level-I but Zn-binding to alpha2-M was more than 10 times
245
that observed at level-I, this could be important 
evidence indicating existence of different binding sites 
and binding to different binding sites. At higher Zn 
concentrations during incubation, dissociation of
alpha2-M might occur as observed under electrophoretic 
conditions (Pratt and Pizzo, 1984) and under such
conditions Zn-binding sites may be available for
occupation by Cu as shown in Expt.4.
Conformational changes in the alpha2-M molcule could have 
occured during incubation with 1500 pg Zn which may be 
responsible for increased Zn-binding observed for 6 weeks 
(Table-XI, Expt.5). The possibility of this could be 
supported by the studies of Adham et al (1977). Adham et 
al (1977) suggested that the occupation of second 
Zn-binding site (weaker affinity site) of alpha2-M 
molcule by Zn initiates irreversible conformational 
changes in the molecule that interferes with enzyme 
binding activity. It is likely that these conformational 
changes may be responsible for exposing the Zn-binding 
sites to bind more Zn.
It can be speculated that Zn-binding amino acids might
have been released on incubation with 1500 p g  Zn, which 
may be responsible for increased Zn-binding. Zn-binding 
to amino acids such as histidine, glutamine, threonine, 
cystine and lysine, increased ultrafiltrable65Zn (Prasad 
and Oberleas, 1970) when added to predialysed serum.
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These Zn-binding amino acids are present in human 
alpha2-M (Heimburger et al, 1964; Dunn and Spiro, 1967; 
Bourrillon and Razafimahaleo, 1972) and glutamine as 
glutamic acid accounts for about 12.3 to 13.5% of 
alpha2-M. However,there are no reports of amino acid 
analysis of sheep alpha2-M. It is not certain whether Zn 
bound to these amino acids will account for all the 
additional Zn bound to alpha2-M.
Increased Zn-binding to alpha2-M observed in 
Cu-deficiency (Tables-X & XI, Expt.5) might have taken 
place at weaker Zn-binding sites in alpha2-M. Evidence 
already available (Parisi and Vallee, 1970) suggests that 
Zn in human alpha2-M is bound with a high stability 
constant, a characteristic feature of other 
metalloproteins (Vallee and Wacker, 1970). Despite 
maintaining increased Zn-binding at both levels of Zn 
(150 and 1500 ^ ig) in vitro Zn-binding to alpha2-M showed 
variability. This indicates the binding of Zn has taken 
place at sites with low affinity for Zn. The existence of 
a class of site with greater affinity (Site 1) for Zn and 
a class of weaker site (Site 2) with low affinity for Zn 
was confirmed by Adham et al (1977), Gettins and 
Cunningham (1986).
In Expt. 6, Tables-XVI & XVII sheep fed on high-Cu diet 
showed significantly (P<0.001) reduced Zn-binding to 
alpha2-M than at the start of the experiment. The
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Zn-binding decreased from 48 x 10* (47.80.102) to 24 x 
102 (24.12.102 ) g-atoms Zn/mol alpha2-M at level-I Zn
(150 p g) and from 76 x 10* (76.39.103 ) to 14 x 102
(14.10.102 ) g-atoms Zn/mol alpha2-M at level-II Zn (1500 
/lg) in 7 weeks. After one week on high-Cu diet, mean 
plasma Cu concentration increased from 0.73 g/ml to 3.18 
p.g/ml. This rise in plasma Cu occured at the same time as 
a decrease of 86% in Zn-binding to alpha2-M at level-I 
and by 90.8% at level-II Zn incubation (Tables-XVI & 
XVII, Expt.6) after 1 and 2 weeks respectively. However, 
the trend reversed after reaching lowest values of 
Zn-binding to alpha2-M and this corresponded with 
decrease in plasma Cu concentrations. After 6 weeks on 
high-Cu diet the above relationship was not obvious. This 
could have been due to altered ratio of concentrations 
between Zn and Cu in plasma (Table-XV, Expt.6).
Despite showing significant reduction in Zn-binding to 
alpha2-M there was continuous variation in vitro 
Zn-binding probably reflecting changes in plasma Cu 
concentration. Zn-binding to alpha2-M reduced directly in 
response to in vivo plasma Cu was clearly demonstrated on 
examination of plasma Cu concentrations and Zn-binding to 
alpha2-M at both levels. The possibility of Zn-binding to 
different sites on alpha2-M was reflected in Zn-binding 
to alpha2-M (Table-XVI, week 1; Table-XVII, week 2). In 
Table-XVI the lowest Zn-binding was after one week, 
whereas, in Table-XVII the lowest Zn-binding was observed
248
after 2 weeks. Using the same alpha2-M samples 
demonstrated different binding properties indicating 
binding of Zn to different sites on alpha2-M. These 
results strongly suggested that Cu is responsible for the 
reduction in Zn-binding to alpha2-M and that the dietary 
concentrations of Cu and Zn were contributing to this; 
there are however many questions which are not answered 
of the relationship between the Cu and Zn in their 
competition for binding sites of different affinity. The 
existence of sites with high and low affinity for Zn have 
been confirmed for human alpha2-M by Adham et al (1977), 
Pratt and Pizzo (1984), and Gettins and Cunningham 
(1986).
A model (Fig.40) is proposed for the distribution of Cu 
in sheep plasma and liver when high-Cu diet was fed to 
sheep. This model broadly explains the changes taking 
place in plasma Cu as a result of high dietary Cu and its 
influence on Zn-binding to alpha2-M. The changes taking 
place in plasma are based on the results from 
Tables-XV,XVI & XVII. The distribution of Cu in liver 
(shown in Fig.40) was based partly on the studies by 
other workers as quoted.
The evidence in support of the above model is as follows:
When high-Cu diet was fed, plasma Cu concentration 
increased significantly (P<0.001) as shown in Expt.6.
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During the same period in vitro Zn-binding to alpha2-M 
significantly decreased (Tables-XVI & XVII). This in 
vitro Zn-binding to alpha2-M showed an inverse 
relationship with plasma Cu in high-Cu sheep. The plasma 
Cu in animals is rapidly removed from circulation by 
liver (Owen, 1980). In animals the copper metabolism is 
maintained by homeostatic regulation by biliary excretion 
(Owen, 1980). Thus the rate of Cu accumulation (Suttle 
and Mills, 1966a) in liver influences the Cu 
concentration in plasma. The Zn-binding to alpha2-M in 
plasma reflects the corresponding changes in plasma Cu 
concentration. It is already established that the 
accumulation of Cu in liver leads to metallothionein 
synthesis (Bremner, 1987). The results in Expt.6 have 
shown that after feeding Cu-supplemented diet Zn-binding 
to alpha2-M increased in response to the availability of 
Cu and Zn.
The model proposed summarizes the results in this study 
and gives possible explanation to the variations in 
Zn-binding to alpha2-M. It was shown by Saylor and Leach 
(1980) that in sheep there is no biliary control of Cu 
removal. Hence, the model showed no biliary removal of Cu 
from liver as shown in the model of Owen (1980). Owen 
(1980) proposed a three compartment model which appears 
to explain liver Cu metabolism in general.
Further evidence which strongly demonstrated that Cu did
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replace Zn on alpha2-M was obtained from the analysis of 
purified alpha2-M obtained from the plasma of high-Cu 
sheep as shown in Table-XIX,Expt.6. These results showed 
the presence of Cu in alpha2-M and increased in
concentration from 0.04 to 0.4 mg/g alpha2-M (Table-XIX, 
Expt.6). Whereas, no Cu was detected in alpha2-M obtained 
from the plasma of Cu-deficient sheep (Table-XIII,
Expt.5).
The concentration of Zn in purified alpha2-M from high-Cu 
sheep varied from 0.440 mg/g alpha2-M at week-0 to 1.330 
mg/g alpha2-M during weeks-4 to 6. However, in 
Cu-deficient sheep as high as 10.75 mg Zn/g alpha2-M was 
observed. These in vivo concentrations of Zn in alpha2-M 
confirmed the in vitro observations, which showed 
significantly (P<0.001) increased Zn-binding in 
Cu-deficienct and significantly (P<0.001) decreased
Zn-binding to alpha2-M in high dietary Cu sheep.
The severity of the influence of high-Cu diet was 
probably reduced by the dietary Zn concentration of 200 
mg Zn/kg as suggested by Bremner et al (1976). The
recommended dietary requirement for sheep (The Nutrition 
Requirements of Livestock, 1980) is 35-50 mg Zn/kg diet. 
However, in high-Cu diet, 200 mg Zn/kg diet was included 
to reduce the severity and to facilitate studying 
Zn-binding to alpha2-M.
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Alpha2-M and albumin pools have been characterized as 
major non-exchangeable and exchangeable (loosely bound) 
Zn pools respectively for human serum (Vikbladh, 1951; 
Parisi and Vallee, 1970). In Cu-deficient (Expts.5) and 
high-Cu (Expt.6) sheep plasma interesting results were 
observed on the Zn concentration of alpha2-M pool 
(Pool-I) and albumin pool (Pool-II). In the Cu-deficient 
sheep, initially, the Zn concentration of Pool-II was 
higher than Pool-I and from week 3, Pool-I Zn was higher 
than Pool-II Zn from 3 to 9 weeks. These results showed 
two points: (a) that dietary Cu-deficiency affects
albumin first with greater reduction of albumin bound Zn 
than alpha2-M bound Zn, which was shown by the results in 
Table-XI (Expt.5). Zn concentration of albumin pool 
decreased from week-0, (b) transfer of Zn occured between 
albumin and alpha2-M such that, alpha2-M pool of Zn 
increased.
There are no previously published reports of similar 
observations in Cu-deficient sheep. However, in 
Zn-deficient sheep, release of albumin bound Zn was 
suggested (Parry, 1976) which could maintain the unbound 
and physiologically available Zn in plasma. In human sera 
considerable variation in albumin bound Zn was reported 
by Foote and Delves (1984). They suggested that human 
albumin exhibits excessive Zn-binding capacity, but under 
normal physiological conditions Zn occupies less than
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0.2% of the capacity. According to these workers, 
reduction in serum albumin concentration as observed in 
gastrointestinal and hepatic disease, reflects 
Zn-deficiency. This is due to the dependence of albumin 
synthesis on the availability of Zn (Bates and McClain, 
1981). Hence, it is apparent that any variations in serum 
Zn may be due to variations in the concentration of 
albumin. However, no reports are available in sheep and 
particularly in Cu-deficient sheep. Further research is 
needed to confirm these suggestions in both human plasma 
as well as sheep plasma.
In Expt.5 the two protein pools (alpha2-M and albumin) 
there is an indication of increased Zn in Pool-I while 
Pool-II Zn decreased. It can only be assumed that albumin 
which binds Zn loosely, lost some of its Zn. 
Cu-deficiency probably decreased Cu bound to albumin. 
There was no indication of Zn replacing Cu. On the other 
hand Zn concentration of alpha2-M has been maintained 
higher than albumin. High affinity of alpha2-M greater 
than albumin (Adham et al, 1977; in this study Expt.5, 
Table-XIV & Fig.35) may be responsible for increased Zn 
in alpha2-M.
Results in Table-XIII, Expt.5 demonstrated that 
Zn-binding to alpha2-M increased in vivo confirming the 
results obtained from in vitro Zn-binding studies as 
shown in Tables-X & XI. Table-XIII showed upto 10.75 mg
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Zn/g alpha2-M obtained from the plasma of Cu-deficient 
sheep. Thus Zn-binding to alpha2-M in vivo and in vitro 
showed similar trends.
Further evidence supporting in vitro and in vivo 
influence of Cu on Zn-binding to aipha2-M was obtained. 
For this, alpha2-M pool and albumin pool Zn 
concentrations from high-Cu sheep plasma were measured. 
Unlike, Cu-deficient sheep, Zn concentration of alpha2-M 
pool reduced. Despite Zn reduction in albumin pool, 
concentration of Zn in albumin pool remained higher than 
alpha2-M pool. Zn-bound to alpha2-M pool increased after 
6 weeks, but Zn concentration at the begining was 
achieved only once. These results confirmed that in 
high-Cu sheep Zn-binding to alpha2-M decreased.
Zn-binding to alpha2-M (Tables-XXIII to XXVIII) in three 
breeds of pregnant ewes on a variable Cu and Zn diet with 
a ratio 1:4 supported the observations made in 
Cu-deficient and high-Cu sheep and confirmed the 
influence of dietary Cu. They further demonstrated that 
the influence of dietary Cu is breed dependent.
Dorset ewes showed increased Zn-binding to alpha2-M 
(Table-XXII & XXIII, Expt.7) for 74 days. Maximum 
Zn-binding was 193.78.102and 118.49.103 g-atoms Zn/mol 
alpha2-M at level-I and level-II Zn incubation, 
respectively. This increased Zn-binding is similar to
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binding observed in Cu-deficient sheep. However, 
Zn-binding to alpha2-M did not reach the maximum binding 
achieved in Cu-deficient sheep. This could have been due 
to Cu to Zn ratio (1:4) of the diet. Higher Zn 
concentration of diet offered protection against high Cu 
concentration due to antagonism between the two metals 
probably influencing the absorption of Cu at the 
intestine.
The results in this study supported the breed differences 
observed by Parry et al (1984) in pregnant Dorset, Clun 
and Finn ewes maintained indoors.
The three breeds (Expt.7) responded differently and 
showed mutual antagonism between Cu and Zn. Thus, the 
variable Cu, Zn (1:4) diet was responsible in Dorset for 
the signs of Cu-deficiency (increased Zn-binding to 
alpha2-M). In Clun and Finn ewes converse effect was 
true. The high-Cu conditon (Tables-XXIV to XXVII) of 
plasma was probably caused by lack of sufficient dietary 
Zn to antagonise Cu.
The effectiveness of the diet was judged by preventing 
death of ewes due to development of Cu-poisoning when 
kept indoors. Additional stress of pregnancy also 
existed. Though the diet was effective in preventing 
death it appears that the effect on Zn-binding to 
alpha2-M strongly suggests further evaluation of
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protection offered and the basis of evaluation.
The evidence obtained from the results in this study 
support the hypothesis on the influence of dietary copper 
on Zn-binding to sheep plasma alpha2-M. The influence of 
copper was dependent on the ratio of dietary 
concentrations between Cu and Zn. The influence of Cu in 
vivo reflected the influence of the ratio between Cu and 
Zn in the diets.
The results in Expt.l showed that sheep plasma alpha2-M 
can be purified using methods (Song et al, 1975; 
McEntire, 1978) used for human alpha2-M. Sheep plasma 
alpha2-M obtained from these methods showed that IgG is 
closely associated with alpha2-M. An isoelectric point of 
4.8 was determined for sheep alpha2-M.
In Expts.2 & 3 the results showed that Zn-binding to
alpha2-M is dependent on the concentration of Zn and a 
linear relationship between Zn-bound and alpha2-M.
In Expt.4 the results showed that Zn and Cu competed for 
the binding sites on alpha2-M and is influenced by the 
concentration of Cu and the incubation time with Cu and 
Zn.
In Expt.5, Zn-binding to sheep plasma alpha2-M increased 
both in vivo and in vitro in dietary Cu-deficiency.
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In Expt.6, Zn-binding to plasma alpha2-M decreased both 
in vivo and in vitro in sheep on high-Cu diet. The 
presence of Cu in alpha2-M obtained from high-Cu sheep 
plasma strongly suggested that Cu occupied sites on 
alpha2-M probably replacing Zn.
In Expt.7 the results showed breed differences in 
Zn-binding to alpha2-M in pregnant Dorset, Clun and Finn 
ewes maintained indoors on a variable Cu, Zn diet with a 
ratio, 1:4.
The results in this thesis strongly suggest the influence 
of Cu on Zn-binding to alpha2-M and paved the way for the 
investigation of other Zn-binding proteins. The 
suceptibility of sheep to Cu toxicity enhances the 
importance of these studies by better understanding to 
improve productivity. However, further studies are needed 
to extend these studies to other breeds of sheep. These 
studies appeared to be more urgent to understand the 
mutual antagonism between Cu and Zn.
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The above results showed that no G5Zn is bound to ]gG 
65Zn is bound to only alpha2-M.
Results of 65Zn binding to IgG using gel filtration 
technique is shown in Fig.47, which shows no 65Zn binding 
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Zn-bindlng to alpha2-M (50-250 ug) incubated with 1500 ug Zn
No. of 
asaaya
Concentration of alpha2-M (ug) 
50 100 150 200 290
Cl C2 C3  —  C4 —  -C9 _ r -  -—  ROW —
zn Bound/100 ug alt
101 90 ^-31. 80 — 33. 10 — ^4. 22 ^-8. 34 -----
= 4 1  =199. 72 -50. 90 =13. 60 =18 59 =7. 99
=r — 9 163.30 49.39 23. 90 — 14.70 - 0.21
: MTB > TTEST Cl C2 C3 C4 C9  -- _ = r
TEST OF MU - 0. 0 VS HU N. E.
T —  ” ' N MEAN 0TDEV —  8E MEAN — — --T =  P VALUE
Cl 9 200. 3 33 1 14.0 13 93 “  0.0002
C2 9 44. 3 9. 0 .-— 4.4 — 10. 12 — -  t  0009
C3 5 - 23. 2 7 2 —  3.2 ■— —  7. 14 — — 0 0020
- C4 - 9 10. 2 - -*4. 3 —  - trf ~— -4. 96 — —  0 0007 ~
- C5 9 7. 2 1. 1 --- — 0  9  —  i4. 24 — — 0. 0001
APPENDIX-IV
Zn-binding to alpha2-M (100 ug) on varying 
incubated Zn from 150-3000 ug
No. of CONCENTRATION OF Zn (ug) ADDED TO 100 ug ALPHA2-M
aaaaya 150 300 450 750 1500 3000
~  TlOW __ Cl . — C2 C3 _ ~ C 4 ~t9 ~ /C6
= * {  ~ 13 90 ~  29. 49 49. 09 79. 00 197. 27~“ 279 69
. a 19. 42 31 76 * 46. 90 73 03 T 140. 66 29 9 30
3 14. 97 20 60 "43. 16 76 47 192. 99 309 17
= L 4 13. 96 26 92 41. 20 74. 69 146 03 i 288. 33
9 14 02 27. 39 49. 20 72. 02 149. 19 290 91
MTB > TTEST Cl C2 C3 C4 C5 C6
TEST OF MU - 0. 000 VS MU N E 0 000
jug Zn Bound/100 p g aIpha2-M
N MEAN 8TDEV BE MEAN T P VALUE
Cl 9 14 494 0 739 0 331 43 71 0 0000
C2 9 28 060 2. 304 1. 030 27 23 0. 0000
C3 9 49 206 3 207 1. 470 30. 79 0. 0000
C4 9 74 994 1 361 0 609 122 46 0 0000
C9 9 190 900 4 129 1 049 81. 79 0. 0000
C6 9 293 400 9 789 4 378 67 02 0. 0000
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APPENDIX-V
Effect of in vitro Cu (5-25 ug) at level-I Zn
No.of ug Zn Bound/100 ug alpha2-M
“-16 B5 =_T7. 3F ^-13 Q9 J76
— — ? ______ 37  20,33 .. 16. 63____9-Zfl ..-6-70-
= ^ - 3 ^ 3 9 - 3 3  =£-gQ 94 ~ ~ 1  Lz 2B 1 1 601:
4 17 62 21 07 13 47 13 86 8 03
JTE5T £Il C2 G3 C « 5 .
^TEST^bF-WU *  OO VS liO N E - 0 00
" ■ . N - MEAN 6TDEV ssr SE HE AN --- T ---"P VALUE
jttC 1 - _ - -3 jr 18 37 - 3 33 - 1.3© - ^12. 23 --0.0003
- C2 — 3. -19 77 - = 1. 73 -“1=^0: 77 —  23 60 - —  O 0000
~ C 3 —  —  3- — - — 14 76 - 2. 50 - 1. 12 r_ 13. 2 2  s — Or 0002
C4 TH-.rt: 3 12 16 I 37 -0 70 17 28 - * 0 0001
C3 —  3 - 8 1 1 J. 16 t 2- 0. 32 . 13.38 - 0.0001
_ J . — - - - —_: —— _!• . 1-1 i—r ■1 -r —
Effect of in vitro Cu (5-25 ug) at level-II Zn
No.of ug Zn Bound/100 ug alpha2-M 
assays
ROU 1- >  JEC6- =  -~  ^C71 ce ^-=Ti=C9:^- Trcio
. ~ I ~ 173 32- 131 02 111 12 127. 48 93 24
2 -169. 81 161. OX-- - 96 33 —  128 67 — 102 73
- — 3 169. 79 169 80 : 126 23 —  136 21 - 103. 14
4 171. 03 158 34 118 71 122 83 98 68
- • — - T~ • r :T .-.- '— • *. .. •
-
-3 168 36 134 63 114 92 rI19 66 93 08
- ~ * J- -- _ .
MTB .3► TTEST C6 _C7 -_CB C9 CIO -- - _ _.
: =r . :‘ i t~ r__ ■“
TEST OF MU • 0 000 vs MU N E. 0. 000
— * - * _ :
N MEAN STDEV - SE MEAN T . P VALUE
C6 3 170 546 1. 881 0 841 202 71 0 0000
C7 - 3 153 976 7 141 3. 193 49 78 0 0000
C8 5 113 470 11 085 4 937 22 89 0 0000
C9 3 126 974 6 304 2 819 43 04 0 0000





Plasma Zn concentrations of Cu-deficient sheep
C3 C 4  C 3 _____ C6 -C7 _ C8— ROW   Cl ____ C2 _   ------------------ -=«-=.■—   n —
^=z .Week 0 1 2 =  L3 r =4 =?*»= 5 ===zS-==
 1 - .1. 10 0 730 1.00__1_130-___1~03 — 0. 923 ---I. 300 — 1. 273
Z==Z2 — 1. 40 0. 900 _ 0 03 =  1 030 ZZO-93 ZE0. 030 3=0- 923 = E  100
 3 0.93 _ 1.130 _0. 73 — 0. 923 __ 0. 90 —  1. OOP —  X  030 — 1-130
'===*=-1. 32 0 773 0 90 0 930 0.03 — 0.030 =0 . 0 0 0  ZZI-073
 3 __0. 93 - 0.930 0.73 _0. 630 - 0. 6 0 — 0.623___ a  030---L-000
=  8C9 
_  0 90 
Z 0 70 
_ 0  83 
=  0 70 
__ 0 63
_xi0-=^_Week^ 9 _ _ ----- ------
= ^ 0  923 0. 923 f O- BOO 0. 030 O. 923 Z = =
ZHTB > TTEST Cl C2 C3 C4 C3 C6 C7 C0 C9 CIO z P 52^ 8 ■ ^ U - ' d e f e c I e n f  
_ .... .    C9 CIO = Cu-suppl.
ZTEST OF MU - 0.0000 VS MU N. E. 0.0000 . =_~~ZZZ==ZZTV Z-.'Z Z - Z
Z I .  ~ N MEAN BTDEV SE MEAN r T P VALUE T = : :  -
Cl 3 I. 1440 0. 2004 . 0. 0932 12. 27 0 0003
C2 _ 3 0. 9030 0. 1603 0. 0718 12. 61 _ - 0. 0002
C 3 ____ 3 0. 0300 0. 1061 0. 0474 . 17-92 . _ 0. 0001 __
C4 ___ 3 0. 9430 0. 1074 . 0. 0038 11. 27 ZZIZO. 0004
C3 . . ... 3 _ 0. 0700 0. 1601 _ . 0. 0732 11. 37 _  0. 0003 ___
rC6 =ZZ . ... 3 _0. 0500 0 1403 0. 0627 __ 13. 33 _'r _^ _0. 0002 - ___ __ .
C 7 _______ 3 _ 0. 9030 0. 1997 __.o. 0093 _ 11.03 ____0. 0004 _________
:CB Z . 3 1. 1200 0. 1022 _ 0. 0437 Z  24. 31 - ±0. 0000 - - —__z.~
C9 ____ 3 0. 7600 0. 1084 _ 0. 0483 13. 68 . 0. 0001 .
CIO ;' 3 . 0. 8030 0 0376 0. 0237 _L  ^34. 30 —  .0. 0000 = = '  -
No.of Plasma Cu concentrations of Cu-deflcient sheep 
sheep
rEZBOW “ ~ C 1 1  C 12
_— _weok—o-----1
= = F -1Z 0. 700 —  0. 430
= 2  --1. 030 0 650
= Z 3  ZZ 1.073 - 0. 730
 4 -- 1. 023 0 023
300 — 1. 025
5eao~ = Week = 9 i s c i l H =  Week^^-1" - - -
m?'775 0 050 ° 4,0 ° ,0° 0 950 ■ -  -  — ciFcie-i^aif icieht
—  MTB > TTEST C U  C12 C13 C14 C13 C16 C17 C10 C19 C20 C19 k  €20 -CU“ SUppl.
-TEST OF MU - 0. OOO VS MU N. E. 0 000 ' . ~ - - T - - -
_ N MEAN STDEV SE MEAN T P VALUE
C U 3 1. 190 0 413 0 106 6 41 0 0030 *
C 12 3 0. 740 0 213 0 093 7 70 - - 0 0013
C13 3 0. 793 0 173 0 070 10 14 0 0003
C 14 3 0 810 0 127 0 037 14. 26 0 0001
CIS 3 0 713 0 113 0 030 14 19 Z-- 0 0001
-C16 3 0. 740 0 121 0 034 - - 13. 71 ----0 0002 —
“ C17 = - 3 0. 833 0 170 0 076 10 90 - - 0 0004
-CIS —  - 3 0 883 0. 137 0 070 12 63 0. 0002 —  -
C19 3 0. 833 0 197 0 088 9. 70 0 0006
C20 3 0. 823 0 117 0 032 13 73 0 0001
C 13 ~= —  C14 C 1 3 = ^ = C 1 6  C ir-=Z-Cie — >-C19
2 _ _  3 - — 4—  _ ,5-^-^-g 8 _
--0. 323 - 0 623 0 330 — 0 330 — O 373 -^ =-0 630 -0 330 -
- 0. 030 — 0. 923 - 0. 773 — 0. 730 973 ==4. 023 — 0 900 -
0. 730 0 023 0 7 73 —  0 000 =^0. 823 — C 023 - 0 800
1.000 — 0 923 - 0. 023 — 0. B73-— I. 000 ^ rrl; 023 — 0. 930
0. 030 — 0. 730 0. 630 =Z© 723 — 0. 800 = 0  900^ = 4-073 _Z
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APPENDIX-VII
Zn-binding to alpha2-M in Cu-deficient sheep plasma 
at level-I Zn 
pg Zn BOUND/100 pg alpha2-M 
MTB >  PRINT <U C2 C3 C9_C5 C t C 7  CB C9 ; C l M i l =?r = =  ^
^=*ow Cl C 2 ~ -  — C3 - ^ = C 4 ----- « ----- C6
--=-=■ —  leek 0 ----- =1 1-:-- _ 2 ==: “ r 5 = = = t := ^
— - 1 39 11 — 34F14 69 13 - 112 20 -“^ 60 B 3 ~ 1 7  56
— r — 2 —  41. 50 =  40 25 -r—64 59 r.lOB. 42 - 72. 56j=-l9. 27
— — '3 - 35 65 -"30. 42 76 92 f 16 6S —  76 47 '— 22 30
■=_. 4 =A3. 56 37. 44 71. 26 ==102. 66 54 90 — =14. 54
* 5 - 30 60 - 32. 60 67 07 ~  121 35 — M  45- 16 02
= 0 b w  *— 9  CIO
1 54 7B 50 51
2 59.35 64 34
3 40 04 46. 25
. =  4 :. 51.60 40 75
- = - 5 - “ 60 55 -49 30
MTB > TTEST Cl C2 C3 C4 C5 C6 C7 C0 C9 CIO Cll
TEST OF MU - 0 00 VS MU N E 0 00
N MEAN STDEV SE MEAN T P VALUE
Cl 5 z 40 10 3. 71 - 1. 66 - 24. 17 0. 0000
C2 - - 5 - - 34 99 3.09 1. 74 - - 20 10 • 0. 0000
C3 5 69 95 4 50 - 2 05 34 13 0. 0000
C4 5 112 27 7 23 3 23 34 75 0 0000
-C5 • 5 67 26 0 30 _ 3 75 .17. 95 0. 0001
C6 5 IB 11 - 2 93 r 1 31 " 13 03 0 0002
C7 5 44 02 4 72 2. 11 -20 07 0. 0000
C0 5 10 05 2 73 1 22 0 24 0 0012
C 9 5 55 02 4 90 2 23 24 70 0 0000
CIO 5 51 05 7. 16 3 20 16 20 0 OOOl
■- = € 7 - :--=-CB
^-44 M  - ' 7 53 
_£50. 14 =-dO 65 
^39 B5 - 14 36 
; 46- 90 r=9. 77
30 94 “—“T  95
Zn-binding to alpha2-M in Cu-deficient sheep plasma at level-II Zn
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No.of assays »S — —
MTB > TTEST Cl C2 C3 C4 C5 C6 C7 C0 C9 CIO 
“TEST OF MU - O O VS MU N. E 0 0
- N MEAN STDEV SE MEAN - i F--- P VALUE
“tl ------- 5 349 2 26 7 1 1 9 29 29 0 0000
-C2 —  — 5 456 5 42. 7 —19. r —  23 90 —  0. 0000
C3 ------ --- 5 974 7 59 1 ‘ “ 26 4 36 90 —  0 0000
T C4 5 3249 9 161 3 72. 1 45. 06 ---  0 0000
C5 —  5 027 6 67 6 30 3 27 3 6 --- 0 0000C6 5 710 0 23 3 “ 10 4 —  60 2B r— 0 0000
-C7 5 1882 5 00 1 —  39 4 47 79 ----0 0000
C0 — - 5 — 201 B “36. 0 " 16. 1 12.‘54 - 0 0002
C9 5 1110 6 36 3 16 2 ---60 90 ---0 0000





Plasma Zn concentrations of high-Cu sheep
£7: SOW Cl C2 C3 r - C4 “ J: C9 -~C6 - C7 ^:a
Week 0 1 - 2 3 4 5 ----6 7
 ^ _1 2. 979 1. 629 t. 900 1. 279 0 B79 1. 29 - .1. 790 1. 300
2 2 000 1. 479 1. 470 I. 090 0. 990 1. 99 1. 329 0. 990
3 2. 900 1. 679 1. 929 1. 109 1 000 1. 40 1. 179 1. 490
4 t. 790 1. 700 ~ 1. 379 1. 129 ' 0. 929 1. 69 1. 400 1. 690
L—  9 Cr 1. 700 1. 649 1. 479 I. 179 1. 079 1. 19 1 129 1. 979
r.Cio a Week 9 2 Cl '« WeeiR JD ■ 2r. . :ZL»,oo„ a; 29 1.30 1.20 j.oo . ^  I^wigh-Cu
MTB > tTEST Cl C2 C3 C4 C9 C6 C7 C8 C? CIO 09 k ClO = ClP-SUppl .
Cl
C2
0. 000 VS MU N. E. 0. 000 . _______  . _____  .
N MEAN STDEV SE MEAN ‘ T P VALUE
9 2 109 0. 412 0. 184 11. 43 0. 0003
9 1. 624 0 088 0. 039 41. 24 0. 0000
OK. MINITAB
C3 9 1. 469 0 097 0 029 97. 69 —  —  0. 0000
C4 9 I. 146 0. 089 0 038 30. 19 0. 0000
C9 y:. 9 0. 969 0 076 0. 034 -J 28 30 ^ S ~ 0 .  0000 v-“r
C6 9 1. 400 0 206 0 092 19 19 0. 0001 __
C7 9 I. 399 0 247 0 111 12 26 0. 0003
CB 9 1. 389 0 277 0 124 11. IS 0 0004
C9 9 1. 324 0 127 0 097 23 31 0 0000
CIO 9 1. 390 0 920 0. 232 9 81 0 0044
NO. Of 
sheep
Plasma Cu concoentration of high-Cu sheep
_.sow c 1 C2 C3 C 4 C 9 C6 _  C7 I C8 C9
.^ Week 0 1 - . 2 • " 3 4 - . i t 6 . : .7 8
1 0 825 3 65 1 825 1 15 1 425 1 10 __0 2 _ 0 100 0
-r=T .■2 0 800 3 50 1.750 1.39 I. 129 1. 10 0 2 0 000 0
3 0 650 2. 55 1. 650 0 90 0 950 0 80 0 2 0 100 0
£-~. * 4 '-=• 0 725 3 80 1.900 0 90 ■ 0 800 0 99 0 0 0 100 0
9 0 650 2.40 1 190 0.90 0 .690 _ 0 70 _  0 0 _ 0  129 0
"MTB > TTEST Cl C2 C3 C4 C9 C6 C7 C8 C9 CIO Cl = Week-0 —
C2-C8 - hieh-Cu
TEST OF MU - 0 0000 VS MU N E O OOOO C9 fc.1 Cio = cu-suppi.
N MEAN STDEV SE m ean T P VALUE
Cl 5 0 7300 0. 0818 0 0366 19 96 0 0000
C2 5 3 leOO 0 6544 0 2927 10 87 0 0004
C3 5 1. 6550 0 2971 0 1329 12 46 0 0002
C 4 5 1 04C0 0 2043 0 09 14 11 38 0 0003
C9 5 0 9900 0 3003 0 1343 7 37 0.0018
C6 5 0 9300 0 1789 0 0800 11 63 0 0003
C7 9 0 1200 0 1095 0 0490 2.45 0 070
C8 9 0 0850 0 0487 0 0218 3. 90 0 018
APPENDIX-IX
Zn-binding to alpha2-M In high-Cu sheep plasma at level-I Zn
^ig Zn BOUND/lOO /ig alphaZ-M
ROW Cl C2 C3 C4 C 3 C6 C7 C8 C 9
Week 0 1 2 3 4 5 6 7 R
1 19 07 3 36 10 43 19 00 27 38 39 33 41 92 19 82 29 33
2 33 03 6.80 13 72 IB 63 29. 43 38 63 40 80 " 23 96 24 33
3 44 66 4 90 8 63 23 32 26 84 43 22 43 46 21 33 33 63
4 38 43 7. 38 7. 33 16 77 24 37 36 39 47. 22 24 69 30 27
3 60 28 3 23 10 16 13. 86 27 66 39 71 36 78 16 72 28 83
CIO (Week 9) - .
73 11 80 26 67. 73 71 .43 68 34 - • -•
No. of assays - S
MTB > TTEST Cl C2 C3 C4 C3 C6 C7 CB C9 CIO
TEST OF MU - 0. 00 VS MU N. E 0 00
N MEAN STDEV SE MEAN T P VALUE
Cl 3 43 10 13 77 7 03 6 11 0 0036
C2 3 3 90 1 13 0 32 11 60 0. 0003
C3 3 10 33 3 23 1 44 7 31 0 0019
C4 3 19 30 3 71 1 66 11 62 0 0003
C5 3 27 18 I 76 0 79 34 39 0 0000
C6 3 39. 70 3. 23 1 46 27 28 0. 0000
C7 3 42 04 3 81 1 70 24 67 0 0000
CB 3 21 73 3 72 1 66 13 06 0 0002
C9 3 29 73 4 04 1 81 16 43 0 0001
CIO 3 72 66 3 11 2. 28 31 81 0 0000
Zn-binding to alpha2-M in high-Cu sheep plasma at level-1I Zn 
/Jg Zn BOUND/lOO /Jg alpha2-M
= r o w - j _ ~ C  i ~ _c2 _ c3 c4 - — - c ?---.— Cf, ~ ~  C7 - ± L r l .  cb
 __ I®®*--_5___ =  1. .... - 2 ________ 3  4 _ ____ 5________ 6 7
=^-.~l 8B3 46 "--436. 67 - 69.22 214 03 IL2B7_J?1::^_447l.44_^432- 44 126 52
2  774._68__502. 73__74.6?____175 BB 312 66 _ 468 39 _  439 AS*  1 4 9 _ U _
= ^ 3^ — 657 57 -^397.43 - 68 36 ^ 1 3 0 . 6 7  ~ 2 7 & _ 5 4  - :39B_6 5— = 521.75—  131. 70
4 _720. 82__442..3B__39_32___ 225-46 -253-39 . _..307_L3__ 476-77___109. 67._
— — s. r^69B 74 —  476. 73 .k.49. 83_ 1J.86. 43-^1=39isiXTJE^SS Bl ==416. 55 1 IB. 22
—  ffDM -~;r_-C9 CIO • ’ — — - — -----r—=--rr— - =  - ._
8 9
=  M — =1?+, 62 - 683 37 ‘ — ... .....■ -r
,2 172 44 720.28 No. of assays ■ 5
3 -"213. 79 630. 16 ..‘ll _ - z-- r-- - -r — ----— - .
____ 4 __ 230. 63 641. 33 ____________ _____
. 168 73 682 4 7 ____ --'
lllTB >.TTEST Cl C2 C3 C4 C3 C6 C7.CB C9 CIO .___I___ _ _ . _
TEST OF MU - 0. 0 VS MU N E. 0. 0 - - ..... - - - ......
___ __  N MEAN STDEV SE MEAN • T P VALUE
_ci _ s 688 7 72 7 32 3 ..21. IB 0 0000
C2 _ 3 435 2 . .39. 3 __ 17. 7 23 79 - .0 0000
_C3 3 63 3 9 4 4 2 13. 10 .. 0 0001
-CA 3 - - 190. 3 30. 0 -13 A 14 21 o oon 1
C3 3 204 7 21 0 9 4 30 36 0 0000
C6 3 431 3 40 1 17 9 23 17 0 0000
C7 3 461 4 40 1 10 0 23 71 0 0000
C8 3 127 I 14 9 6 7 19. 03 0 0000
C9 3 196 0 26 9 12 0 16 39 0 0001
CIO 3 673 6 31 3 14 0 40 30 0 0000
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a p p e n dIx-x
Effect of varying dietary Cu and Zn concentrations in 
the ratio 1:4 on Zn-binding to alpha2-M in the plasma 
of pregnant Dorset ewes maintained indoors 
Alpha2-M incubated with level-I Zn (150 ug)
ROW Cl C2 C3 ~ C4 r * C9 C6 . C7
Days 0 35 42 55 69 74 86
1 e. 90 149. 32 . 37. 72 .36. 30 _ 79. 09 60. 79 17. 07
. 2 19. 99 212.66 .108.99 43.99 .89.94 28. 90 - 3. 30
_ _ 3 29. 32 17B. 94 "L 79. 6B 91.29 163.72 _ 49. 66 IB. 69
4 12. 69 163. 72 69. 88 46. 26 71. 97 92. 78 29. 68
. 9 23. 40 172. 91 76. 49 44. 93 68. 49 98. 20 19. 29
MTB > TTEST Cl C2 C3 C4 C9 C6 C7 Days s Days on experi-
TEST OF MU - o. oo vs mu n. E. o. oo mental diet
ug Zn Bound/100 ug alpha2-M
N MEAN STDEV SE MEAN T P VALUE
Cl 9 17.97 7.01 3.14 9. 73 0. 0046
C2 9 174.71 24.73 11.06 19. BO 0.0001
CD 9 73.74 29.33 11.33 6. 91 0. 0029
C4 9 44. 39 9. 41 • 2. 42 18. 33 0. 0001
C9 9 72. 87 8. 22 3. 68 19. 82 0. 0000
C6 9 49. 98 12. 78 9- 71 8. 79 0. 0009
C7 9 16. 80 8. 23 3. 68 4. 97 0. 010
Alpha2-M incubated with level-II Zn (1500 ug)
ROW Cl C2 CD C4 C9 C6 C7
Days 0 35 42 55 - 69 74 86
1 267. 02 1189. 72 677. 19 639. 69 . 910. 43 404. 96 331. 04
2 333. 12 992. 18 607. 79 488. 67 - 907. 04 292. 20 198. 79
3 284. 69 1219. 39 728. 44 928. 29 842. 64 379. 99 . 227. 46
4 292. 79 1086. 96 621. 73 437. 76 819. 29 328. 72 . 202. 93
9 . 290. SB 897. 49 998. 86 490. 49 . 799. 66 416. 17 210. 07
MTB > TTEST Cl C2 C3 C4 C9 C6 C7 Days=Days on experimental diet
TEST OF MU ■ 0.0 VS tIU N.E. 0 0
ug Zn Bound/100 ug alpha2-M
N MEAN STDEV SE MEAN T P VALUE
Cl 9 289 6 30 4 13. 6 20. 98 0.0000
C2 9 1068. 3 140 9 63. 0 16. 96 0. 0001
CD 9 646 8 94 9 24. 9 26-; 36 0. 0000
C4 9 917. 0 79. 8 33. 9 19. 26 0. 0001
C9 9 894. 2 92. 9 23 9 36. 37 0. OOOO
C6 9 363. 6 92. 3 23. 4 19. 99 0 0001
C7 9 234 0 99. 3 24. 7 . 9. 46 0. 0007
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APPENDIX-XI
Effect of varying dietary Cu and Zn concentrations in 
the ratio 1:4 on Zn-binding to alpha2-M in the plasma 
of pregnant Clun ewes maintained indoors 
Alpha2-M incubated with level-I Zn (150 ug)
ROM Cl C2 C3 C4 C5 C6 C7
Days 0 14 21 35 40 48 62
1 37. 94 24. B1 23 69 26 90 7. 60 11 74 29 01
2 121.92 21.47 24.37 17 99 12 25 0 63 7 17
3 55. 00 23 17 26 72 21 35 9. 95 10 27 14 15
4 69. 75 27.91 22 54 19 B7 8 74 7. 55 B 93
5 64. B3 25.56 24 05 IB 66 11. 4B 9. 76 11 47
MTB > TTEST Cl C2 C3 C4 C5 C6 C7 Days=Days on experimental
TEST OF MU • 0 
N
diet
.0 VS MU N E 0 O
ug Zn Bound/100 ug alpha2-M *
MEAN STDEV SE MEAN T P VALUE
Cl 5 69. 9 31.5 14 1 4 96 0 0077
C2 5 24. 6 2 4 1 1 22 55 0 0000
C3 5 24 4 1 5 0. 7 35 34 0 0000
C4 5 21.0 3.6 1 6 13 16 0 0002
C5 5 10 0 1.9 0 9 11 71 0 0003
C6 5 9 6 1 6 0 7 13 43 0 0002
C7 5 14 I B 7 3. 9 3. 63 O 022
Alpha2-M incubated with level-II Zn (15CX) ug)
ROW CB C9 CIO
Days 0 14 21
1 723 05 349 07 409 71
2 363. 05 317. 95 402 72
3 412 74 356 22 421 76
4 563 67 402 55 305 63
5 39B. 30 376. 00 391 04
MTB :► TTEST CB C9 CIO Cll C 12 C 13
TEST OF MU » 0. 0 VS MU N E 0
ug Zn Bound/100
N MEAN STDEV
CB 5 492 2 150 2
C9 5 360 5 31 4
CIO 5 402. 3 14 3
Cl 1 5 405 2 12 6
C 12 5 120 5 16 B
C 13 5 160 B 15 2
C 14 5 313 B 36 9
35C"
C 12
40 48 C,:1 62 r 1i
416 04 104 91 152 99 0 ^
404 35 145 59 171 41 3'j 06
3BB 36 120 45 1 BO 30 *i»*rr »’ T"'1
4 1B 95 107 19 141 96 312 ~a
390 51 1 16 21 1 57 45 3n5 n~>
c m  Days=Days on experimental 
diet
ug alpha2-M
MEAN T P VALUE
67 2 7 33 0 0019
14 1 25 65 0 9009
6 4 62 79 0 0999
5 6 71 B8 0 099n
7 5 16 02 0 0991
6 B 23 67 0 0090
16 5 IB 99 0 0000
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APPENDIX-XII
Effect of varying dietary Cu and Zn concentrations in 
the ratio 1:4 on Zn-binding to alpha2-M In the plasma 
of pregnant Finn ewes maintained indoors 
Alpha2-M incubated with level-I Zn (150 ug)
^— ROW Cl ‘ C2 C3 - C4
Days 0 14 40 48
—  - 1 - 38. 93 9 77 24 23 : 2 27
-= ^ = rS 41. 22 9.14 18 47 _ 3.76
= - ' 3  -^24 76 -12. 03 22 68 11 88
—  4 — 20 33 —  7. 96 17. 39 _7. 30
^ ^ 3 ' ^ 3 1 . 4 3  10 87 20 35 ~ 9 66 =^9. ^  :
~ Htb > TTEST Cl C2 C3 C4 C3 Day s =Days cm experiment a l'-di et
-TEST OF MU - 0 00 vs nu n E 0 00 l.- .
.............. ug Zn Bound/100 ug a l p h a 2 - - M . , — . - ■
N MEAN STDEV SE MEAN " T P VALUE
Cl 3 31 38 8 88 3 97 - t 7. 90 --0. 0014
- C2 3 11 36 4 33 1. 93 3 94 0 0040
C3 3 20 66 2 79 1 23 16 36 - - 0 0001
C4 3 7 41 3 68 1 63 4 30 -0011
- C3 3 19 93 2 38 1. 13 17. 27 0 0001
-  20248 -  -  -  -  -  '
^ 1 6  09     ~
__r-23. 1 4 tt= — —  --- - - -  ._
Alpha2-M incubated with level-II Zn (1500 ug)
"4o“C9"4 !'-L^ 5S^ r--> f
 ^1- -402, 77 - 89.33 ! . 168 07 _I39 00-^184 3 4 ~ =  "==~=T^'-
=  z z l l l  *Z 103 22-_3 163 08 -^04.30 _ 463 70 ____
—  - 3 — 29? J3 —  81 9 * --154 67 - ^ 6 8  73 - ^ 2 0 2 . 3 3 ^ = ^ ^ = ^ '^ ^ j=0»2^76^. -^79 .23 -=83r-B7^_lZl^37 ~
I T . _ 9I 8; *2Z]171 91 1  35 Z 3 8 0 ^ ' b o £ T  £
I"78.* TTEST C6 C7 CB c9 C1° Days =Deys7 
TEST OF MU - 0.0 VS hU N E o.
- ug Zn Bound/100 u g ~ a l p h a 2 - M --- ~
-C6 - S 3:EAC SISEo 'SE MEAN ' T ~  P^ L U E
C7 5 93 3 J? ? 19 2 18 20 - r o 0001
— CB 9 7 l* 3 6 4 - 14 63 ~0 0001
—C9 - j  Bi" p • .-- 3.7 28. 77 - 0. 0000
-CIO 3 ,51 I !! ; - 0 i »0 14 -- 0 0005
  3 100 6 14 6 6.3 - 2 7 . 6 1 -  0.0000
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only 250 mg F e /k g . It appears therefore that the rats adapted in some way to the highest level of Fe 
supplementation, and this m ay explain why only m inor effects on Cu ava ilab ility  were observed previously 
when rats were given a diet w ith 1000 mg F c /k g  for I I  weeks (B rcm ncr &  Young, 1981).
Expt. 2.
Further evidence o f a rapid reduction in the apparent availab ility  of Cu in Fc-lrcatcd rats was obtained 
using the technique o f Price &  Chesters (1 9 8 5 ). In  this procedure the degree o f restoration in intestinal 
cytochrome oxidase activ ity  which occurs when Cu-deficient rats are repletcd w ith  Cu is used as a measure 
of Cu availability . W hen  cytochrom e oxidase activ ity  was calculated relative to that o f N A D H  cytochrome 
c reductase, values o f 0.83 ±  0.11 were obtained in the untreated Cu-dcficicnt rats, whereas those in rats 
repleted with 1 0 ^ g C u /d  and given 50, 250 or 500  mg F e /k g  diet were 1.70 ±  0 .12 , 1.26 ±  0.11 and 0.96 ±
0 .10  respectively. This indicates that the ava ilab ility  o f Cu was reduced by 50 and 85%  w ith in  only 4 days by 
dietary Fe contents of 250 and 500 m g /k g  respectively.
Fe is therefore a more potent antagonist o f C u metabolism than has hitherto  been suspected. The  
mechanism(s) whereby Fe has this effect is unknown but, in rats at least, would appear not to involve 
inhibition of intestinal Cu absorption (B rem ner &  Young. 1981). Anim als appear to adapt to continued 
intakes o f large amounts o f Fe and the effects o f C u  metabolism dim inish in intensity, w ith  resultant 
development of abnorm al dosc-response relationships.
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Effects of High Dietary Zinc on Copper Transport 
in Three Breeds of Housed Pregnant Sheep
W .H . P A R R Y , P .G .G . J A C K S O N ', S .R .R . R A O  and B.C. C O O K E "
Department of Science, Bristol Polytechnic. Coldharbour Lane, Bristol BSI6 1QY, ‘Depart­
ment of Clinical Veterinary Medicine, Madinglcy Road, Cambridge, “ Dalgcty Spillers, C lif­
ton, Bristol, U .K .
There is very little  evidence that a d ie tary  level o f Cu can be recommended for sheep under the stress of 
housing and pregnancy which lessens the risk o f Cu toxicity. Although evidence by Brem ner et al. (1976)  
indicated that increased d ie tary  Zn  in housed ewe lambs functioned as a metabolic antagonist, C am pbell &  
M ills  (1979) found that d ietary  Zn supplem entation in pregnant ewes resulted in symptoms o f Cu deficiency 
and Zn  toxicity. Such evidence would suggest that the ratio  of Zn:Cu could be more im portant than the 
absolute amounts.
This study set out to test whether differences could be observed in the plasma bound Cu and Z n  in three 
breeds o f housed pregnant sheep fed a Zn-supplcm cntcd diet.
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I .  E x p e rim e n ta l design and M e th o d s
Thirty-six pregnant ewes were allocated to three groups of different breeds - Dorset, Clun and Finn, each of 
twelve animals. They were housed in a polypcn (thick polythene sheeting draped over and fixed to a steel 
frame). Immediately before, and after the five month period of housing, all ewes were grazing on a 
neighbouring paddock. Lam ing  was completed in the polypcn.
Commercially available pelleted feedstuff, with Cu content varying from 20 mg up to 82 mg Cu/kg, 
was supplemented with Zn up to 352 mg Zn /kg ; an attempt was made to achieve a dietary ratio, Cu : Zn of 
1:4 throughout the period of housing. No deaths occurred during the period of housing.
I I .  R esults  and D iscussion
The plasma Cu and Zn concentrations in Dorset ewes were more variable than in either Clun or Finn breeds, 
and also responded more raptdly to dietary changes in concentration of these metals. The immediate effect 
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Fig I -4 E lu tio n  p rofiles o f  Cu and Zn concentration in fra c tio n s  o f  p lasm a pro te in  separated on Sephadex G~75 colum n  
15 x 90 cm eq u ilib ra ted  and eluted * i t h  0 01 M  T r is -H C I buffer. p H  8 6. conta in ing 0 02%  sod ium  azide  30 ml of 
plasma was applied on the column and a lotal of 120 fractions, 13.5 ml each, were collected at a flow rale of 60 m l/h  
Protein bound Cu was found in two protein peaks : peak I of molecular weight >  100.000, and peak 2, approx 45.000 
Fig I Dorset ewes on Day-0, fir*t day in the poly pen Fig 2 Dorset ewes after 21 days of housing Figs. 3 and 4. Clun and 
Finn ewes respectively on Day-0
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and Clun ewes than before housing; in contrast this stress cfTcct o f housing was not observed in Finn ewes 
which showed no significant increase in plasma Cu.
Fractionation o f plasma proteins from Dorset ewes showed that the bound C u in Peak I representing a 
mean 0.061 g. atom  C u per mole a fte r 21 d o f housing (F ig . 2) was significantly higher (P c O .O I) than the 
bound copper, mean 0 .030g  atom  C u per mole, in this peak at D ay -0 , Fig. I .  The bound copper at 21 d 
decreased very significantly ( P < 0 . 0 0 1) by 48 d. This  indicated antagonism o f Zn  to Cu decreasing the 
transport o f Cu to liver and thus showed the protective efTcct o f a Zn-supplcm cnted diet for intensive rearing  
of Dorset lambs threatened w ith  toxicity.
The mean C u  bound to Peak I on D ay -0  in Finn ewes, 0 .033  g atom C u per mole, was significantly  
lower (P c O .O O l) than mean bound Cu. 0.048g atom Cu per mole, in C lun ewes on D ay-0  (Figs. 4 and 3 
respectively). T he  pregnant Finn ewes were the least affected by the stress of housing on plasma bound Cu.
Table I Mean plasma Cu and Zn concentration in Dorset. Clun and Finn sheep
Days Dorset Clun Finn
Cu Zn Cu Zn Cu Zn
pg/ml pg/ml pg'ml pg/ml pg'ml pg/ml
0 2.31 ±0 .13 1.0010.07 1.4310.08 0.6610.01 1.1410.16 0.9810.05
4 1.5810. 10* ** 1.0010.06
14 1.1710.06** 0 .8610 .03 *** 0.91 ±0.18 0.6010 .04***
21 1.2910 .07*** 0 .6610.55* • •
27 1.1510.04** 0.K4 ± 0.03* * * 0.7810.11 0.8610.04
35 1.5510.0V*** 0 .8210.05
48 1.1210 .07*** 0 .7210.03* •
8X 1.4310.08 1.1010.02*** 1.2110.07 1.1510.04*
105 1.6210 .07*** 1.1810.03
• If "V A c .05 **  = P<0..01 PcO.OOl
The results suggest that the three breeds differed considerably w ith  regard to the Cu bound to Peak I 
and thus the efficiency o f C u  homeostasis, whilst depending on dietary ratios o f Zn  : Cu influencing the 
plasma protein (m o l. w t. > 1 0 0 ,0 0 0 )  binding capacity for C u , m ight d iffer between breeds. Evidence by 
W iener el al.  (1 9 7 8 ) and later W oolliam s el al.  (1 9 8 2 ), and van dcr Berg el al.  (1 9 8 3 ), suggest that Cu  
metabolism m ay d iffer between breeds. It is reasonable therefore to speculate that Cu could be transported 
to livers in d ifferent breeds at speeds which arc dependent on com petitive plasma protein binding o f Z n  and 
Cu.
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Abstract 50
IN VITnO ZINC UINDINQ TO PLASMA ALPHA 2-MACnOOLODULIN IN SHEEP FED COPPER 
DEFICIENT AND COPPER EXCESS DIETS
S.R.R.IIAO AND W.II,PAnnY,Faculty of Science,Bristol Polytechnic,Frenchay,
Drlstol,BS16 1QY., U.K.
Zino bound to alpha 2-macroglobulin (alpha 2-M) aooounta for naarly 30 to <10 percent
pf the total plasma sino.In thia atudy Cu dofloient dlot (<1,0 my Cu/Ug and 60 mr
Jp/kg diet) and Cu exoesa diet (250 mg Cu/kg and 200 mg Zn/ltg diet) were fed to
(jheep for a period of 7 weeks.Dlood samples wero obtained and alpha 2-M from
plasma was separated using lmmunoadsorbent chromatography.Zn binding to alpha 2-M 
'was studied at two levels of zino:level 1,150 fig Znjlevel 11,1500 fig Zn.In Cu 
defloient sheep alpha 2-M lnoubated with both levels of Zn showed slgnifioantly 
'(P< O.OOl) lncreasod Zn binding over the first 4 weeks.At Zn lovel II (1500 fig Zn), 
the lncreasod Zn binding was maintained ovur tho entlro 0 wooks,whilst nt Zn lovol.
I (150 /ig Zn) this incroasod Zn binding to alpha 2-M was subso<|iiontly lost after 
an initial* period of 4 weeks,Thus confirming tho existence of different binding 
sites on alpha 2-M and highlighting the importance of the concentration of zinc in 
Cu deficient animals.'llieso results also confirm the antagonisms botwoon copper and 
zina.
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